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Abstract 
Genome maintenance and stability are essential goals for all the organisms in order 
to transfer the correct genetic information to the progeny and to keep fully 
functional the cellular metabolism. In eukaryotic cells, the presence of DNA lesions 
causes the activation of an evolutionary conserved mechanism called the DNA 
damage checkpoint that arrests the cell cycle and stimulates the repair pathways. 
Double strand breaks (DSBs) are deleterious lesions that can be a serious threat for 
the cell. In fact, the formation of only one DSB is enough to activate a robust 
checkpoint response. This DNA lesion is processed by several factors leading to the 
checkpoint factors recruitment and to the homologous recombination repair. After 
lesion repair the checkpoint is switched off through a process called recovery; 
however it has been demonstrated that damaged cells are able to inactivate the 
checkpoint and restart the cell cycle also in the presence of a persistent DNA lesion, 
through a checkpoint adaptation process. The reason why this process occurs is not 
understood, but it has been related to the unrestrained proliferation of cancer cell. In 
my laboratory we are interested in shedding light on the molecular mechanism of 
these checkpoint inactivation processes and in the characterization of the involved 
factors. 
During the PhD I focused on the characterization of the functions and regulation of 
some factors already known to play a role in DSB ends processing and checkpoint 
switch off: the polo kinase Cdc5, the DNA translocase Tid1/Rdh54 and the 
nuclease-associated protein Sae2. 
First of all we found that high levels of Cdc5 lead to checkpoint switch off and cell 
cycle re-enter. Relying on this data we decide to perform a biochemical screening 
in order to identify the Cdc5 targets in presence of DNA damage. This biochemical 
screening was based on a GST pulldown approach, coupled with tandem mass 
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spectrometry protein identification. As expected, we identify many interactors and 
among them we found the repair protein Sae2. Interestingly, we found that in 
presence of elevated levels of Cdc5, Sae2 is hyperphospholylated and binds 
strongly to the DSB ends. In order to understand the functional role of the Cdc5-
Sae2 interaction, I mutagenized different putative Cdc5 binding sites in Sae2. It 
turned out that Cdc5 binds a C-terminal region of Sae2, which is conserved in other 
eukaryotes orthologs. 
The obtained Sae2 mutants give us interesting results that can be useful for the 
proper comprehension of the Sae2 function in DNA damage response. Indeed in 
this thesis I will present preliminary results on the characterization of the Sae2 role 
in the recovery process. 
I was also involved in a project with the aim to study the regulation of Tid1/Rdh54 
in the presence of DSB. Tid1 belongs to the Swi2/Snf2 family of chromatin 
remodellers, is an ATP-dependent DNA translocase able to induce DNA structure 
remodelling, Rad51 removal from double strand DNA and promote D-loop 
formation during homologous recombination. Moreover this protein has also a 
puzzling function in checkpoint inactivation during adaptation since TID1 deletion 
causes a permanent G2/M block in the presence of one irreparable DSB. I found 
that Mec1 and Rad53 checkpoint kinases, through a process that requires also the 
recombination factor Rad51, phosphorylate Tid1 in the presence of DSBs. I also 
found that Tid1 is recruited on to the DSB site, and that its ATPase activity is 
dispensable both for the loading and the phosphorylation of the protein. We believe 
that Tid1 phosphorylation is important to stabilize the binding of the protein on the 
lesion and to regulate its functional role during checkpoint adaptation. 
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State of the Art 
 
The DNA is a stable molecule but it may suffer different kind of damages caused 
by endogenous or exogenous agents. First of all the aqueous cell environment is 
essential to give the correct structure to DNA but, paradoxically, causes 
spontaneous hydrolysis of the molecule. These hydrolytic damages are 
deamination, that causes misappropriate base coupling, or depurination, that create 
an abasic site (Lindahl, 1993). The DNA replication, chromosomes segregation and 
cellular metabolism are other sources of endogenous genome instability. During 
cell lifespan DNA must be duplicated and divided between the two daughter cells. 
DNA replication can causes wrong base insertions, short DNA deletions or 
insertions (McCulloch & Kunkel, 2008) while replicative fork progression in zones 
containing particular DNA structures, transcribed genes or DNA binding proteins 
may lead to fork collapse and generation of recombinogenic intermediates, 
prerequisite of chromosomal rearrangements (Branzei & Foiani, 2010). After 
genome duplication cell divides, but errors in the chromosomes alignment on the 
metaphase plate lead to chromosomes missegregation and aneuploidy (Tanaka & 
Hirota, 2009). In addition also the cellular energetic metabolism synthetizes many 
dangerous side products like reactive oxygen or nitrogen species. These compounds 
attack the DNA molecule producing a variety of different DNA lesions like base 
and sugar modification, DNA intra-strand crosslinks and single or double strand 
breaks (SSBs or DSBs, respectively) (Dizdaroglu, 2012). Finally also exogenous 
physical or chemicals agents cause DNA damage. Examples of physical agent are 
ionizing radiations (IR) and ultraviolet light (UV), IR is mainly involved in the 
formation of SSBs and DSBs but creates also oxidative stress, while UV light 
induces 6-4 photoproducts or thymidine dimers. Many chemical agents cause a 
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plethora of DNA lesions: alkylating agents like methyl methanesulfonate (MMS) 
attack alkyl groups to DNA bases; crosslinking agents such as cisplatin, mitomycin 
C and psoralen link DNA strands together; topoisomerases inhibitors (camptothecin 
and etoposide) induce SSB or DSB formation; other cancer causing chemicals are 
those produced by smoking or contained in contaminated foods, an example of 
these dangerous compounds are aflatoxins (Ciccia & Elledge, 2010; Wogan et al., 
2004). 
All this DNA damages can lead to genome instability that is a serious threat for all 
the organisms and a hallmark of cancer cells, thereafter to preserve genome 
integrity, organisms evolved different molecular mechanisms that are able to 
recognize the lesions and activate the correct cellular response. 
 
The DNA Damage Response (DDR) 
During evolution, organisms develop an intricate system to cope with DNA lesions; 
this mechanism has been called DNA Damage Response (DDR). The DDR 
functions are essentially two: slow down the cell cycle progression and activate the 
proper repair pathway. However, in the case of large amount of irreparable DNA 
lesions, DDR induces apoptosis or senescence, leading to cell death. The 
fundamental cellular function of the DDR is highlighted by the fact that depletion 
and mutation of its components strongly increase cell sensitivity to DNA damage; 
moreover it is frequently deregulated in tumors and in several genetic diseases 
characterized by genetic instability (Ciccia & Elledge, 2010). 
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The DNA repair systems 
 
According to the type of DNA lesion and the enzymes involved, the repair pathway 
is sub-divided in 5 main categories: direct damage reversal, base excision repair, 
nucleotide excision repair, mismatch repair and the double strand break repair. 
Below I will present the DNA double strand break repair system because it is the 
objective of my thesis. 
 
The Double Strand Break Repair pathways 
 
DNA double strand breaks (DSBs) are considered the most dangerous DNA lesion 
that can occurs. In fact, if not immediately repaired, DSBs may cause chromosomes 
rearrangements like translocations, chromosome arm loss and amplification, all 
typical features of cancer cells. DSBs can be created not only by exogenous source 
like ionizing radiations or chemical compounds, but also by fork collapse during 
replication, meiotic recombination and V(D)J rearrangements in the 
immunoglobulins genes. The cell has two different repair systems to cope with 
DSBs: Non Homologous End Joining (NHEJ) and Homologous Recombination 
(HR). These systems share different components and the choice between them is 
strongly regulated by the cell cycle phase and DNA structures. In fact NHEJ occurs 
mainly in the G1 phase of the cell cycle, while HR occurs in G2/M phases, when the 
donor sequence is available on the homologous chromosome. 
The nucleolytic degradation of the 5’ DSB end is at the basis of the molecular 
switch between NHEJ and HR. This process is called DSB ends resection and 
leaves a 3’ DNA tail that mediates homologous sequence searching and annealing 
(Symington & Gautier, 2011). 
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Non Homologous Ends Joining (NHEJ) 
NHEJ is a repair mechanism that acts rejoining the two DSB ends. The core 
proteins of the system are: the Ku heterodimer (Ku70 and Ku80), DNA ligase 
4/Dnl4, XRCC4/Lif1, Nej1 (protein present only in yeast) and the MRN/X complex 
(formed by the Mre11, Rad50 and Nbs1/Xrs2 proteins) (Daley et al., 2005). After 
the formation of a DSB, the Ku complex and the MRN/X complex bind the DSB 
ends through an independent mechanism (Wu et al., 2008). The Ku complex acts as 
a barrier against exonucleases activity and protects DSB ends, whereas the MRN/X 
complex keeps the DSB ends in close proximity and, through the Mre11 nuclease 
activity, can remove some bases from the DSB ends when it is necessary in order to 
promote a correct end joining. This alternative NHEJ pathway is called 
microhomology-mediated end joining (MMEJ) and requires the nuclease activity of 
Mre11 and the CtIP/Sae2 protein. The nucleolytic process is not required in the 
presence of compatible ends formed by a 5’-Phosphate or a 3’-OH (McVey & Lee, 
2008). Then, Ku complex and MRX recruit Dnl4 and Lif1, respectively. This two 
proteins form the DNA ligase 4 heterodimer (Palmbos et al., 2008). In yeast, Nej1 
binds independently to the Ku complex and keeps the Ligase 4-Ku complex stable 
(Chen & Tomkinson, 2011). At this point DSB ligation occurs. It is important to 
observe that NHEJ is not an error free mechanism, in fact, errors in the annealing 
reaction can lead to deletion of few nucleotides and, moreover, NHEJ is responsible 
of chromosomes rearrangements like DSB-telomere fusions or chromosomes 
translocations (Myung et al., 2001). 
 
Homologous Recombination (HR) 
Homologous recombination is a process that allow DSB repair using another DNA 
homologous sequence as a template. The template is also called donor sequence. 
For the correct functionality of the HR machinery many factors are required and 
many of them are part of the Rad52 epistasis group. Different models and 
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mechanisms of HR repair have been proposed (see Figure 1 for a scheme): Single 
strand annealing (SSA), Synthesis dependent strand annealing (SDSA), double 
Holliday junction sub-pathway (dHJ) and break induced replication (BIR) (Heyer et 
al., 2010).  
 
	  
Figure 1: DSB repair mechanisms (from Heyer et al., 2010) 
 
Whatever HR sub-pathways the cell use to repair, the starting event is the DSB 
ends resection. In order to avoid the unscheduled degradation of the single stranded 
DNA filament, the RPA heterotrimeric complex covers the 3’ end tail. At this point, 
if a homolog sequence is found nearby the lesion, the repair can occurs by SSA. If 
this is not the case, RPA is substituted by Rad51 protein, leading to the formation 
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of a nucleoprotein recombinogenic filament required for the strand invasion 
process, homologous sequence recognition, pairing, and the HR process can 
proceed through the other pathways (Heyer et al., 2010). 
 
Single Strand Annealing (SSA) 
This system is preferentially used to repair a DSB arose between two direct repeats, 
which is a very common situation in higher eukaryotes, such as mammals, whose 
genomes contain a large amount of frequently repeated sequences. The presence of 
a donor sequence nearby the lesion lead to a direct reannealing reaction dependent 
only on the Rad52 protein (Ivanov et al., 1996), then specific flap endonuclease 
complex, formed by Slx4 and Rad1-Rad10, removes non-homologous flanking 
regions (Flott et al., 2007), and the gaps are filled by DNA repair synthesis (see 
Figure 1). This process causes the loss of the region between the direct repeats, 
leading to a genomic deletion as big as the distance between the two homologs 
sequences. SSA is the only HR repair pathway that doesn’t require the Rad51 
protein because strand invasion doesn’t take place. 
 
Synthesis dependent strand annealing and the dHJ subpathways  
After resection and the formation of the Rad51 nucleoprotein filament, the 3’ tail 
can invade the donor sequence. This step, which is also called strand invasion, 
requires several factors and mediates the formation of a DNA intermediate 
commonly named D-loop. The DNA helicase Srs2 can remove Rad51 from the 
nucleoprotein filament, counteracting the strand invasion, while two 
ATPases/translocases, Rad54 and Rdh54/Tid1, stimulate the D-loop formation and 
stabilization. After the stabilization of the D-loop, DNA polymerases are recruited 
and extend the 3’ filament using the homolog strand as a template. At this point, 
according to the HR sub-pathways used, DSB repair will give different outcome. If 
the invading tail, after the elongation step, is displaced from the homolog and 
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annealed with the other complementary end tail, the resulting gap can be filled, 
leading to DSB repair without crossover events. This sub-pathway is called SDSA, 
and it is responsible for gene conversion events that occur in mitotic cells. The 
situation is more complicated if also the second end is captured, leading to the 
formation of a double Holliday Junction intermediate (dHJ). Indeed, the jointed 
DNA filaments require to be cut to complete the recombination process, and to 
allow chromosomes segregation. 
There are multiple enzymes that can cut the cruciform structures at the dHJs, and 
they work through two distinct mechanisms. The first is called dissolution, and is 
mediated by the helicase/topoisomerase Sgs1-Top3-Rmi1 complex, leading to non-
crossovers events (Bernstein et al., 2010).  Alternatively, if the HJs are kept far 
away each other, specific nucleases, called resolvases, including Slx4-Slx1 
(Andersen et al. 2009; Fekairi et al., 2009; Munoz et al., 2009; Saito et al., 2009; 
Svendsen et al., 2009), Mus81-Mms4 (Kaliraman et al., 2001) and Yen1 (Ip et al., 
2008), cut single strand filaments, leading to both crossovers and non-crossovers 
events. Therefore from random dHJ resolution it is expected an equal number of 
crossovers and non-crossovers products (See Figure 1). This DSB-induced 
recombination process is particularly relevant in meiotic cell cycle to promote 
genetic variation. 
 
Break Induced Replication 
Sometimes it is possible that only one end of the DSB is able to anneal with a 
homologous sequence; in this case a replication fork is assembled and the repair 
synthesis can go till the end of the chromosome through a process called BIR. It has 
been implicated in replication restart after fork collapse at telomeres, and can 
mediate telomere elongation when telomerase is not functional or telomere capping 
is lost. It is important to note that if only one end of a DSB is engaged in a BIR 
process, the other chromosome region is lost, resulting in loss of heterozygosis 
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(LOH), and relevant phenotypes can arise (Llorente et al., 2008). In a study made in 
Haber’s lab it has been shown that BIR requires only a 72 bp homology (Bosco & 
Haber, 1998); this short homologies requirement makes BIR prone to introduce 
chromosomes aberration. Because of this, it is believed that BIR is a backup 
system, used only when all the others DSB repair pathways fail (Malkova et al., 
2005). 
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The DSB Ends Processing 
 
Ends resection is a fundamental step in order to repair a DSB through HR 
pathways. The 5’ end degradation is a nucleolytic process in which multiple factors 
are involved. Among them the MRN/X complex, CtIP/Sae2, Exo1 and Dna2 
nucleases (Mimitou & Symington, 2009) are the main players but also other factors, 
such as helicases and chromatin remodelers are required. For example the 
Bloom/Sgs1 helicase (Mimitou & Symington, 2008; Zhu et al., 2008; Gravel et al., 
2008) and the chromatin remodelers like the RSC complex (Shim et al., 2007) and 
SMARCAD1/Fun30 (Chen et al., 2012; Costelloe et al., 2012; Eapen et al., 2012). 
As mentioned above, the MRN/X complex and the Ku heterodimer are the first 
factors loaded on the DSB ends. Although both complexes protect DSB ends and 
are involved in NHEJ, the MRN/X complex plays an additional role in starting 
DSB ends resection through the endonuclease and 5’-to-3’ exonuclease activities of 
the Mre11 subunit.  
Both in yeast and man, it has been shown that the DSB resection is a finely 
regulated process. This is not surprising, if we consider that the initiation of the 
DSB resection is a fundamental step to channel a DSB into HR. 
Initially, it was shown that CDK1 kinase activity promotes the DSB resection (Ira 
et al., 2004; Aylon et al., 2004), maybe counteracting a Ku-dependent inhibitory 
step (Clerici et al., 2008; Mimitou et al., 2010; Shim et al., 2010). Then, it has been 
demonstrated that CDK1 targets the MRN/X-associated factors CtIP/Sae2. 
 In G2/M phase, CtIP/Sae2 is phosphorylated by CDK1 in a residue present in the 
evolutionary conserved C-terminal part of the protein, serine 267 in S. cerevisiae 
and threonine 847 in human. This phosphorylation primes DSB ends processing. 
Indeed, alanine substitution of the corresponding S267 or T847 causes severe DSB 
resection and repair defects (Sartori et al., 2007; Huertas et al., 2008; Huertas & 
Jackson, 2009). The effective role of CtIP/Sae2 in starting resection has not been 
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fully understood so far, the more promising hypothesis is that CtIP/Sae2 stimulates 
the MRN/X complex activity towards particular DNA structures but also, in a 
recent publication, it has been found that in yeast Sae2 has also an endonucleolytic 
activity in vitro. This can suggest a possible role of Sae2 in the DNA processing but 
at the moment no in vivo nuclease activity has been found and the human CtIP has 
no nuclease activity at all (Lengsfeld et al., 2007). 
It’s important to note that in presence of DSBs induced by an endonuclease like HO 
or I-Sce1 (that leaves clean ends) the nucleolytic activity of the MRN/X complex is 
not essential (Clerici et al., 2005; Llorente & Symington, 2004), whereas in 
presence of DSB end produced by IR or other drugs that create particular DNA 
structures (hairpins or proteins covalently bound to the DSB ends), the catalytic 
activity of the complex becomes determinant (Lobachev et al., 2002; Deng et al., 
2005). In agreement with all these data, Neale and colleagues (Garcia et al., 2011), 
proposed a bidirectional model for DSB resection, based on their recent studies on 
meiotic DSB processing in yeast. In meiosis the MRX complex, together with Sae2, 
is essential; in fact, by an endonucleolytic cut, it mediates the removal of the 
specific endonuclease Spo11 from the DSB ends in order to allow meiotic 
recombination. MRX complex binds and introduces a nick at 300 nucleotides away 
from the 5’ strand DSB ends. Then the MRX complex resects the break heading to 
the DSB ends in order to remove all the possible obstacles present at the DSB ends. 
This causes the removal of Spo11 from the ends and allows to all the other DSB 
resection factors to process the lesion (Garcia et al., 2011). 
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Figure 2: Model of the DSB resection initiation from Garcia et al., 2011 
 
Therefore, the MRN/X complex is important for the resection early step and other 
nucleases and factors would be required to produce longer ssDNA tracts. A number 
of works have recently clarified this aspect. The two key factors for processive 
resection are the 5’-to-3’ exonuclease Exo1 and the endonuclease Dna2 that acts 
together with the helicase Sgs1. In fact it has been demonstrated that a yeast strain 
carrying EXO1 and SGS1 or DNA2 deletions accumulates only short ssDNA tracts 
of about 100-700 nucleotides (Mimitou & Symington 2008; Zhu et al., 2008; 
Gravel et al., 2008). These short tails are not enough to permit optimal homologous 
recombination events. In fact, normally, mitotic recombination requires a ssDNA 
tail length between 2 and 4 kb (Chung et al., 2010). 
The Sgs1 helicase belongs to the RecQ family of 3’-to-5’ DNA helicases and forms 
a complex with Top3 and Rmi1. This complex is very well conserved in human, 
where the Bloom helicase interacts with Top3α, Rmi1 and Rmi2. This complex 
processes the double Holliday Junction (dHJ) through the dissolution pathway 
(Heyer et al., 2010), but it is also necessary for the Sgs1 function in DSB resection. 
In this case the Top3 catalytic activity is not required, suggesting that the complex 
has only a structural function during resection (Niu et al., 2010). As mentioned 
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above, Dna2 is the BLM/Sgs1 partner in the resection process. Dna2 protein has a 
flap endonuclease activity that cuts the 5’ DNA filament unwounded by BLM/Sgs1. 
Recently, it has been shown that CDK1 phosphorylates Dna2, mediating its loading 
on to the DSB lesion and its checkpoint-dependent phosphorylation. Considering 
that CDK1 phosphorylates also Sae2 factor (see above), it is believed that CDK1 
plays a central role in the regulation of the DSB resection, influencing the process 
throughout the cell cycle (Chen et al., 2011). 
 
	  
Figure 3: Schematic representation of DSB repair in the different phases of the cell cycle, and of the dual steps 
resection process (from Mimitou & Symington, 2009) 
 
DSB resection, as well as all other DNA metabolic processes, occurs within the 
context of chromatin. It is not surprising, therefore, that cells evolved a complex 
network of post-translational histone modifications and ATP-dependent chromatin 
  18 
remodeling reactions to modulate chromatin structure and its accessibility with each 
step of DNA repair (reviewed in Van Attikum & Gasser, 2009; Soria et al., 2012; 
Seeber et al., 2013), following an “access-repair-restore” model (Smerdon, 1991). 
So far, three factors have been involved in DSB resection. 
i) RSC (Remodels the Structure of Chromatin) is an ATP-dependent chromatin 
remodeler of the SWI/SNF-family, and it is necessary for the establishment of a 
normal nucleosome pattern in unperturbed conditions, suggesting that at least a 
small amount of RSC is constitutively present onto the chromatin (Kent et al., 
2007). On the other hand, different subunits of the RSC complex are recruited at 
HO-induced DSB sites a few minutes after HO induction, suggesting a role in the 
early step of DSBR (Chai et al., 2005; Shim et al., 2005). It was later shown that 
RSC is required for nucleosome repositioning around the HO-induced break site, 
after break induction, suggesting that RSC might open the chromatin to the DSBR 
machinery (Kent et al., 2007; Shim et al., 2007).  Indeed, ChIP analysis 
demonstrated that Mre11 and Ku70 recruitment to DSB are reduced in rsc mutants, 
as are ssDNA formation and loading of RPA. These findings indicate that loss of 
RSC activity likely leads to a resection defect. (Liang et al., 2007; Kent et al., 2007; 
Shim et al., 2007). 
ii) Ino80 is a Swr1-like ATP dependent chromatin remodeler composed by 15 
subunits in budding yeast, seven of which are conserved also in human INO80 
(Chambers & Downs, 2012). Similarly to rsc mutants, ino80 mutants accumulate 
less ssDNA compared to a wild type, consistently with a mild defect in resection 
(Van Attikum et al., 2004; van Attikum et al., 2007; Morrison et al., 2007), 
probably linked to a reduction in MRX loading at the break observed in this mutant 
(Van Attikum et al., 2007). How Ino80 modulates the recruitment of end resection 
machinery is still unknown, however, it has been proposed that, by catalyzing 
nucleosome sliding or histone exchange, it may increase accessibility to the break 
(Shen et al., 2003; Udugama et al., 2011; Papamichos-Chronakis et al., 2011). 
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Ino80 involvement in DSB processing seems to be conserved among eukaryotes. 
Indeed, in human cells, after ionizing radiation treatment, hINO80 localizes to 
damaged chromatin, and it is required for the homology-directed repair of a I-SceI 
induced break (Gospodinov et al., 2011). 
iii) Fun30/SMARCAD1 is an ATP-dependent chromatin remodeler belonging to 
the Etl1 Snf2 family.  As other family members, Fun30 binds nucleosomes and, 
thanks to its ATPase activity, facilitates the exchange of H2A-H2B dimers and the 
sliding of nucleosomes in vitro (Awad et al., 2010). The ATP-dependent chromatin 
remodeling activity is required in vivo to establish gene silencing in 
heterochromatic regions such as the HMR locus, rDNA repeats and telomeres 
(Neves-Costa et al., 2009), and for the formation of correct architecture at 
centromeres (Durand-Dubief et al., 2012). In the last year, three independent groups 
reported a role for Fun30 in resection of DNA ends. Deletion of Fun30 mildly 
affects nucleolytic processing in the close proximity of an HO-cut site, whereas it 
strongly impairs resection further from the break, suggesting an involvement of this 
protein in the control of long-range resection (Chen et al., 2012; Costelloe et al., 
2012; Eapen et al., 2012). Consistently with a role in DSB processing, Fun30 is 
recruited to DSB sites and spreads along the chromatin in both directions, similarly 
to the DNA resection machinery. Moreover, epistasis analysis revealed that Fun30 
promotes both Exo1- and Sgs1/Dna2- dependent resection pathways (Chen et al., 
2012; Costelloe et al., 2012; Eapen et al., 2012). This would be consistent with the 
observation that in fun30Δ mutants Exo1 and Dna2 are recruited at the DSB site, 
but fail to spread along the chromatin. Fun30 seems to stimulate long-range 
resection by removing the barrier represented by nucleosome-bound Rad9 (see 
below for the discussion on the barrier). 
Similarly, the human counterpart of Fun30, SMARCAD1, is recruited to laser- and 
FokI-induced DSBs, and its downregulation affects DSB ends processing, reducing 
the formation of RPA foci as well as of ssDNA. In agreement with a resection 
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defect, SMARCAD1 knockdown cells are defective in recombinational repair 
(Costelloe et al., 2012). 
Moreover, recent data showed that the checkpoint factor 53BP1/Rad9 plays and 
additional role in regulating DSB ends resection. In yeast, the Rad9 loading on the 
break slow down resection speed, in fact deletion of RAD9 causes an increase in 
ssDNA tracts length that is not dependent on Exo1 (Lazzaro et al., 2008). Also in 
human 53BP1 depletion causes an increase in resection rate that is fundamental to 
stimulate HR instead of NHEJ (Bunting et al., 2010), this phenotype is made 
together with Rif1, a protein also involved in telomeres homeostasis (Zimmerman 
et al., 2013; Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Diaz et al., 
2013).  
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The Checkpoints 
 
The genome integrity and the ability to transfer it correctly at the offspring is an 
essential goal for the cell. For this purpose the cell cycle progression is carefully 
controlled by different surveillance mechanisms called checkpoints. 
This control mechanisms act in specific cell cycle phases checking that all the cell 
cycle events happen in the correct order and, in case of errors, they are able to slow 
down or even stop cell cycle progression, therefore activating the proper repair 
system. Different types of checkpoints exist, for example a morphogenetic 
checkpoint is activated in case of cell’s shape problem (Lew, 2003), and a mitotic 
checkpoint, called Spindle Checkpoint, is activated in case of mitotic spindle 
assembly errors (Lara-Gonzalez et al., 2012).  Accordingly with the aims of my 
projects, I will speak only about the DNA damage checkpoint. 
In higher eukaryotes the alteration of this mechanisms lead to an increased genome 
instability that can be correlated with an increased risk of tumorigenesis (Nyberg et 
al., 2002). 
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The DNA Damage Checkpoint 
 
Activation of the DNA damage checkpoint 
In the presence of DNA lesions such as DSBs, the cell activates a surveillance 
mechanism, called the DNA damage checkpoint. Depending on the cell cycle phase 
in which the lesion occurs, three distinct DNA damage checkpoints can be induced: 
the G1/S phase checkpoint blocks cell cycle before replication starts, the intra S 
phase checkpoint works during replication and the G2/M phase checkpoint prevents 
chromosomes segregation, blocking cell cycle at the metaphase/anaphase transition 
(Branzei & Foiani, 2008). 
By using the HO nuclease-based system in yeast (Sandell & Zakian, 1993; Moore 
& Haber, 1996), many details of the cellular response to DSB have been 
understood. First of all, it was shown that a single DSB is enough to trigger 
checkpoint activation, blocking the cell cycle progression in G2/M (Sandell & 
Zakian, 1993). 
Moreover, it turned out that the checkpoint proteins are very well conserved from 
yeast to mammals (see a list of factors in table 1), thus suggesting Saccharomyces 
cerevisiae as an ideal system to study genetic and biochemical details of the 
checkpoint mechanisms. 
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Table 1: Homologous recombination and DNA damage checkpoint factors (from Mimitou & Symington, 2009) 
 
 
The upstream factors required for checkpoint activation are the two evolutionary 
conserved proteins kinases ATR/Mec1 and ATM/Tel1. In fact, the DNA damage 
checkpoint is a signal transduction cascade, based on phosphorylation events, and 
requires the activity of other protein kinases. 
Generally speaking, we distinguish different classes of checkpoint factors: i) the 
DNA damage sensors, ii) the signal transducers and iii) the effector kinases that 
phosphorylate multiple targets (Table 1) (Harrison & Haber, 2006). 
Supporting evidence in all the organisms correlates the formation of a ssDNA 
intermediate, covered by RPA, with the checkpoint activation. Indeed, it was shown 
that the upstream checkpoint kinases have been recruited on to DNA lesion through 
two distinct mechanisms. ATM/Tel1 arrives on the break through MRN/X complex 
binding, in particular through Nbs1/Xrs2 recruitment (Nakada et al., 2003; Falck et 
al., 2005), whereas the other kinase ATR/Mec1 recruitment requires different 
factors and a ssDNA-RPA structure. In different studies has been demonstrated that 
the main factor involved in ATR/Mec1 activation is the checkpoint factor 
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ATRIP/Ddc2 (Paciotti et al., 2001; Melo et al., 2001; Zou & Elledge, 2003) but, 
depending on the cell cycle phase and the nature of the DNA damage, other factors 
like TopBP1/Dpb11 (Puddu et al., 2008; Navadgi-Patil & Burgers, 2008; Mordes et 
al., 2008a; Mordes et al., 2008b), the 9-1-1 complex (Majka et al., 2006a) and the 
Dna2 nuclease (Kumar & Burgers, 2013) are involved. 
Both the yeast protein Ddc2 and the corresponding human ATRIP bind tightly the 
catalytic subunit, Mec1 or ATR respectively, forming a protein dimer essential to 
interact with the ssDNA covered by RPA. 
The ATR/Mec1 activation is dependent upon an additional complex of checkpoint 
factors. This complex is formed by Rad9/Rad17, Hus1/Mec3 and Rad1/Ddc1 
proteins and shares structural homology with the PCNA complex; in fact it is also 
called PCNA-like complex (Kondo et al., 1999). The 9-1-1 is recruited on the 
lesion immediately after its formation in a Mec1 independent manner (Kondo et al., 
2001), while it is dependent on the Rad24 protein together with the Rfc 2-5 proteins 
(Majka & Burgers, 2003), and the ssDNA-RPA structure (Majka et al., 2006b). The 
role of this complex in the ATR/Mec1 activation is dependent on the cell cycle 
phase. In G1 the complex is necessary and sufficient for the ATR/Mec1 activation, 
while in S and G2/M phases the activation requires also TopBP1/Dpb11. The 
TopBP1/Dpb11 protein strongly stimulates the ATR/Mec1 activity together with 
the 9-1-1 complex (Puddu et al., 2008; Mordes et al., 2008a), in fact in yeast it has 
been demonstrated that Dpb11 coordinates a ternary complex formed by the 9-1-1 
complex, Mec1 and Rad9, this complex is essential for the correct phosphorylation 
of Rad9 by Mec1 and the consequent checkpoint activation (Pfander & Diffley, 
2011). 
Recently, it has been demonstrated that also the endonuclease Dna2 is involved in 
the ATR/Mec1 activation, but its requirement is restricted only to the intra-S phase 
checkpoint and its role in the mechanism is not completely understood  (Kumar & 
Burgers, 2013). 
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Figure 4: Model of the DNA damage checkpoint activation (from Symington & Gautier, 2010) 
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After the upstream kinases activation, the DNA damage signal transduction to the 
checkpoint targets occurs. Among the many factors that are targeted by the apical 
kinases, the two well conserved Chk1 and Chk2/Rad53 kinases are activated and, in 
turn, phosphorylate several proteins, triggering an intricate regulatory network. This 
transduction cascade rapidly amplifies and propagates the DNA damage signal.  
In yeast the main role of Chk1 is the stabilization of the securin Pds1 (Wang et al., 
2001). The Pds1 stabilization is essential to prevent the separase Esp1 activation, 
avoiding cohesins cleavage and chromosomes segregation (Ciosk et al., 1998). Also 
Chk2/Rad53 is able to block cell cycle progression, but through a completely 
different mechanism. Rad53 phosphorylates the Anaphase Promoting Complex 
(APC) regulatory subunit Cdc20, causing the inhibition of the complex (Agarwal et 
al., 2003). The APCCdc20 is the ubiquitin ligase that degrade Pds1, therefore the 
checkpoint blocks the Pds1 degradation acting on two different mechanisms: 
directly, through Chk1 phosphorylation of Pds1, and, indirectly, through Rad53 
phosphorylation of Cdc20. 
In yeast, the two effectors kinases are activated by Mec1 or Tel1 through an 
activation mechanism that requires the contribution of other proteins called 
adaptors, Rad9 and Mrc1 (Vialard et al., 1998; Alcasabas et al., 2001). Rad9, is a 
protein of 150kDa containing different functional domains: two Breast Cancer C-
Terminal (BRCT) domains that are required for the protein-protein interaction, a 
SCT domain rich in SQ/TQ clusters and a TUDOR domain that is able to bind 
directly the DNA (Lancelot et al., 2007). The SCT domain is phosphorylated by the 
apical kinases; and its mutation or deletion causes the inability to activate Rad53; in 
fact Rad53 has a phosphothreonine-binding FHA domain that binds the SCT 
domain of Rad9, mediating the Rad53 oligomerization (Sweeney et al., 2005). This 
process allows the full activation of Rad53 by in trans autophosphorylation 
(Pellicioli et al., 1999), at this point the Rad53 oligomers are disassembled and 
Rad53 is able to phosphorylate its targets (Ma et al., 2006). The Mec1-dependent 
  27 
Rad9 SCT domain phosphorylation induces also the interaction between a Rad9 
protein with the BRCT domain of another Rad9 molecule, inducing the formation 
of homo-oligomers. It was shown that the Rad9 oligomerization is essential for the 
maintenance of the checkpoint response but not for its activation, in fact Rad9 
mutant variants defective in protein oligomerization are able to activate the 
checkpoint, but at a certain moment the checkpoint signal decays (Usui et al., 
2009). 
Interestingly, different studies in both human and yeast have demonstrated that 
Rad9 and its human counterpart 53BP1 are loaded on to a DSB through the binding 
to the phosphorylated serine 129 on the histone H2A and the methylated lysine 79 
on the histone H3, made by Mec1 and the methyltransferase Dot1 respectively 
(Giannattasio et al., 2005; Wysocki et al., 2005; Toh et al., 2006; Hammet et al., 
2007). 
Furthermore, Smolka and colleagues showed that in presence of replication stress 
the Slx4-Rtt107 scaffold protein is recruited near the stalled replication forks and 
counteracts the Rad9 binding. This phenomenon leads to Rad53 signal damping and 
avoids a too much prolonged checkpoint block (Ohouo et al., 2013). 
 
DNA damage checkpoint switch off and cell cycle restart 
The DNA damage checkpoint inactivation is an essential process required to restart 
the cell cycle after DNA damage. Two genetically distinct finely regulated 
mechanisms are responsible for the cell cycle restart. They are called checkpoint 
recovery and adaptation. After successful repair cell cycle restarts through 
checkpoint recovery, however it has been demonstrated that also in presence of an 
irreparable DNA lesion cells are able to switch off the checkpoint and divide 
despite the damage still remains; this process is called checkpoint adaptation 
(Clemenson & Marsolier-Kergoat, 2009). Interestingly, this process occurs not only 
in unicellular organisms like yeast (Sandell & Zakian, 1993), where it can be 
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considered as an extreme attempt to survive, but it has been shown also in Xenopus 
laevis and human cells (Yoo et al., 2004; Syljuasen et al., 2006). In this case, the 
functional role of checkpoint adaptation is unclear; in fact on one hand it can be 
related to unrestrained proliferation, which is a main feature of cancer cells, but it 
may be also induced by cells in order to undergo a mitotic catastrophe and 
apoptosis, in the presence of high levels of unrepaired DNA lesions (Syljuasen, 
2007). In yeast, checkpoint adaptation has been studied mainly in the presence of a 
single DSB induced by the endonuclease HO that activates the G2/M phase 
checkpoint (Sandell & Zakian, 1993; Toczyski et al., 1997; Lee et al., 1998; 
Pellicioli et al., 2001); however in other organisms adaptation occurs in the 
presence of unrepaired DSBs induced by IR (Syljuasen et al., 2006), and following 
replication stress induced by aphidicolin (Yoo et al., 2004). 
Different studies, mainly in yeast, have been made in order to identify the factors 
involved in these processes. From this analysis emerge that the key factors in both 
the checkpoint shutdown systems are phosphatases. In fact, since the checkpoint is 
a kinases-based signaling cascade, it was expected that dephosphorylation events 
would be involved to signal switch off. In yeast PP2C phosphatases Ptc2 and Ptc3 
are involved in Rad53 dephosphorylation during checkpoint deactivation both 
through recovery and adaptation, whereas a PP2A like phosphatase, Pph3, 
dephosphorylates the serine 129 on the histone H2A during checkpoint recovery. It 
is not understood why Pph3 is not involved in checkpoint adaptation too (Heideker 
et al., 2007). 
However, additional factors, such as different kinases and repair proteins, are 
required to mediate the checkpoint recovery and adaptation processes. Among 
them, the DSB end binding factor Ku, the resection-involved factors Sgs1, MRX 
and Sae2, the chromatin remodelers Fun30, Tid1/Rdh54 and Ino80, the helicase 
Srs2, the recombination proteins Rad52 and Rad51, the polo-kinase Cdc5 and the 
casein kinase 2 (CKII) (Toczyski et al., 1997; Lee et al., 1998; Lee et al., 2001; 
  29 
Vaze et al., 2002; Lee et al., 2003; Clerici et al., 2006; Papamichos-Chronakis et al., 
2006; Eapen et al., 2012). 
Interestingly, it is noticed that factors involved in the DSB resection, (the Ku 
complex, MRX complex, Sae2, Sgs1, Ino80 and Fun30) are also important to 
checkpoint switch off (Lee et al., 1998; Clerici et al., 2006; Papamichos-Chronakis 
et al., 2006; Eapen et al., 2012). The reasons why these proteins are implicated is 
not understood, although it was suggested that a fine regulation of the formation of 
the ssDNA covered by RPA is a fundamental step to get a proper checkpoint switch 
on and off. 
Other works underline a possible role of Rad51 in modulating the checkpoint 
inactivation process. For instance, it turned out that the DNA helicase Srs2, which 
is involved to dismantle Rad51 from ssDNA (see the discussion on HR above), 
promotes both checkpoint recovery and adaptation. One possibility is that, in the 
absence of Srs2, Rad51 could remain bound to the filament, even after the repair 
process, keeping the checkpoint signal active (Vaze et al., 2002: Yeung & 
Durocher, 2011). Interestingly, mutations of TID1/RDH54 gene, which codify for a 
DNA translocase involved in Rad51 removal from dsDNA cause a severe defect in 
checkpoint adaptation (Lee et al., 2001). I will discuss more details of this pathway 
in the main results section, as it was an issue of my PhD projects. 
Finally also two kinases are important regulators of checkpoint inactivation: the 
Casein Kinase 2 (CK2) and the polo kinase Cdc5 (Toczyski et al., 1997). CKII 
phosphorylates and activates PP2C phosphatases, thus mediating both checkpoint 
recovery and adaptation (Guillemain et al., 2007). On the contrary, the involvement 
of Cdc5 is still not understood, although the corresponding factors in human cells 
(PLK1), has been implicated in checkpoint switch off (Smits et al., 2000; Macurek 
et al., 2008; Van Vugt et al., 2010), supporting the notion that polo kinases are 
central players of the checkpoint inactivation mechanism (Bahassi, 2011). 
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During my PhD, I will be involved in a project to further characterize Cdc5 role in 
cells responding to DNA damage (see Main Results section 1, 2 and 4). 
In the following chapter I will briefly summarize the regulation and functions of the 
polo kinase Cdc5 and its pathways. 
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The Polo Kinase Cdc5 
 
Polo Kinases are fundamental regulators of the cell cycle in almost all the 
eukaryotes, in fact, all of them, excluding plants, have at least one polo related 
kinase (Golsteyn et al., 1996). In budding yeast the CDC5 gene was identified as a 
fundamental cell cycle player in the pioneering work of L. Harwell (Harwell, 
1970). These proteins contain a N-terminal Ser/Thr kinase domain and a C-terminal 
characteristic polo box domain (PBD). This domain is specific for this class of 
kinases and it is required for their particular functions and cellular localization (Lee 
et al., 2005). In mammals cells 5 different polo kinases were found (Plk1, Plk2, 
Plk3, Plk4 and Plk5), whereas in S. cerevisiae and S. pombe only a polo kinase 
homolog is present, named Cdc5 and Plo1 respectively (de Carcer et al., 2011). A 
study performed in human cell lines reveals that Plk1 localized at the centrosome 
and at the kinetochore in late S phase, remaining at this structure till the 
metaphase/anaphase transition (see in figure 5); in yeast Cdc5 is closely related to 
Plk1, in fact starts to localize at the spindle pole bodies (SPBs) in G1 and at the ring 
shaped structure that divides the mother and the daughter cells (bud neck) during 
the G2/M phases. 
 	  
Figure 5: Localization of Plk1 during mitosis. Upper panel: Immunofluorescence of Plk1 (green) in HeLa cells 
during the main mitotic phases. Lower panel: staining of DNA (blue), kinetochores (purple) and α-tubulin (red) 
(From Strebhardt, 2010). 
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Mutagenesis experiments and crystallographic studies on the PBD structure were 
performed in order to understand the function of this domain. It was understood that 
the PBD is formed by two homodomains called polobox 1 and polobox 2, both 
necessary for the interaction with the substrates (Elia et al., 2003). Moreover this 
domain is able to bind specifically consensus sequences containing a serine or 
threonine that was previously phosphorylated by CDKs or MAPK (Elia et al., 
2003), although in the last few years it has been demonstrated that this particular 
consensus motif is not always necessary in budding yeast (Chen & Weinreich, 
2010). 
CDK1 is not only involved in the polobox substrates recognition, but it is also 
necessary for Cdc5 activation. In fact CDK1 phosphorylates the threonine 242 
located in the kinase domain of Cdc5, this causes the activation of the protein 
during the G2/M phase of the cell cycle, exactly when the polo kinases are essential 
for the orchestration of the mitotic events (Mortensen et al., 2005). This residue is 
extremely conserved, suggesting a possible common activator mechanism in all 
PLKs. In fact, in human cells the phosphorylation of the corresponding residue 
T210 by the Aurora kinase is essential for the DNA damage checkpoint inactivation 
and recovery (Smits et al., 2000; Macurek et al., 2008). 
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Figure 6: Two different models of PBD mediated substrate targeting. In the processive phosphorylation model 
the PLKs bind a protein for subsequent direct phosphorylation, while in the distributive phosphorylation model 
the PLKs bind to a protein and phosphorylate another nearby protein.  
 
Thus, in yeast CDK1 is important to activate the polo kinase, which in turn, through 
a feedback loop, is required to keep active CDK1. Indeed Cdc5 phosphorylates 
Swe1, a CDK1 inhibitor, leading to Swe1 polyubiquitination and degradation by 
the APC complex and full activation of the CDK (Lee et al., 2005). During an 
unperturbed cell cycle, Cdc5 phosphorylates several targets. Among these factors, 
the cohesin subunit Scc1 is one of the most relevant. This event promotes the 
cohesins ring opening and, as a consequence, the chromosomes segregation 
(Alexandru et al., 2000).  Moreover, Cdc5 is an activator of the Mitotic Exit 
Network (MEN), which promotes the release of the Cdc14 phosphatase from the 
nucleolus in order to dephosphorylate the CDK1-dependent targets at the latest 
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stage of the mitosis (Segal, 2011). Accordingly to all these evidences, Cdc5 is 
considered a master regulator of the mitosis. Furthermore, recent findings revealed 
a functional role for PLKs in cells responding to different types of DNA damage 
(Bahassi, 2011). As mentioned above, in yeast Cdc5 is involved in the checkpoint 
adaptation process, which is a role described for PLK1 in other eukaryotes too. In 
particular, in human and X. laevis during the recovery from DNA damage, PLK1 
targets the checkpoint adaptor proteins Claspin and 53BP1, functional ortholog of 
Mrc1 and Rad9. During recovery from the intra-S phase checkpoint, induced by the 
replication stress agent aphidicolin, Claspin is phosphorylated by PLK1, this event 
causes Claspin removal from chromatin in Xenopus; in human cells, the PLK1-
dependent phosphorylation of Claspin leads to its degradation, Chk1 inactivation 
and cell cycle restart (Mailand et al., 2006; Peschiaroli et al., 2006; Yoo et al., 
2004). In G2/M phase, PLK1 binds 53BP1 and in trans phosphorylates Chk2, 
causing its inactivation and checkpoint signaling switch off (Van Vugt et al., 2010).  
  35 
 
  
  36 
Aim of the Project 
 
Genome maintenance and stability are essential goals for all the organisms in order 
to transfer the correct genetic information to the progeny and to keep fully 
functional the cellular metabolism. In eukaryotic cells, the presence of DNA lesions 
causes the activation of an evolutionary conserved mechanism called the DNA 
damage checkpoint that arrests the cell cycle and stimulates the repair pathways. 
This control mechanism is organized as a signal transduction cascade that 
progressively activates different kinases that phosphorylate many downstream 
targets. After lesion repair the checkpoint is switched off through a process called 
recovery; however it has been demonstrated that after a prolonged checkpoint 
response, damaged cells are able to inactivate the checkpoint and restart the cell 
cycle despite the presence of dangerous DNA lesion, through a checkpoint 
adaptation process. The reason why this process occurs is not understood, but it has 
been related to the unrestrained proliferation of cancer cell. Therefore, it is expected 
that further comprehension of the mechanisms leading to checkpoint switch off will 
provide important information to identify novel targets for cancer therapy. 
During the PhD I focused my attention on the characterization of the functions and 
regulation of some factors already known to play a role in DSB ends processing and 
checkpoint switch off: the Polo kinase Cdc5, the DNA translocase Tid1/Rdh54 and 
the nuclease-associated protein Sae2. 
The Polo kinases are involved in the regulation of the checkpoint switch off and the 
cell cycle re-enter after DNA damage in different organisms. Moreover, it has been 
shown that the human Polo-like kinase Plk1 is overexpressed in many tumours and 
is essential for tumour growth, as well for normal cells. In fact an increasing number 
of chemotherapeutic compounds that target PLK1 are in clinical trial. 
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Despite PLKs are subjected to extensive studies; their role and targets regulated 
during the checkpoint switch off are not completely characterized. Thus, taking 
advantages of the simple yeast model system we decided to investigate the role of 
the yeast polo kinase Cdc5 in the checkpoint inactivation process.  In order to 
identify the Polo kinase target in DNA damage condition, I performed a biochemical 
screen using the PBD domain as bait. As expected, I identified several factors, 
including Sae2, which is an important player involved in the checkpoint response. 
Sae2 is required for the DSB end processing and in the checkpoint inactivation by 
recovery or adaptation. The role of Sae2 in the checkpoint switch off is unclear, thus 
we expect to get novel information on this mechanism by the studying of the Cdc5-
Sae2 crosstalk. Moreover, we believe that these finding will shed light on the 
checkpoint mechanism that regulates genome stability and protect from cancer. 
Checkpoint adaptation also requires the Tid1/Rdh54 factor. This protein belongs to 
the Swi2/Snf2 family of chromatin remodellers and it has been involved in different 
processes related to homologous recombination. Although several phenotypes 
related to DSBs have been described for tid1 mutant cells, the regulation of the 
corresponding protein has been poorly studied. Thus, in our laboratory we started a 
project with the aim to characterize the in vivo regulation of Tid1 protein in cells 
responding to DSBs. We found that the Tid1 protein is a novel target of the DNA 
damage checkpoint, which is also involved in the checkpoint adaptation. 
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Main Results, Conclusion and Future 
Perspectives 
 
 
 
1. Elevated Levels of the Polo Kinase Cdc5 Override the Mec1/ATR 
Checkpoint in Budding Yeast by Acting at Different Steps of the 
Signaling Pathway (Donnianni et al., 2010) 
 
In this work, we took advantage of the yeast model organism to study the DSB-
induced checkpoint when the polo kinase Cdc5 is overexpressed. Indeed, it was 
known that the polo kinase Plk1 is frequently overexpressed in cancer cells 
(Strebhardt & Ullrich, 2006), while Plk1 silencing by siRNA causes a fast apoptosis 
induction in different cancer cell lines. Thus, starting from this intriguing finding, 
we were interested to investigate how the Plk1 overexpression promotes the tumour 
cells growth. In previous works made in yeast, it has been shown that a Mec1 and 
Rad53-dependent phosphorylation inhibit Cdc5 in order to stop the cell cycle 
progression in the presence of DNA damage (Cheng et al., 1998; Sanchez et al., 
1999; Zhang et al., 2009). Moreover, a point mutation in CDC5 gene was 
responsible of a permanent G2/M cell cycle block in the presence of one irreparable 
DSB, and to a defect in switching off Rad53 kinase (Toczyski et al., 1997; Pellicioli 
et al., 2001). All these data prompts us to hypothesize that Cdc5 overexpression may 
cause a checkpoint bypass in presence of DNA damages. In fact we found that high 
levels of Cdc5 activity remove the block of the cell cycle after treatment with the 
alkylating agent MMS, and inhibit the activity of the Rad53 kinase after treatment 
with zeocin, an agent that causes DSBs, in G2/M blocked cells (Donnianni et al., 
2010, Fig. 1). The same occurs also after the formation of a single DSB through the 
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expression of the HO nuclease under the galactose promoter (Donnianni et al., 2010, 
fig. 2). Therefore we concluded that the overexpression of Cdc5 activity is able to 
switch off both the replicative and the mitotic DNA damage checkpoint, blocking 
the Rad53 kinase activity. Then, to test if Cdc5 might act upstream Rad53 
activation, we decided to verify if also the Mec1-dependent in trans phosphorylation 
of Rad53 was abrogated. Using a specific kinase-dead allele of Rad53, which can be 
phosphorylated in trans by Mec1, but has lost the auto-phosphorylation activity, we 
found that also the Mec1 dependent phosphorylation of Rad53 is inhibited 
(Donnianni et al., 2010, fig.3). We analyse also the phosphorylation of the upstream 
checkpoint factors Ddc2 and Rad9, both depending on Mec1. As expected, the Ddc2 
and Rad9 phosphorylation were strongly reduced, confirming our hypothesis that 
Cdc5 acts upstream in the checkpoint signal transduction cascade. 
One possibility that we decide to investigate was that the overexpression of Cdc5 
might affect the DSB resection process, reducing the checkpoint activation. Indeed 
this was the case, as we found that the overexpression of Cdc5 lead to a mild 
resection defect, which is dependent on Rad9. However, we also noted that the 
effect on DSB resection is likely too low to be considered the only mechanism 
through which Cdc5 counteract the activation of the checkpoint response (Donnianni 
et al., 2010 fig. 4-5). We also excluded that Cdc5 might block the recruitment of 
checkpoint activator factors, in fact, by ChIP analysis we found that Ddc1, Dpb11, 
Ddc2 and Rad9 have been loaded at the same amount with or without Cdc5 
overexpression (Donnianni et al., 2010, fig. 6). Then, we surprisingly found that 
Sae2 loading near the DSB site increased when Cdc5 was overexpressed and, 
moreover, we also found that it was hyper-phosphorylated (Donnianni et al., 2010, 
fig. 7). As I discussed in the State of the Art section, Sae2 is phosphorylated by 
CDK1 in G2/M (Huertas et al., 2008), raising the possibility that Cdc5, through its 
PBD domain, binds CDK1-dependent phosphorylated sites in Sae2. Indeed, we 
performed two hybrid and pulldown assays using the Cdc5 PBD domain as bait. 
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This domain is essential to target all the PLKs on the correct targets. Interestingly, 
the PBD interacts with the Sae2 protein in both the assays (Donnianni et al., 2010, 
fig.8), supporting the idea that Cdc5 binds and phosphorylates Sae2, regulating its 
binding activity to DSB sites. 
In conclusion in this paper we showed that: 1) elevated levels of Cdc5 cause the 
inhibition of the DNA damage checkpoint acting at an apical step of the signaling; 
2) Cdc5 overexpression affects the DSB end processing in a Rad9 dependent 
manner; 3) Cdc5 binds and likely phosphorylates Sae2 causing its accumulation on 
the break. 
Sae2 was already involved in checkpoint switch off after the formation of a DSB 
and, interestingly, also the Sae2 overexpression, counteracts the checkpoint response 
(Clerici et al., 2006), as we found for Cdc5. This raises the intriguing possibility that 
the overexpressed Cdc5 targets Sae2, leading to an increased loading of Sae2 on the 
break, and a faster checkpoint switch off. 
 
  
  42 
2. The RSC chromatin-remodeling complex influences mitotic exit 
and adaptation to the spindle assembly checkpoint by controlling 
the Cdc14 phosphatase (Rossio et al., 2010) 
 
A prerequisite to correct chromosomes segregation is the binding between the 
mitotic spindle and kinetochores. After this event has been established accurately, 
cohesins cleavage and sister chromatids separation can occur, promoting cell 
division. 
A surveillance mechanism, called the Spindle Assembly Checkpoint (SAC), 
monitors the correct sequence of these events. SAC is a well conserved pathway in 
all the eukaryotes. During the kinetochores-spindle attachment the mitotic 
checkpoint complex formed by Bub3, Mad2 and Mad3 inhibits the APC subunit 
Cdc20, arresting the cell cycle until all the kinetochores are properly attached to the 
mitotic spindle (Musacchio & Salmon, 2007). However it has been shown that cells 
do not arrest indefinitely in the presence of an active SAC. Indeed, after a prolong 
block, cells re-enter the cell cycle despite the presence of unattached kinetochores. 
This process is called SAC adaptation or mitotic slippage, and it has been linked 
with the ability of tumoral cells to survive to the treatment with chemotherapeutic 
compounds that affect the mitotic spindle stability like taxanes and vinca alkaloids 
(Rieder & Maiato, 2004). Different factors are required for this event and, 
collaborating with Dr. Piatti (CRBM, Montpellier, France) we showed that Cdc5 and 
the chromatin remodelled complex RSC have a role in the release of Cdc14 
phosphatase from the nucleolus, leading to SAC adaptation. In this work, my 
experimental contribution was the pulldown approach to show the physical Cdc5-
Rsc2 interaction, which was suggested by other genetic results previously obtained 
by Dr. Piatti laboratory. I found that the Cdc5 PBD domain interacts in vitro with 
the Rsc2 protein and, interestingly, the residues in the PBD domain responsible for 
the interaction with the target proteins through a canonical mechanism are 
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dispensable (Rossio et al., 2010, fig.9 panel B), suggesting that a priming 
phosphorylation of the Rsc2 protein is not required for the interaction The functional 
role of the Cdc5-Rsc2 interaction is still not understood, however it is tempting to 
speculate that it might influence the Cdc5 ability to regulate the Cdc14 release from 
the nucleolus. Further investigations are required to characterize the molecular 
mechanism and function of this novel pathway. 
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3. Tid1/Rdh54 translocase is phosphorylated through a Mec1- and 
Rad53-dependent manner in the presence of DSB lesions in budding 
yeast (Ferrari et al., 2013) 
 
Tid1/Rdh54 is a recombination factor, member of the Swi2-like family of chromatin 
remodellers. These proteins have dsDNA ATP dependent translocase activity and, 
moving along dsDNA filament, remodel nucleosome positioning and chromatin 
state, and might also affect chromatin around a DSB lesion. 
Moreover, these factors can supercoil and unwind DNA and promote D-loop 
formation and branch migration in homologous recombination processes (San 
Filippo et al., 2008). Different in vitro and in vivo data indicated that Tid1 
dissociates Rad51 recombinase from dsDNA, thus preventing the accumulation of 
toxic Rad51-DNA intermediates and also ensuring that a sufficient amount of Rad51 
will be available for DSB repair and recombination (Shah et al., 2010). Tid1 shares 
some molecular functions and mechanisms with the Swi2-like homologs Rad54 and 
Usl1. However, they likely have distinct functions, as indicated by the distinct 
phenotypes of the corresponding mutants (Shah et al., 2010). Tid1 plays major role 
in meiotic recombination, while it is involved in minor pathway in mitotic 
recombination, specifically in diploids (Shinohara et al., 1997; Klein, 1997). 
Interestingly, Tid1 has been involved in checkpoint adaptation from a G2/M arrest 
induced by an irreparable DSB (Lee et al., 2001). To further address the functional 
role of Tid1 in cells responding to DSB and in checkpoint adaptation, we tested 
whether Tid1 translocase activity is essential for the adaptation process and also if 
this protein is post-translationally regulated in the presence of DNA damages. We 
found that the Tid1 ATPase activity is required for the adaptation process; in fact the 
ATPase defective mutant tid1-K318R cells are not able to switch off the checkpoint 
after the formation of a single irreparable DSB (Ferrari et al., 2013, fig. 3). Then, by 
western blotting analysis we could not see any mobility shift of Tid1 protein during 
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a normal cell cycle or after treatment with drugs that activates the intra-S phase 
checkpoint but, strikingly, we are able to see a mobility shift of Tid1 when a single 
DSB is formed by the HO nuclease, or after treatment with zeocin and 4-NQO 
(Ferrari et al., 2013, fig. 1 and 3). This modification was completely reverted in vitro 
by phosphatase treatment, indicating that it is due to a phosphorylation event 
(Ferrari et al., 2013, fig. 1). 
Both the wild type and the ATPase defective protein showed the DSB-induced 
phosphorylation, even if the Tid1-K318R variant has a slightly higher mobility shift 
respect to the wild type protein (Ferrari et al., 2013, fig. 3). We hypothesized that the 
DSB-induced phosphorylation was made by the checkpoint kinases, since 
Tid1protein sequence has several putative Mec1/Tel1 and Rad53 phosphorylation 
motifs. In fact, we found that the DSB-induced Tid1 phosphorylation and hyper-
phosphorylation are affected in mec1 and rad53 mutants (Ferrari et al., 2013, fig. 1-
3), similarly to other factors such as Srs2, Rad51, Sae2, and Cdc5 involved in 
turning off Rad53 during checkpoint adaptation (Liberi et al., 2000; Flott et al., 
2011; Baroni et al., 2004; Cheng et al., 1998). 
Then, we found that the ATPase activity is dispensable for Tid1 loading near a DSB 
site and, interestingly, the Tid1-K318R variant accumulates on to the DSB to a 
greater extend (Ferrari et al., 2013, fig. 5). Thus it is possible to suggest that the 
ATPase defective variant remains blocked onto the lesion, and this event enables us 
to see more clearly a very transient Rad53 and Rad51-dependent phosphorylation of 
Tid1. We also found that the recruitment of Tid1 near the DSB site is strongly 
reduced in mec1 mutant cells (Ferrari et al., 2013, fig. 5), suggesting that the 
checkpoint-dependent phosphorylation might affect the binding of Tid1 to the DSB. 
The functional role of Tid1 onto the DSB lesion is still unclear, but we can 
hypothesize that it is involved in the regulation/removal of nucleosome or other 
proteins from the lesion, which might allow a correct DSB processing and 
checkpoint adaptation.	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4. A biochemical screening to identify novel Cdc5 interactors in 
DNA damage condition. 
 
In this part of the results, I’m presenting the work done during the last period of my 
Ph.D. In particular, the project on the DSB resection in sae2 mutant cells is very 
promising and hopefully it will be ready soon for a publication manuscript. 
 
4.1. The screening procedure 
It has been shown that the polo kinases are involved in checkpoint switch off in 
different organisms but the molecular mechanism and the factors involved are 
unknown. Cdc5 is the only polo kinase in S. cerevisiae, which is the model organism 
I used in my Ph.D. project. In order to identify novel Cdc5 interacting factors during 
DNA damage checkpoint response, I performed a biochemical screening by GST 
pulldown coupled with mass spectrometry to obtain the interactors identification. 
This kind of approach has already been used for the identification of the PLK1 and 
Cdc5 interactors in undamaged condition (Lowery et al., 2007; Snead et al., 2007). 
First of all I prepared a plasmid expressing just the Polobox domain of Cdc5 (PBD, 
aa 357 to 705), carrying one N-terminal GST tag and a small C-terminal 6XHis tag 
(GST-PBD-His) (Supplementary Figure 1). The chimeric protein was produced and 
purified from E. coli in two sequential steps. By the first step, the E. coli crude 
extract was passed through a Ni-NTA resin column, in order purify only the full 
length GST-PBD-His polypeptides, discarding the unwanted truncated forms of the 
protein. Then, the GST-PBD-6His proteins were eluted and passed through a second 
column containing a glutathione resin. This tandem purification system allowed the 
production of a nearly clean bait protein, which can be used in the pulldown 
experiments. To that purpose, I prepared yeast crude extracts from cells suffering 
DNA damage. In particular, in one case I collected cells after 6 hours of induction of 
the HO nuclease, which causes the formation of one irreparable DSB in the genetic 
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system I was using (Moore & Haber, 1996); in the second case I collected cells after 
12 hours from DSB formation, during the checkpoint adaptation process; in the third 
case I collected cells after 3 hours treatment with the alkylating agent MMS, which 
blocks DNA replication and activates the DNA damage checkpoint. In the three 
different treatments, Rad53 phosphorylation was monitored to test the activation of 
the DNA damage checkpoint (data not shown). 
The yeast crude extracts were incubated with the GST-PBD-6His resin, and then the 
resin was boiled and run on a SDS-PAGE gel in order to separate the proteins from 
the resin. At this point the gel was stained with the coomassie and gel slices 
containing putative interacting proteins were cut, processed and analysed by mass 
spectrometry in the Dr. Santocanale laboratory (Galway, National University of 
Ireland). See Supplementary Figure 2 for a scheme of the procedure. 
The mass spectrometer output was analysed with the online free software GPM 
(www.thegpm.org) in order to obtain the interactors identification; then a graphical 
representation of the interaction network was obtained for each experiments using 
the Cytoscape program (www.cytoscape.org) (Supplementary Figures 3, 4 and 5). 
As expected by previous genetic and biochemical findings (Snead et al., 2007), 
many proteins were found to interact with the Cdc5-PBD. These proteins are 
involved in cell cycle regulation, translation regulation, energetic metabolism and 
DNA damage response. The pulldown of some factors, including the cohesins 
complex, Dbf4, Cdc48 and Ivy1, already known to interact with Cdc5, validated the 
screening procedure. 
In the following table I’m listing the more promising interactors involved in DNA 
damage response, and in the lab we are planning to further characterize their roles. 
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Protein	   MW	  (KDa)	   Peptides	   Deletion	   DDR	   Function	  (from	  SGD	  database)	  
Gcn2	   190.1	   9	   Viable	   Si	   Protein	  kinase,	  phosphorylates	  the	  alpha-­‐subunit	  of	  translation	  initiation	  factor	  eIF2	  (Sui2p)	  in	  response	  to	  starvation;	  activated	  by	  uncharged	  tRNAs	  and	  the	  Gcn1p-­‐Gcn20p	  complex;	  contributes	  to	  DNA	  damage	  checkpoint	  control	  
Tom1	   374,2	   5	   Viable	   Si	   E3	  ubiquitin	  ligase	  of	  the	  hect-­‐domain	  class;	  has	  a	  role	  in	  mRNA	  export	  from	  the	  nucleus	  and	  may	  regulate	  transcriptional	  coactivators;	  involved	  in	  degradation	  of	  excess	  histones	  
Mms1	   161,2	   1	   Viable	   Si	   Subunit	  of	  an	  E3	  ubiquitin	  ligase	  complex	  involved	  in	  resolving	  replication	  intermediates	  or	  preventing	  the	  damage	  caused	  by	  blocked	  replication	  forks;	  regulates	  Ty1	  transposition;	  involved	  with	  Rtt101p	  in	  nonfunctional	  rRNA	  decay	  
Bre1	   80,7	   1	   Viable	   Si	   E3	  ubiquitin	  ligase,	  forms	  heterodimer	  with	  Rad6p	  to	  monoubiquinate	  histone	  H2B-­‐K123,	  which	  is	  required	  for	  the	  subsequent	  methylation	  of	  histone	  H3-­‐K4	  and	  H3-­‐K79;	  required	  for	  DSBR,	  transcription,	  silencing,	  and	  checkpoint	  control	  
Sae2	   40	   1	  	   Viable	   Si	   Endonuclease	  that	  processes	  hairpin	  DNA	  structures	  with	  the	  MRX	  complex;	  involved	  in	  meiotic	  and	  mitotic	  double-­‐strand	  break	  repair;	  phosphorylated	  in	  response	  to	  DNA	  damage	  and	  required	  for	  normal	  resistance	  to	  DNA-­‐damaging	  agents	  
Fyv6	   20	   1	   Viable	   Si	   Protein	  of	  unknown	  function,	  required	  for	  survival	  upon	  exposure	  to	  K1	  killer	  toxin;	  proposed	  to	  regulate	  double-­‐strand	  break	  repair	  via	  non-­‐homologous	  end-­‐joining	  
Sap190	   125	   4	   Viable	   	   Protein	  that	  forms	  a	  complex	  with	  the	  Sit4p	  protein	  phosphatase	  and	  is	  required	  for	  its	  function;	  member	  of	  a	  family	  of	  similar	  proteins	  including	  Sap4p,	  Sap155p,	  and	  Sap185p	  
Sap185	   121,3	   1	   Viable	   	   Protein	  that	  forms	  a	  complex	  with	  the	  Sit4p	  protein	  phosphatase	  and	  is	  required	  for	  its	  function;	  member	  of	  a	  family	  of	  similar	  proteins	  including	  Sap4p,	  Sap155p,	  and	  Sap190p	  
Sit4	   35,5	   1	   Viable	   	   Type	  2A-­‐related	  serine-­‐threonine	  phosphatase	  that	  functions	  in	  the	  G1/S	  transition	  of	  the	  mitotic	  cycle;	  cytoplasmic	  and	  nuclear	  protein	  that	  modulates	  functions	  mediated	  by	  Pkc1p	  including	  cell	  wall	  and	  actin	  cytoskeleton	  organization	  
 
 
Interestingly, in all the analysis the Gcn2 kinase was scored with the larger number 
of the peptides found, suggesting that it can be a relevant Cdc5 interactor. Gcn2 has 
been already involved in the response to alkylating agent MMS (Menacho-Marchez 
et al., 2007), and its human homolog hGcn2 has a role in apoptosis induction in 
tumoral cells after chemotherapeutic treatment (Peidis et al., 2010). For these 
reasons, in the lab we are validating the in vivo interaction between Cdc5 and the 
kinase Gcn2 with other methods (Two Hybrid, CoIP), and we are investigating the 
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role of this protein in checkpoint adaptation and recovery from DNA damage. 
However in this thesis I will focus my attention only on the pulldown factor Sae2, 
that is involved in DSB ends resection process (See the State of the Art section). 
 
4.2. Characterization of the Cdc5-Sae2 interaction 
I have already found by 2H and pulldown assays that Sae2 interacts with Cdc5, and 
that Sae2 is hyper-phosphorylated when Cdc5 is overexpressed (see the result 
section R.2 and the accompanying paper Donnianni et al., 2010). 
It is known that the PBD domain preferentially binds proteins previously 
phosphorylated by a priming kinase, which is often CDK1 (Elia et al., 2003). In 
particular, in the case of the Cdc5 PBD, the best consensus binding motif is a SSP, 
in which the second serine has been phosphorylated by CDK1. Interestingly, 
through the analysis of the Sae2 aminoacid sequence, we identified 3 putative CDK1 
sites that can be bind by Cdc5: serine 134, serine 179 and serine 267 (Donnianni et 
al., 2010, fig. 8). Among these sites, serine 267 is in the evolutionary conserved C-
terminal domain and it was already shown that the CDK1-mediated phosphorylation 
of this site primes Sae2 for the DSB resection (Huertas et al., 2008).  
To verify if these sites were involved in the Cdc5 binding, I mutagenized the 
corresponding sites by substituting each serine with alanine (an aminoacid that 
cannot be phosphorylated), in SAE2 gene cloned in to an integrative plasmid vector 
that I used to direct the gene replacement at the endogenous locus. I obtained the 
following mutant strains: sae2-S134A, sae2-S179A, sae2-S267A and the triple 
mutant called sae2-3Ala, in which all the three sites are mutagenized to alanine.  
First of all, I analyse the expression level and the phosphorylation state of the 
various protein variants by western blot after a SDS-PAGE (Supplementary Figure 
6). I produced the protein extracts from yeast cells grown in untreated condition, or 
treated with nocodazole, to block cell cycle in G2/M phase, or in the presence of one 
irreparable HO-cut. I found that the different protein variants are expressed more or 
  50 
less at the same level in the untreated conditions, while the wild type protein is 
phosphorylated in cells treated with nocodazole, and hyper-phosphorylated 
following DNA damage, according to previous data (Baroni et al., 2004). 
Interestingly, the mobility shift of the sae2-3Ala variant is severally impaired respect 
to the wild type protein, while the single protein variants do not show any clear 
differences. 
Then I tested if the same phosphorylation sites were involved in the interaction with 
Cdc5-PBD. To address this question, I performed a GST-pulldown assay using the 
same GST-PBD-6XHis column described above and crude protein extract prepared 
from sae2-3Ala mutant cells. I found that the Cdc5-PBD is able to bind normally the 
Sae2-3Ala protein variant (Supplementary Figure 7), suggesting that the Cdc5-Sae2 
interaction may follow unconventional role, as already described for other target 
proteins (Rahal & Amon, 2008; Rossio et al., 2010; Chen & Weinreich, 2011). 
Therefore, I decided to further investigate the Cdc5-Sae2 interaction and, in order to 
find the Sae2 region bound by the Cdc5-PBD, I prepared yeast strains expressing 
different truncated variants of Sae2 protein (Supplementary Figure 8). Then, I 
performed GST-pulldown experiments and I found that the region involved in the 
Cdc5-Sae2 interaction is probably localized at the C-terminal part of Sae2 
(Supplementary Figure 8). Unfortunately, I also noted that the Sae2-ΔC170 variant is 
a very instable protein, thus I am not confident on the obtained result. However, the 
finding that the Cdc5-PBD interacting region is in the evolutionary conserved C-
terminal domain of Sae2, suggests the intriguingly possibility that this interaction 
could be also conserved in other organisms, between PLK1 and CtIP. 
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4.3. The CDK1-mediated phosphorylation of Sae2 is required for checkpoint 
recovery 
 
As I discussed in the State of the Art section, a CDK1-mediated phosphorylation 
activates Sae2 in the DSB resection process (Huertas et al., 2008). Moreover, it has 
been published by Longhese laboratory that sae2Δ cells do not recover from a DSB, 
leading to a prolonged Rad53 activation (Clerici et al., 2005). 
I decided to test the possibility that the CDK1-mediated phosphorylation of Sae2 
may be involved not only in the early step of the DSB processing, but also in the 
checkpoint recovery. To this aim, I took advantage of the YMV80 genetic 
background (Vaze et al., 2002), in which the conditional expression of the HO 
endonuclease under the galactose promoter causes the formation of one DSB in a 
specific locus in chromosome III. It was shown that this DSB could be repaired 
through SSA or BIR process (Jain et al., 2009), as summarized in the following 
scheme (fig. 6). 
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Figure 6: Schematic representation of the DSB repair by SSA or BIR in the YMV80 strain (from Jain et al., 
2009).  
 
First of all, I analysed the viability of the sae2Δ cells in YMV80 background, in 
plates containing raffinose or galactose. I also tested the contribution of the Rad51-
dependent BIR pathway analysing double mutant sae2Δ rad51Δ. According to 
previous finding (Clerici et al., 2005), I found sae2Δ cells do not completely recover 
from a single DSB, moreover the viability of the double mutant sae2Δ rad51Δ cells 
is almost completely abolished (Supplementary Figure 9), supporting the hypothesis 
that the residual cell viability observed in the single sae2Δ mutant is likely due to 
BIR-mediated repair. 
Then I introduced the various sae2 mutations described above in the YMV80 
background, and I tested cells viability on plates containing galactose or raffinose. I 
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found that the sae2-3Ala mutant cells show a reduced viability following DSB 
formation (galactose plate), mirroring the phenotype already observed in sae2Δ 
cells. Interestingly, I also found that while the sae2-S179A cells are able to grow as 
the wild type, the single sae2-S134A and sae2-S267A mutations show a mild 
sensitivity to the DSB, I also tested sae2-S134A-S267A double mutant, and I found 
that it had the same phenotype of the sae2-3Ala and the sae2Δ strains. Thus, I 
concluded that the CDK1-mediated phosphorylation of both the S134 and the S267 
sites are required for the Sae2 function in DSB repair and checkpoint recovery 
(Supplementary Figure 10, panel A). 
Then, to further characterize the functional role of the CDK1-dependent Sae2 
phosphorylation, I checked the cells viability of the various sae2 mutants in 
camptothecin (CPT). This drug is an alkaloid compound that blocks the 
topoisomerase 1 in a protein-DNA toxic complex, leading to the formation of an 
intermediate normally converted in to a DSB during replication. Sae2 has already 
been shown to be required to remove the DNA-Top1 adduct and promote DSB 
repair, and sae2Δ cells are sensible to CPT treatments (Deng et al., 2005).  I found 
that the sae2-3Ala and the sae2-S134A-S267A double mutant showed the same 
sensibility to CPT as the sae2Δ, while the sae2-S134A and the sae2-S267A showed 
a minor sensitivity (Supplementary Figure 10, panel B). 
 
4.4. DSB-related defects of sae2 mutants are suppressed by the deletion of RAD9 
gene 
Few years ago, in our laboratory we discovered a functional role of the checkpoint 
factor Rad9 in controlling DSB resection. In particular, it was showed that Rad9 
counteracts the DSB processing, likely acting as resection barrier (Lazzaro et al., 
2008). I also found that the deletion of RAD9 gene rescues the resection delay 
caused by the overproduction of Cdc5 (Donnianni et al., 2010). 
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Therefore, I decided to test if the rad9Δ mutation may rescue the sae2Δ phenotype 
observed in the presence of one DSB in the YMV80 background. Interestingly, I 
found that it was the case: the double mutant sae2Δ rad9Δ cells are perfectly viable 
following DSB formation in the plates containing galactose (Supplementary Figure 
11). Moreover, I also found that the deletion of RAD9 rescues the lethality observed 
in the sae2-3Ala cells (Supplementary Figure 11). 
At the same time I performed a Southern blot analysis of the repair process (as 
described in Vaze et al., 2002), and I confirmed that the increased viability of the 
sae2Δrad9Δ double mutant correlates with an increase in DSB repair 
(Supplementary Figure 12). 
I have also tested the possibility that the Rad9 deletion in some way may channel the 
unprocessed DSB, generated in sae2Δ, in to the BIR repair pathway. However the 
triple mutant sae2Δ rad9Δ rad51Δ cells recovers very well respect the sae2Δ 
rad51Δ cells, indicating that BIR is not involved (Supplementary Figure 13). 
Then, I tested if also the deletion of DDC1, which acts upstream Rad9 in the 
checkpoint signaling pathway (see the State of the Art section), and the kinase-
defective rad53-K227A mutation, may rescue sae2Δ phenotype. Interestingly, I 
found that both the ddc1Δ and the rad53-K227A mutations do not rescue cell 
viability of the sae2Δ strain (Supplementary Figure 14). These results support the 
hypothesis that the suppression is due to a Rad9 function different than its role in the 
checkpoint signaling pathway, and we believed it is related to the DSB resection 
barrier. 
It is known that Sae2 works together with the MRX complex in the first step of the 
DSB resection. Thus, if this model would be correct I was expected to find the same 
Rad9-dependent sensitivity to DSB in both the sae2Δ and mre11 nuclease-defective 
mutants. Indeed I found that the two different mre11 nuclease-defective alleles 
mre11-D16A and mre11-D56A show cells lethality following DSB formation, 
which is partially suppressed by the rad9Δ mutation (Supplementary Figure 15). 
  55 
Theses results further confirm that the MRX complex, together with Sae2, plays a 
fundamental role to initiate DSB resection and trigger the extensive processing to 
allow SSA repair. 
Moreover, taking all these data together I could hypothesize that Rad9 plays an 
inhibitory role in the formation of long ssDNA tracts, probably acting on the 
resection factors involved in this process. 
The Exo1 nuclease and the Sgs1-Dna2 helicase-nuclease complex have been 
involved in the second step of the DSB resection (Mimitou & Symington, 2008; Zhu 
et al., 2008, and see also the State of the Art section). 
Therefore, in order to test which nuclease mediate the DSB processing in sae2Δ 
cells in the absence of Rad9 barrier, I generated the triple mutant strains sae2Δ 
rad9Δ exo1Δ and sae2Δ rad9Δ sgs1Δ. It is important to mention that the generation 
of the triple mutant sae2Δ rad9Δ sgs1Δ was particularly difficult, because it is 
known that the deletion of SGS1 gene is lethal in sae2Δ cells (Mimitou & 
Symington, 2010). However, we found that the deletion of RAD9 gene suppresses 
the sae2Δ sgs1Δ synthetic lethality, as it does for dna2Δ lethality (Budd et al., 2011). 
Then I plated the cells in galactose, and I interestingly found that Exo1 is not 
involved; in fact the triple mutant has the same cells viability of the double mutant 
sae2Δ rad9Δ and wild type (Supplementary Figure 16). 
On the contrary, the viability of the sae2Δ rad9Δ sgs1Δ cells in the presence of the 
DSB is dramatically reduced (Supplementary Figure 17), strongly supporting the 
idea that Sgs1-Dna2 activity is required for the DSB processing and checkpoint 
recovery in sae2Δ rad9Δ. 
At the moment I have in progress the experimental analysis by Southern blotting to 
test the DSB processing in these mutants and confirm the model.	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Abstract
Checkpoints are surveillance mechanisms that constitute a barrier to oncogenesis by preserving genome integrity. Loss of
checkpoint function is an early event in tumorigenesis. Polo kinases (Plks) are fundamental regulators of cell cycle
progression in all eukaryotes and are frequently overexpressed in tumors. Through their polo box domain, Plks target
multiple substrates previously phosphorylated by CDKs and MAPKs. In response to DNA damage, Plks are temporally
inhibited in order to maintain the checkpoint-dependent cell cycle block while their activity is required to silence the
checkpoint response and resume cell cycle progression. Here, we report that, in budding yeast, overproduction of the Cdc5
polo kinase overrides the checkpoint signaling induced by double strand DNA breaks (DSBs), preventing the
phosphorylation of several Mec1/ATR targets, including Ddc2/ATRIP, the checkpoint mediator Rad9, and the transducer
kinase Rad53/CHK2. We also show that high levels of Cdc5 slow down DSB processing in a Rad9-dependent manner, but do
not prevent the binding of checkpoint factors to a single DSB. Finally, we provide evidence that Sae2, the functional
ortholog of human CtIP, which regulates DSB processing and inhibits checkpoint signaling, is regulated by Cdc5. We
propose that Cdc5 interferes with the checkpoint response to DSBs acting at multiple levels in the signal transduction
pathway and at an early step required to resect DSB ends.
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Introduction
Saccharomyces cerevisiae cells suffering a double stranded DNA
break (DSB) activate a robust Mec1-dependent checkpoint
response when DSB ends are processed to expose single-stranded
DNA (ssDNA), and progression through the cell cycle is arrested
prior to anaphase. Several well conserved factors are recruited at
the DSB lesion, and contribute to the activation of a signaling
pathway based on sequential phosphorylation events driven by the
upstream kinases Tel1/ATM and Mec1/ATR which, in turn,
activate the transducer kinases Rad53/Chk2 and Chk1 [1,2]. The
checkpoint response is influenced at several levels by kinases such
as CDK1, CKII and Polo-like Cdc5, all involved in promoting key
events throughout an unperturbed cell cycle, supporting the notion
that the cellular response to DNA damage is tightly linked to cell
cycle events [3]. The intensity of the DSB-induced checkpoint
response correlates to the amount of the ssDNA that is
accumulated at DSB lesions [4]. 59-to-39 nucleolytic processing
of DNA ends is dependent upon several factors, including CDK1
and the nucleases Mre11, Sae2, Dna2 and Exo1 [5]. Moreover,
the checkpoint is a reversible signaling pathway which is turned off
when DNA lesions are repaired, thus permitting the resumption of
cell cycle progression [6]. Different types of phosphatases (Pph3,
Ptc2 and Ptc3) dephosphorylate and inactivate Rad53 and other
checkpoint kinase targets [7]. Further, mutations in several DNA
repair genes, including SAE2, KU70/80, RAD51, RDH54, SRS2,
affect the inactivation of the DSB-induced checkpoint response
[7,8]. These observations suggest that the attenuation, as well the
activation, of the checkpoint pathway are related to the
metabolism of DSB ends, in a way that is not yet completely
understood. It is also known that the checkpoint response can be
attenuated when an irreparable DNA lesion is formed in the cell,
leading to adaptation to DNA damage. Checkpoint inactivation
during recovery and adaptation to DNA damage is a phenomenon
described also in higher eukaryotes [6]. The functional role of
adaptation is not completely understood; however, it was
suggested that it may be partly responsible for chromosomal
rearrangements, genome instability and tumorigenesis [6,9].
Interestingly, the well conserved family of Polo-like kinases (Plks)
has been involved in checkpoint adaptation and/or recovery both
in budding yeast and vertebrates [10]. Cdc5 is the only polo kinase
expressed in yeast, whereas higher eukaryotes usually express three
or four Plks [11]. However, only Plk1, which is the most
extensively studied, is a true mitotic kinase homolog to the
Drosophila Polo kinase [11]. In yeast, CDC5 is an essential gene and
the point mutation cdc5-ad (a Leucine-to-Tryptophan substitution
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at residue 251, within the kinase domain) causes the inability to
adapt to one irreparable DSB lesion and to turn off Rad53 kinase
[12,13]. However, cdc5-ad cells can recover from checkpoint when
the DSB is repaired, suggesting that adaptation and recovery are
two genetically separate processes [14]. A corresponding cdc5-ad
mutation in Plks has not yet been isolated in mammals; however, it
was found that Plk1 depletion severely blocks checkpoint recovery
and adaptation [10,15,16], and rapidly causes cell death in cancer
cells [17,18]. Based on the fact that the DNA damage checkpoint
pathway is well conserved in all the eukaryotes, it is reasonable to
expect that the functional role of Cdc5 in budding yeast and of
Plk1 during adaptation (and perhaps in recovery) may be
conserved. Polo-like kinases contain in the C-terminal region of
the protein a polo box which mediates the interaction of Plks with
substrates previously phosphorylated by CDK or MAPK kinases
[19]. Indeed, Cdc5 targets multiple substrates during an
unperturbed cell cycle [20] and could functionally interact with
several checkpoint proteins as well. In vertebrates, polo kinases
regulate the DNA damage checkpoint acting on multiple factors.
They phosphorylate Claspin [21–24], a Chk1 kinase regulator,
and the Fanconi-Anemia protein FANCM [25], promoting their
degradation and checkpoint inactivation. Further, Plk1, Plk3 and
Plk4 interact with and phosphorylate Chk2, the ortholog of Rad53
in human cells, likely influencing its activity [26–28]. Interestingly,
yeast Cdc5 is phosphorylated and inhibited in a Mec1- and
Rad53-dependent manner [29], and several studies indicate that
in mammals Plk1 activity is inhibited by ATM/ATR-signaling in
response to DNA damage [30–33]. Further, the DNA damage
checkpoint regulates Plk1 protein stability in response to DNA
damage in mitosis [34]. It was also shown that Aurora kinase A
phosphorylates and re-activates Plk1 to promote recovery from
DNA damage [35]. Altogether, these informations suggest that the
DNA damage checkpoint inhibits Plk1, thus contributing to block
cell cycle progression in response to DNA damage; however, the
re-activation of Plk1 is a crucial event of a feedback regulatory
loop in the inactivation of the DNA damage checkpoint during
recovery and adaptation.
Therefore, the activity of Plks must be finely regulated during
the DNA damage checkpoint response, and it is worth
mentioning that the expression of a constitutively active Plk1
protein variant overrides the G2/M arrest induced by DNA
damage [30]. Indeed, Plks are frequently overexpressed in tumor
cells with uncontrolled proliferation and genome instability [36–
39], and high level of Plk1 is predictive of a bad prognosis in
several cancers [40–44].
To further characterize the functional link between Plks and the
DNA damage checkpoint and, possibly, to understand why Plks
are frequently overexpressed in cancer cells, we used budding
yeast as a model system to study DNA damage related events in
the presence of high levels of Cdc5.
Here, we show that overproduction of Cdc5 impairs the Mec1-
signaling pathway in response to an inducible DSB lesion, altering
phosphorylation of Ddc2, Rad9, Rad53 and other Mec1 targets.
We also found that elevated levels of Cdc5 slow down DSB ends
processing, although it does not prevent the formation of ssDNA,
which triggers the recruitment of checkpoint factors. Consistently,
we observed that overexpression of Cdc5 does not alter the loading
of the apical Mec1 kinase checkpoint complex and recruitment of
the checkpoint mediator Rad9, but surprisingly it physically
interact with the checkpoint inhibitor Sae2, inducing its hyper-
phosphorylation and an increased and persistent binding onto a
DSB lesion.
We propose that high levels of polo kinase Cdc5 override Mec1-
induced checkpoint response to DSB lesions, likely by regulating
multiple factors, previously phosphorylated by CDK1, involved in
both DSB processing and checkpoint signaling. Our work may
represent a simple model to further understand why polo kinases
are frequently overexpressed in cancer cells.
Results/Discussion
Elevated levels of Cdc5 override Mec1 signaling
DNA damage checkpoints represent a barrier to oncogenesis; in
fact, loss of these surveillance mechanism is a characteristic of early
tumor development [45]. Several evidences indicate that Plks are
targets of the DNA damage checkpoint in all the eukaryotes
[29–34], suggesting a functional model in which the DNA damage
checkpoint inhibits Plks to maintain a cell cycle block at the
metaphase to anaphase transition. Indeed, numerous cancer cells
have been reported to display overexpression of Plks, and this may
contribute to their transformed phenotype [36–39].
In budding yeast, overproduction of the polo kinase Cdc5 in
cdc13-1 mutant cells with uncapped telomeres has been reported to
override the checkpoint-dependent cell cycle block in the G2
phase of the cell cycle [46,47]. We found that overproduction of
Cdc5 impairs the replication checkpoint, which delays S phase in
the presence of the alkylating agent MMS (methylmetane
sulfonate, Figure 1A). Indeed, Figure 1A shows that MMS treated
wild type cells accumulate in S phase for a very long period
(1C,DNA,2C), while Cdc5 overproducing cells rapidly go
through the replication phase and reach a G2/M DNA content
(2C). Moreover, the DNA damage-induced phosphorylation of
Rad53 is essentially abolished in Cdc5 overproducing cells treated
with zeocin, an agent causing DSBs (Figure 1B).
We have to assume that, although the DNA damage checkpoint
inhibits Cdc5 [29,46], contribuiting to block cell cycle in the
presence of DNA damage, when CDC5 is placed under the control
Author Summary
Double strand DNA breaks (DSBs) are dangerous chromo-
somal lesions that can lead to genome rearrangements,
genetic instability, and cancer if not accurately repaired.
Eukaryotes activate a surveillance mechanism, called DNA
damage checkpoint, to arrest cell cycle progression and
facilitate DNA repair. Several factors are physically recruit-
ed to DSBs, and specific kinases phosphorylate multiple
targets leading to checkpoint activation. Budding yeast is a
good model system to study checkpoint, and most of the
factors involved in the DSBs response were originally
characterized in this organism. Using the yeast Saccharo-
myces cerevisiae, we explored the functional role of polo
kinase Cdc5 in regulating the DSB–induced checkpoint.
Polo kinases have been previously involved in checkpoint
inactivation in all the eukaryotes, and they are frequently
overexpressed in cancer cells. We found that elevated
levels of Cdc5 affect the cellular response to a DSB at
different steps, altering DNA processing and overriding the
signal triggered by checkpoint kinases. Our findings
suggest that Cdc5 likely regulates multiple factors in
response to a DSB and provide a rationale for a proteome-
wide screening to identify targets of polo kinases in yeast
and human cells. Such information may have a practical
application to design specific molecular tools for cancer
therapy. Two related papers published in PLoS Biology—by
Vidanes et al., doi:10.1371/journal.pbio.1000286, and van
Vugt et al., doi:10.1371/journal.pbio.1000287—similarly
investigate the phenomenon of checkpoint adaptation/
overriding.
Cdc5 Affects Double-Strand DNA Break Response
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of the GAL1 promoter, the DNA damage-induced inhibition on
overproduced Cdc5 is not complete. This is likely due to the
elevated Cdc5 levels, which are higher than the endogenous
amount (see also Figure S1), leading to the override of the
checkpoint response. Indeed, it was previously shown that the
overproduction of Cdc5, which is a finely regulated protein [29],
causes severe phenotypes during an unperturbed cell cycle
[48–51].
In order to expand the analysis on the crosstalk between polo
kinases and checkpoint pathways, and possibly to understand why
overexpression of Plks is often found in tumor cells characterized
by uncontrolled proliferation and genome instability, we analysed
the effects of elevated Cdc5 levels on the DSB-induced checkpoint
cascade in S. cerevisiae. We took advantage of a standard yeast
genetic system (JKM background) in which one irreparable DSB
can be induced at the MAT locus by expressing the site-specific
HO nuclease [8]. We overexpressed wild-type CDC5 and the two
cdc5-ad and cdc5-kd mutant alleles (adaptation-defective and
kinase-dead alleles, respectively [51]) from the galactose-inducible
promoter and examined Rad53 phosphorylation and in situ auto-
phosphorylation activity, which are routinely used as markers of
DNA damage checkpoint activation [52]. To prevent variations
due to cell cycle differences, we first arrested cells with nocodazole
in mitosis, a cell cycle stage in which the DSB-depended
checkpoint can be fully activated [12], and subsequently added
galactose to induce Cdc5 overproduction and HO-break forma-
tion, while maintaining the cell cycle block. Figure 2A shows the
FACS profiles of the cell cultures. We observed that overproduc-
tion of Cdc5 impairs the accumulation of hyper-phosphorylated
Rad53 forms and prevents Rad53 auto-phosphorylation activity in
Figure 1. Overproduction of Cdc5 overrides the DNA replication and DNA damage checkpoints. (A) Exponentially (L) growing culture of
the strain Y114 (GAL1::CDC5) was grown in YEP+3%raffinose and treated for 3 hours with 0.02% MMS (time 0). Then the culture is split in two and 2%
galactose was added to one half, while the other half was maintained in raffinose. Samples were taken at the indicated time and analysed by FACS.
(B) Cultures of the strains Y79 (wild type), Y114 (GAL1::CDC5), exponentially (L) growing in YEP+3%raffinose were blocked in G2/M by nocodazole
treatment (0). Zeocin (50 mg/ml) was then added to cause DSBs formation and after 30 minutes of treatment, 2% galactose was added. Samples were
taken at the indicated time and Rad53 protein was analyzed by western blotting with Mab.EL7 antibody.
doi:10.1371/journal.pgen.1000763.g001
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response to DSB formation (Figure 2B). Interestingly, overpro-
duction of the protein variants Cdc5-kd or Cdc5-ad did not
significantly interfere with Rad53 phosphorylation and activation,
suggesting that the kinase activity of Cdc5 and its capacity to
interact with specific target(s) are required to override the DSB-
induced Rad53 activation.
In vertebrates, polo kinases regulate the DNA damage
checkpoint response by affecting the signal transduction pathway
at different levels; interestingly, Chk2, the homologue of Rad53 in
human cells, interacts with and is phosphorylated by the polo
kinases Plk1, Plk3 and Plk4 [26–28].
Therefore, we tested whether the overproduction of Cdc5 might
override Rad53 activation by targeting directly the Rad53 protein
and/or by acting on other upstream checkpoint factors.
We failed to co-immunoprecipitate Rad53 and Cdc5, when
expressed at endogenous levels or by using the polo box of Cdc5 in
a standard GST pull down assay; however, we retrieved Rad53
with overproduced Cdc5 (Figure S2). Considering such physical
interaction, we analyzed how overproduction of Cdc5 might affect
the events leading to full activation of Rad53, which involves a two
steps-based mechanism: an in trans phosphorylation event
mediated by PIKKs, followed by auto-phosphorylation [53]. In
theory, Cdc5 might affect any of these events required to activate
Rad53. We analysed the effect of Cdc5 overexpression on the
PIKKs-dependent phosphorylation of Rad53 by taking advantage
of the catalytically inactive rad53-K227A mutant. Such protein can
be phosphorylated in trans by the upstream kinases, but does not
undergo auto-phosphorylation in the presence of DNA damage
[52], allowing us to separate and discriminate the two steps.
In nocodazole blocked cells, induction of a single irreparable
HO cut induced Mec1-dependent phosphorylation of the Rad53-
K227A protein variant (Figure 3A). As expected, the correspond-
ing phosphorylated bands of Rad53-K227A protein were not
visualized by western blot using the monoclonal antibody
(Mab.F9) which is specific for the auto-phosphorylated and active
Rad53 isoform [54]. Moreover, the same phospho-specific
antibody did not significantly detect Rad53 in wild type cells
responding to DSB when Cdc5 is overproduced, confirming the
results of the in situ kinase assay (Figure 2B). A residual shifted
band of Rad53, visualized in CDC5 overexpressing cells through
the highly sensitive Mab.EL7 antibody (both in Figure 2B and
Figure 3A, and in other figures below), could reflect low levels of
Rad53 activation not detected by the antibody against the active
form; this is consistent with the residual Rad53 activity in the in situ
analysis in Figure 2B. In any case, it is unlikely that this remaining
Rad53 activity is sufficient to maintain a full checkpoint response,
since overproduction of Cdc5 functionally overrides the cell cycle
block in the presence of DNA damage.
Significantly, Cdc5 overproduction abolished DSB-induced in trans
phosphorylation of the Rad53-K227A variant (Figure 3A). This result
rules out the hypothesis that Cdc5 may override the DSB-induced
checkpoint acting only on the auto-phosphorylation step of Rad53
activation, and suggests that CDC5 overexpression likely impairs the
Mec1-dependent in trans phosphorylation and activation of Rad53.
The residual Rad53 phosphorylation and activity in the
presence of high levels of Cdc5 might suggest that the upstream
Mec1 kinase, which is mainly responsible of the Rad53 activation
in the presence of a single DSB in wild type cells [55], is strongly
Figure 2. Overproduction of Cdc5 affects DSB–induced Rad53 phosphorylation and activity. (A,B) YEP+raffinose nocodazole-arrested cell
cultures of wild type JKM and isogenic GAL1::CDC5, GAL1::cdc5-kd (kinase dead, K110A mutation) and GAL1::cdc5-ad (adaptation defective, L251W
mutation) strains were transferred to nocodazole-containing YEP + raffinose + galactose (time zero). (A) Samples were taken at the indicated time
points and analyzed by FACS. (B) Overproduced Cdc5 proteins have an additional HA epitope and their accumulation in galactose was analyzed by
western blots using 12CA5 antibody. Rad53 was analyzed by western blots with Mab.EL7 antibodies. Rad53 in situ auto-phosphorylation activity was
analyzed by ISA assay.
doi:10.1371/journal.pgen.1000763.g002
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but not fully inhibited. Alternatively, Mec1 may still be functional
as a kinase, but impaired in fully trans-activating Rad53. To test
more directly the activity of the upstream kinase Mec1, we
analysed the phosphorylation state of its interacting subunit Ddc2,
the ortholog of human ATRIP, and that of the checkpoint
mediator Rad9, which are known to be directly phosphorylated by
Mec1 [1]. Cells were arrested with nocodazole and CDC5
overexpression and induction of a single unrepairable DSB were
induced by galactose addition (Figure 3B). Western blot analysis
indicate that phosphorylated isoforms of Ddc2 and hyper-
phosphorylated Rad9 (indicated by the arrow in Figure 3)
accumulated after the formation of the HO cut in wild type cells,
as expected; however, overexpression of Cdc5 reduced the DSB-
induced hyper-phosphorylated form of both Ddc2 and Rad9,
suggesting that the activity of Mec1 kinase is strongly impaired in
the presence of high level of Cdc5. A careful analysis of the blot
shown in Figure 3B or in analogous experiments indicates that
reduced levels of phosphorylated Rad9 isoforms are present in
CDC5 overexpressing cells, suggesting that Mec1 could still retain
a flebile activity toward Rad9 and Rad53, as discussed above. In
addition, it is known that Rad9 is a target of multiple kinases [56]
and we cannot rule out the possibility that the residual
phosphorylation of Rad9 observed in cells with elevated levels of
Cdc5 may be due to other kinase(-s), including Cdc5 itself.
Taken together the results shown in Figure 1, Figure 2, and
Figure 3 indicate that Cdc5 activity overrides the DSB-induced
checkpoint by influencing an early step of the Mec1 signaling
pathway, likely reducing the functionality of Mec1 activity.
However, it is possible that Cdc5 may target multiple substrates,
including the Mec1 interactor Ddc2, the checkpoint mediator
Rad9, whose role in promoting Mec1-to-Rad53 signaling is well
established, and Rad53 itself, thus counteracting the checkpoint
signaling pathway at several levels.
High levels of Cdc5 affect DSB resection
Robust Mec1 and Rad53 activation is not triggered by the DSB
itself, but requires multiple interconnected events following the
formation of the lesion, including the generation of nucleolytic-
dependent 59-to-39processing of the DNA ends and recruitment of
various DNA repair and checkpoint factors onto the long stretches
of the generated ssDNA [4].
Therefore, we investigated whether Cdc5 may control Mec1
signaling by affecting DSB processing. We measured the kinetic of
Figure 3. Overproduction of Cdc5 overrides Mec1 checkpoint signaling. (A) YEP+raffinose nocodazole-arrested cell cultures of wild-type
JKM and isogenic rad53-kd (kinase dead, K227A mutation) derivative strains, with or without GAL1::CDC5, were transferred to nocodazole-containing
YEP + raffinose + galactose (time zero). Samples were taken at the indicated time points and Rad53 was analyzed by western blots using monoclonal
antibodies Mab.EL7 or Mab.F9, which recognized, respectively, all the forms of Rad53 or only the auto-phosphorylated and active forms. (B)
YEP+raffinose nocodazole-arrested cell cultures of wild type JKM and isogenic GAL1::CDC5 derivative strains, expressing DDC2-HA, were transferred to
nocodazole-containing YEP + raffinose + galactose (time zero). Ddc2 protein was analyzed by western blots using 12CA5 antibody; Rad9 protein was
analyzed by polyclonal antibodies. An arrow denotes the hyper-phosphorylation band of Rad9 accumulated specifically in response to DNA damage.
doi:10.1371/journal.pgen.1000763.g003
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ssDNA formation after a single unrepairable DSB in cells
overexpressing CDC5. Cells were arrested in mitosis, to prevent
cell cycle-dependent effects on resection [57], and samples were
collected at various time points after HO nuclease induction
(Figure 4). The kinetic of production of ssDNA regions in genomic
DNA was tested by the loss of restriction sites distal to the HO-cut
site which leads to the accumulation of undigested ssDNA
fragments detectable with a strand-specific probe after alkaline
electrophoresis (see the scheme of the unprocessed and processed
DNA locus in Figure 4A). CDC5 overexpressing cells reproducibly
Figure 4. Overproduction of Cdc5 affects DSB processing. (A–D) YEP+raffinose nocodazole-arrested cell cultures of wild-type JKM MATa and
isogenic GAL1::CDC5 strain were transferred to nocodazole-containing YEP + raffinose + galactose (time zero). (A) Schematic representation of the
system used to detect DSB resection. Gel blots of SspI-digested genomic DNA separated on alkaline agarose gel were hybridized with a single-strand
RNA probe specific for the un-resected strand at the MAT locus, which shows HO-cut and uncut fragments of 0.9 and 1.1 kb, respectively. 59-to-39
resection progressively eliminates SspI sites located 1.7, 3.5, 4.7, 5.9, 6.5, 8.9, and 15.8 kb centromere-distal from the HO-cut site, producing larger SspI
fragments (r1–r7) detected by the probe. (B) Analysis of ssDNA formation as described in (A). (C) The time of the first appearance over the
background of each undigested band in the blot shown in (B) was graphically represented for both the wild type and GAL1::CDC5 strains. (D) Western
blot analysis of protein extracts with anti-Rad53 Mab.EL7 antibody.
doi:10.1371/journal.pgen.1000763.g004
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exhibited a slower DSB resection, measured by the kinetic of
appearance of DNA fragments, which correlated with a reduced
phosphorylation of Rad53 (Figure 4B–4D). However, we found
that, although the kinetic of DSB ends resection was delayed, high
levels of Cdc5 do not prevent the generation of a long ssDNA track
(25 kb) which is required to repair the DSB in a specific yeast
genetic background [14] by the single-strand annealing process
(Figure S3).
We previously identified a role for the checkpoint mediator
Rad9 in inhibiting the kinetic of DSB ends resection, likely by
generating a non-permissive chromatin configuration around the
DSB and/or interfering with the action of nucleases [58].
Therefore, we analyzed the Rad9 contribution in delaying DSB
processing in CDC5 overexpressing cells. Wild-type or rad9D cells,
with or without GAL1::CDC5, were arrested in mitosis by
nocodazole treatment and the same experiment described in
Figure 4B was performed. We found that the kinetic of appearance
of ssDNA fragments was accelerated in rad9D strains, despite the
high levels of Cdc5 kinase (Figure 5A and 5B). Moreover, the
faster DSB resection in CDC5 overexpressing rad9D cells also
correlated with a modest increase in Ddc2 phosphorylation
(Figure 5C); however, the phosphorylated state of Ddc2 did not
reach the same level found in wild-type and rad9D cells, suggesting
that overproduction of Cdc5 impaired Mec1-dependent signaling
also in a rad9D background. These results suggest that elevated
levels of Cdc5 may slow down DSB processing through the action
of the Rad9-dependent barrier on resection [58], likely targeting
Rad9 itself or other factors involved in this mechanism.
Interestingly, many of the proteins involved in DSB ends
processing (i.e. Rad9, Dna2, Xrs2 and Sae2) are phosphorylated
Figure 5. Deletion of RAD9 gene accelerates DSB resection despites high Cdc5’s levels. YEP+raffinose nocodazole-arrested cell cultures of
wild type JKM MATa and isogenic rad9D strains, with or without GAL1::CDC5, were transferred to nocodazole-containing YEP + raffinose + galactose
(time zero). (A,B) Analysis of ssDNA formation as described in Figure 4. (C) Ddc2 protein was analyzed by western blots using 12CA5 antibody; Rad53
protein was analysed by monoclonal antibody Mab.EL7.
doi:10.1371/journal.pgen.1000763.g005
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by CDK1 [59,60] and inspection of their protein sequence reveals
that they may be potential targets of Cdc5.
Hence, Cdc5 may influence the DSB response acting on
multiple factors, affecting DSB processing and Mec1-signaling;
moreover, the possibility that Cdc5 might specifically regulate
Rad53 by influencing its interaction with the checkpoint mediator
Rad9 cannot be excluded.
Recruitment of checkpoint factors in CDC5-
overexpressing cells
Since high levels of Cdc5 did not prevent the generation of long
ssDNA regions but inhibit Mec1-signaling, we tested, by
chromatin immunoprecipitation (ChIP), whether overexpression
of CDC5 affected the recruitment of checkpoint factors onto the
HO-induced DSB lesion in nocodazole-arrested cells. Sheared
chromatin from formaldehyde crosslinked cells taken at different
time-points after galactose addition was immunoprecipitated to
recover checkpoint proteins (i.e. Ddc2, Ddc1, Dpb11, Rad9)
carrying the MYC or HA epitope tags at their carboxyl-terminal
end. Quantitative multiplex PCR was then used to monitor co-
immunoprecipitation of DNA fragments located either 66 kb
centromere-proximal to the MAT locus (CON) or 1 kb away from
the HO-cut site (DSB) (Figure 6A).
Ddc2 and Ddc1 association at the DSB was not significantly
affected in CDC5 overexpressing cells blocked by nocodazole
treatment (Figure 6B and 6C). The Mec1 interacting factor Ddc2
and Ddc1, one of three subunits of the stable PCNA-like 9-1-1
checkpoint complex, are recruited early onto a DSB lesion [61–
63]. We, therefore, assume that Cdc5 overproduction does not
prevent the recruitment of upstream checkpoint protein complexes
onto damaged DNA. This observation also confirms that elevated
levels of Cdc5, while delaying resection, do not prevent the
generation of ssDNA (see Figure 4, Figure 5, and Figure S3) which
is required for the recruitment of checkpoint factors [4].
Similarly, we found that overproduction of Cdc5 did not
prevent the localization near the DSB of Dpb11 (Figure 6D), the
yeast ortholog of TopBP1, which, together with the 9-1-1
complex, stimulates the Mec1 kinase activity [64].
Moreover, when we tested by ChIP analysis the binding of the
checkpoint mediator Rad9, we found that also its localization onto
the DSB was not altered in CDC5 overexpressing cells (Figure 6E).
Taken together, the ChIP analyses of checkpoint factors at a
DSB site indicate that high levels of Cdc5 kinase do not
significantly interfere with the binding of checkpoint proteins to
a processed DSB.
We then tested the DSB binding of Sae2, which is a protein
regulated by CDK1 [60] and PIKKs [65] after DNA damage and
is involved in DSB processing [5] and checkpoint inactivation
[66,67]. Surprisingly, while in wild-type cells Sae2 loading was not
significantly enriched at the HO-cut site (Figure 7A), likely because
of its dynamic and transient binding to DSBs [67], Sae2
localization near the break greatly increased in CDC5 overex-
pressing cells (Figure 7A). To test whether Cdc5 may specifically
target Sae2 influencing its binding onto DSBs, we analysed the
level and modification of Sae2 by western blotting following DSB
formation. In nocodazole-blocked cells, induction of the HO cut
caused PIKKs-dependent phosphorylation of Sae2 at the same
time-points at which Rad53 phosphorylation was observed
(Figure 7B). Interestingly, although high levels of Cdc5 impair
Rad53 phosphorylation, they seem to cause hyperphosphorylation
of Sae2. Infact, in CDC5 overexpressing cells we observed the
appearance of a ladder of slower migrating forms of Sae2
(Figure 7B), which are abolished by in vitro treatment with l
phosphatase (Figure 7C), indicating that they are due to
phosphorylation events of Sae2. We then found that overproduc-
tion of Cdc5 induces Sae2 hyper-phosphorylation in untreated
cells and in nocodazole-blocked cells without the HO-cut
formation (Figures 7D), supporting the idea that Sae2 might be
a direct target of Cdc5. Indeed, as mentioned above, Sae2 protein
sequence reveals several sites that could be bound and/or
phosphorylated by Cdc5 (Figure 8A). The C-terminus of Cdc5,
like other Polo-like kinases, contains a phospho-serine/phospho-
threonine binding domain called the Polo-box Domain (PBD)
[19]. The PBD is known to bind Plk substrates after they have
been ‘‘primed’’ by a preliminary phosphorylation by another
protein kinase [19]. Interestingly, the putative PBD binding motif
of Sae2 has been previously shown to be phosphorylated by
CDK1 [60], making it a perfect candidate for mediating the
interaction between Sae2 and Cdc5. Indeed, by a 2-hybrid assay
we found that the PBD of Cdc5 interacts with Sae2 (Figure 8B),
and a recombinant GST-PBD fusion protein, purified from E. coli,
precipitated Sae2-3HA from yeast extracts (Figure 8C).
Taken together, the results shown in Figure 7 and Figure 8
indicate that Cdc5, through its PBD, interacts with Sae2, causing
its hyper-phosphorylation and accumulation at the DSB (see also a
model in Figure 8D). It is interesting to point out that CtIP, the
functional ortholog of Sae2 in human cells, was found to be
associated to chromatin following DNA damage and its chromatin
binding is promoted by phosphorylation and ubiquitination [68].
Indeed, recent evidences indicate that CtIP and Ctp1 (the CtIP
counterpart in S. pombe [69]), are recruited to DSB sites through
their interaction with Nbs1 [70–72], a subunit of Mre11 complex,
and BRCA1 [73,74]. Moreover, CtIP is phosphorylated and
regulated by CDK1 [74,75]. In yeast, Sae2 is involved both in
promoting an early step of DSB ends resection [5] and in
inactivating checkpoint signaling during recovery and adaptation
[66,67], although the exact role of Sae2 in these processes is not
yet fully understood. Interestingly, the overproduction of Sae2 also
causes the overriding of the Mec1-signaling [66], while deletion of
SAE2 gene prevents switching off of the checkpoint [65,66].
One possible working model (Figure 8D), which needs to be
verified, predicts that the increased and persistent binding of Sae2
to a DSB, induced by overproduction of Cdc5, may affect both
DSB resection and Mec1-signaling. It is tempting to speculate that
even physiological levels of Cdc5 may regulate Sae2 during
recovery and adaptation, contributing to switch off the checkpoint
signal. It is also possible that Sae2 is regulated by Cdc5 only when
this kinase is expressed at elevated levels, leading to the checkpoint
overriding. Indeed, such situation is frequently observed in cancer
cells, when Plks are overexpressed [36–39], suggesting that what
we found in yeast may represent a model for a pathological
condition in human cells. Future works, requiring the analysis of
sae2 mutations in the sites regulated by Cdc5, may help to
discriminate between the two possibilities.
In conclusion, in the present study we further explored the role
of the polo kinase Cdc5 in attenuating the DNA damage
checkpoint in budding yeast. We found that overproduction of
Cdc5 affects different parameters of the cellular response to an
inducible DSB: i) it overrides Mec1 signaling and prevents the
phosphorylation of various Mec1 targets (Rad53, Rad9, Ddc2); ii)
it causes a slower resection of DSB ends in a RAD9-dependent
manner; iii) it binds Sae2 protein, causing its hyper-phosphory-
lation and leading to its increased and persistent binding onto
DSB.
The emerging scenario suggests that Cdc5 may target multiple
factors involved in various aspects of the cellular response to DSB
lesions and DNA damage checkpoint signaling. Indeed, Cdc5 is a
fundamental regulator of cell cycle progression and targets many
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Figure 6. Recruitment to DSB of checkpoint factors in CDC5-overexpressing cells. (A) Schematic representation of the HO cleavage site
with the positions of the primers used to amplify regions 1 kb (DSB) and 66 kb (CON) from the HO cut site. PCR analysis at the CON site is used as a
control of background signal. (B–E) YEP+raffinose nocodazole-arrested cell cultures of wild-type JKM and isogenic GAL1::CDC5-MYC or GAL1-CDC5-HA
strains, expressing DDC2-HA, DDC1-MYC, DPB11-MYC, and RAD9-MYC alleles, were transferred to nocodazole-containing YEP + raffinose + galactose
(time zero). Cells were collected at the indicated times and then subjected to chromatin immunoprecipitation. Representative ChIP time-course
analysis of protein-DSB association is shown for each protein tested before (Inputs) and after protein immunoprecipitation (IP).
doi:10.1371/journal.pgen.1000763.g006
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proteins throughout a normal cell cycle [20]. Most of the Cdc5
substrates are proteins previously phosphorylated by CDK1,
which is the principal regulator of the DSB-induced response,
regulating DSB processing, recombination and checkpoint signal-
ing [57]. Here we found that high levels of Cdc5 separately
affected Mec1 signaling and DSB processing, leading us to
speculate that Cdc5 may regulate multiple targets in response to
DNA damage, including factors phosphorylated by CDK1. In
support of such hypothesis, Plks phosphorylate, in vertebrates,
several proteins involved in various aspects of the DNA damage
response, such as FANCM [25], Claspin [21–24], Chk2 [26–28],
MCM5 [76], MCM7 [77] and others. Moreover, our findings on
the functional role of Cdc5 in responding to a DSB in yeast rise the
possibility that Plks may also regulate CtIP.
Recently, a proteome-wide screening led to the identification of
novel Cdc5 targets in a normal cell cycle [20]; we believe that a
similar approach is promising to identify Cdc5 targets regulated in
response to DSBs. Good experimental evidence indicates that the
Figure 7. Analysis of Sae2 protein in CDC5 overexpressing cells. (A,B) YEP+raffinose nocodazole-arrested cell cultures of wild type JKM and
isogenic GAL1::CDC5-MYC strain, expressing SAE2-3HA allele, were transferred to nocodazole-containing YEP + raffinose + galactose (time zero). Cells
were collected at the indicated times and then subjected to chromatin immunoprecipitation (ChIP) as described in Figure 6. Representative ChIP
time-course analysis of protein-DSB association is shown before (Inputs) and after protein immunoprecipitation (IP). (B) Western blot analysis of
protein extracts. (C) Western blot analysis of protein extracts prepared 3 hrs after HO induction and treated with or without l phosphatase before gel
electrophoresis. (D) YEP-raffinose growing cells of wild type and of wild-type JKM MATa-inc and isogenic GAL1::CDC5-MYC strains, expressing SAE2-
3HA allele, were split in two. One half was treated with nocodazole to block cells in G2. Galactose was then added to the cultures to induce
overproduction of Cdc5. Cells were collected at the indicated times after galactose addition. (B–D) Sae2-HA protein was analyzed by western blots
using 12CA5 antibody; Rad53 protein was analysed by monoclonal antibody Mab.EL7.
doi:10.1371/journal.pgen.1000763.g007
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Figure 8. Sae2 protein interacts with PBD of Cdc5. (A) Sae2 protein sequence. The putative Cdc5 phosphorylation sites and PBD binding sites
are indicated. (B) Plasmid pEG202-PBD340–705, carrying the polo box domain of Cdc5 (PBD, aa 340 to 705), and pJG4-5-SAE2, carrying the full length
SAE2 gene under the GAL1 promoter, were co-transformed with pSH18-34, a b-galactosidase reporter plasmid in the wild type yeast strain EGY48. To
assess two-hybrid interaction, these strains were patched on to 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X Gal) plates containing either
raffinose (RAF, prey repressed) or galactose (GAL, prey expressed). Accordingly to [50], the strain Y692 (PBD versus Swe1173–400 protein fragment) was
used as positive control. (C) Cells of the strain Y202, expressing SAE2-3HA gene, were blocked in G2/M by nocodazole treatment. Whole cell protein
extract was prepared and incubated with glutathione-Sepharose beads carrying GST or GST-PBD357–705. Input and pull-down samples were analyzed
by western blotting with monoclonal antibody 12CA5 (aHA) or polyclonal antisera raised against GST (aGST). Asterisk denotes bands of GST-PBD
degradation or expression of truncated proteins. (D) Schematic model to summarize the results presented in this work. (i) Sae2 transiently binds DSB,
regulating ends resection and influencing Mec1-signaling. The checkpoint signal is amplified downstream, regulating several targets, including Cdc5.
(ii) After a prolonged checkpoint response, adaptation to damage takes over and Cdc5 is re-activated, likely by an activating kinase (in human cells, it
is aurora A [35]); Cdc5 then inhibits checkpoint signaling in a feedback regulatory loop, by likely targeting several factors, including Sae2 whose
loading on the irreparable DSB increases, slowing down resection and contributing to counteract the checkpoint signaling (red circles denote
phosphorylation). Alternatively, or in addition, Cdc5 function on several targets, including Sae2, is enhanced in the presence of elevated levels of
Cdc5, a situation frequently found for Plks in tumor cells.
doi:10.1371/journal.pgen.1000763.g008
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functional role of Cdc5 in the DNA damage response is
evolutionary conserved and the outputs of such a screening may
provide important information for new cancer therapy strategies,
targeting Plks and their substrates with specific tools.
Materials and Methods
Yeast strains and plasmids
Strains are listed in Table S1. All the strains were constructed
during this study, and all were derivatives of JKM (MATa,
hmldelta::ADE1, hmrdelta::ADE1 ade1-100, trp1delta::hisG, leu2-3, leu2-
112, lys5, ura3-52, ade3::GAL::HO), with the exception of strain
Y38, which was generated from strain Y5 (YMV80, matD::hisG1,
hmlD::ADE, hmrD::ADE1, lys5, ura3-52, leu2::HOcs, ade3::GAL::HO,
his-URA3-59Dleu2-is4). To construct strains, standard genetic
procedures for transformation and tetrad analysis were followed.
Y38 and Y210 were obtained by integration of ApaI-digested
plasmid pJC57 (pGAL1::CDC5-3HA) at the URA3 locus. Y215 was
derived by integration of ApaI-digested pJC59 (pGAL1::CDC5-
3myc) at URA3 locus. Y220 was obtained by integration of ApaI-
digested plasmid pJC62 (pGAL1::cdc5-K110A-3HA) at URA3
locus. Y222 was obtained by integration of ApaI-digested plasmid
pJC69 (pGAL1::cdc5-L251W-3HA) at URA3 locus. Deletions and
tag fusions were generated by the one-step PCR system [78]. The
yeast two-hybrid assay was performed using the B42/lexA system
with strain EGY48 (Mata his3 ura3 trp1 6lexAOP-LEU2; lexAOP-lacZ
reporter on plasmid pSH18-34) as the host strain [79]. Bait
plasmid pEG202-PBD340–705 for the two-hybrid assay, expressing
lexA fusion with polo box domain of Cdc5, was obtained by
amplifying the corresponding coding sequence of CDC5 gene (aa
340 to 705) from genomic DNA and ligating the resulting
fragment into pEG202 (kind gift from R. Brent). Prey plasmids
pJG4-5-Swe1173–400 and pJG4-5-SAE2, expressing B42 activating
domain fusions, were obtained by amplifying the corresponding
coding sequence of SWE1 (aa 173 to 400) and SAE2 (full length)
from genomic DNA and ligating the resulting fragments into
pJG4-5.
Western blot analysis
The TCA protein extraction and the western blot procedures
have been previously described [29]. Rad53, Rad9, Sae2-HA,
Ddc2-HA, Ddc1-myc, Dpb11-myc, Cdc5-HA, Cdc5-myc were
analysed using specific monoclonal or polyclonal antibodies: anti-
Rad53 Mab.EL7 and Mab.F9 monoclonal [54], anti-HA 12CA5
monoclonal, anti-myc 9E10 monoclonal, anti-Rad9 polyclonal (a
kind gift from N Lowndes’s lab).
In situ auto-phosphorylation assay
It was performed as previously described [52].
Immunoprecipitation analysis
Yeast whole cell extracts were prepared by FastPrep (MP
Biomedicals) in NP-40 lysis buffer (1% NP-40, 150 mM NaCl,
50 mm Tris (pH 7.5), 1 mM dithiothreitol (DTT), 60 mM b-
glycerophosphate, 1 mM NaVO3, cocktail proteases inhibitors
(Roche)). HA-tagged proteins were immunoprecipitated using anti
HA monoclonal antibody (12CA5) conjugated to protein G
Agarose.
GST pulldown assay
GST and GST-PBD were induced in BL21 E. coli cells as
previously described [80] and conjugated to glutathione-Sephar-
ose 4B beads (GSH beads, Amersham). Yeast whole cell extracts,
prepared as indicated above, were incubated with GST or GST-
PBD GSH beads and rotated for 1 hour at 4uC. Samples were
washed three times with NP-40 buffer, boiled in SDS-based
sample buffer, and analyzed by Western blotting analysis.
In vitro dephosphorylation assay
Crude extracts were prepared as described [52], and resus-
pended in l phosphatase buffer with or without 4000 U of l
phosphatase (Biolabs). Samples were incubated 30 min at 30uC
and resuspended in Laemmli buffer.
Measurements of DNA resection and SSA at DSBs
Cells grown in YEP-raffinose 3% medium at 28uC to a
concentration of 56106 cells/ml were arrested with nocodazole
(20mg/ml). A DSB was produced by adding 2% galactose and
inducing the production of the HO endonuclease. The mainte-
nance of the arrest was confirmed by FACS analysis and
monitoring of nuclear division. Genomic DNA was isolated at
intervals, and the loss of the 59 ends of the HO-cleaved MAT locus
was determined by Southern blotting [14,81,82]. To visualize the
kinetics of resection, the graphs shown in Figure 4C and Figure 5B
display, for each strain and for each ssDNA fragment (r1–r7), the
time of the first appearance in the blot. In particular, since the
appearance of a ssDNA fragment signal in the gel was due to the
loss of the internal SspI sites, we represented the length of the
minimal resection for each time point in the graph (see scheme in
Figure 4A). All the experiments have repeated al least 3 times. In
the corresponding figures, one representative example is shown
with its graphic representation.
Chromatin immunoprecipitation analysis (ChIP)
ChIP analysis was performed as described previously [83,84].
Multiplex PCRs were carried out by using primer pairs
complementary to DNA sequences located 1 kb from the HO-
cut site at MAT (DSB) and to DNA sequences located 66 kb from
MAT (CON). Gel quantitation was determined by using the NIH
Image program. The relative fold enrichments of DSB-bound
protein were calculated as follow: [DSB_IP/CON_IP]/[DSB_
input/CON_input], where IP and Input represent the amount of
PCR product in the immunoprecipitates and in input samples
before immunoprecipitation, respectively.
Supporting Information
Figure S1 Cellular levels of endogenous and overproduced
Cdc5 protein. (A) Exponentially (L) growing culture of the strain
Y79 (wild type) and Y114 (GAL1::CDC5) were grown in
YEP+3%raffinose. The cell cultures were treated with nocodazole
to block and maintained the cells in G2/M. Galactose was then
added to induce the overproduction of Cdc5 and sample have
been taken at the indicated times. (A) The cell cycle block in G2/
M was analyzed by FACS. (B) Cdc5 protein was analysed by
western blotting with polyclonal antibody, which recognized both
the endogenous Cdc5 and the overproduced Cdc5-myc tagged
protein.
Found at: doi:10.1371/journal.pgen.1000763.s001 (0.96 MB TIF)
Figure S2 Overproduced Cdc5 co-immunoprecipitates with
Rad53. (A) Cultures of the strains Y79 (wild type), Y114
(GAL1::CDC5-MYC), exponentially (L) growing in YEP+3%raffi-
nose were blocked in G2/M by nocodazole treatment (N) and
zeocin (50 mg/ml) was then added to cause DSBs formation. After
30 min. of treatment with zeocin, 2% galactose was added and
samples were taken after 1 hour. Overproduced Cdc5 protein has
been immunoprecipitated with anti MYC antibody. Cdc5-MYC
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and Rad53 proteins were analysed by western blotting with
monoclonal antibodies 9E10 (aMYC) and Ma.EL7 (aRad53).
Found at: doi:10.1371/journal.pgen.1000763.s002 (0.32 MB TIF)
Figure S3 Overproduction of Cdc5 does not prevent DSB repair
by Single Strand Annealing (SSA). (A) Schematic representation of
the YMV80 system used to detect DSB repair by SSA. Vertical
bars show the relevant KpnI sites. After the HO cleavage, DNA is
resected. When the left and right leu2 sequences have been
converted to ssDNA, repair by SSA can take place and can be
monitored by the appearance of a SSA product in a Southern blot.
(B,C) YEP+raffinose nocodazole-arrested cell cultures of wild type
YMV80 and isogenic GAL1::CDC5 strain were transferred to
nocodazole-containing YEP+raffinose+galactose (time zero). (B)
KpnI-digested genomic DNA, prepared from cells collected at the
indicated times, was analysed by Southern blotting with a LEU2
probe. Two fragments, 8 and 6 kb long (his4::leu2, leu2::HOcs) are
evident in the absence of HO cut, whereas the HO-induced DSB
causes the disappearance of the 6-kb species and the formation of a
2.5-kb fragment (HO-cut fragment). Repair by SSA converts such
fragment to a repair product of 3.5-kb (SSA-product). (C) Western
blot analysis of protein extracts with anti-Rad53 antibodies
(Mab.EL7).
Found at: doi:10.1371/journal.pgen.1000763.s003 (0.81 MB TIF)
Table S1 Yeast strains used in this study.
Found at: doi:10.1371/journal.pgen.1000763.s004 (0.05 MB
DOC)
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Introduction
Chromosome segregation during anaphase requires the attach-
ment of kinetochores to the mitotic spindle and removal of sister 
chromatid cohesion (Peters et al., 2008). In particular, cohesin 
must be cleaved by separase (Esp1 in yeast), which is kept in check 
by securin (Pds1 in yeast) until anaphase onset (Uhlmann, 2001). 
The ubiquitin ligase anaphase-promoting complex (APC) bound 
to its activator Cdc20 drives securin proteolysis and cohesin cleav-
age by separase at the metaphase-to-anaphase transition, thereby 
allowing sister chromatid separation (Nasmyth, 2002; Peters, 
2006). Separase also contributes to mitotic exit and cyclin B prote-
olysis by acting in the Cdc14 early anaphase release (FEAR) path-
way for nucleolar release and activation of the Cdc14 phosphatase. 
Indeed, Cdc14 is kept inactive in the nucleolus for most of the cell 
cycle as part of the regulator of nucleolar silencing and telophase 
exit (RENT) complex, which includes the Cdc14 inhibitor Net1/
C!1 and the silencing protein Sir2 (Stegmeier and Amon, 2004). 
Besides separase, FEAR involves the polo kinase Cdc5, the Slk19 
kinetochore protein, Spo12, and Bns1 (Stegmeier et al., 2002) and 
is negatively regulated by protein phosphatase 2A (Queralt et al., 
2006), the replication fork block protein Fob1 (Stegmeier et al., 
2004), and Tof2 (Waples et al., 2009). By promoting a !rst wave 
of partial Cdc14 release from the nucleolus in early anaphase, 
FEAR allows activation of the mitotic exit network (MEN), which 
leads to complete Cdc14 release and activation, thereby triggering 
cyclin B proteolysis and mitotic exit (Visintin et al., 1998).
The spindle assembly checkpoint (SAC) is a ubiquitous 
safety device ensuring the !delity of mitotic chromosome segrega-
tion. During the process of microtubule capture by kinetochores in 
Upon prolonged activation of the spindle assembly checkpoint, cells escape from mitosis through a mechanism called adaptation or mitotic slippage, 
which is thought to underlie the resistance of cancer cells 
to antimitotic drugs. We show that, in budding yeast, this 
mechanism depends on known essential and nonessential 
regulators of mitotic exit, such as the Cdc14 early ana-
phase release (FEAR) pathway for the release of the 
Cdc14 phosphatase from the nucleolus in early anaphase. 
Moreover, the RSC (remodel the structure of chromatin) 
chromatin-remodeling complex bound to its accessory 
subunit Rsc2 is involved in this process as a novel compo-
nent of the FEAR pathway. We show that Rsc2 interacts 
physically with the polo kinase Cdc5 and is required for 
timely phosphorylation of the Cdc14 inhibitor Net1, which 
is important to free Cdc14 in the active form. Our data 
suggest that fine-tuning regulators of mitotic exit have im-
portant functions during mitotic progression in cells treated 
with microtubule poisons and might be promising targets 
for cancer treatment.
The RSC chromatin-remodeling complex influences 
mitotic exit and adaptation to the spindle assembly 
checkpoint by controlling the Cdc14 phosphatase
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GAL1-MAD2 cells remained arrested for Y4–5 h and then 
started to escape mitosis and enter in the next cycle, forming 
microcolonies of four or more cells on galactose-containing 
plates 6–8 h after release from G1 (Fig. 1 B) and eventually gen-
erating visible colonies (Fig. S1 B). Thus, Mad2-overproducing 
cells undergo mitotic slippage.
Characterization of SAC adaptation  
in yeast
In vertebrate cells, adaptation to the SAC takes place with SAC 
components still bound to kinetochores and is accompanied 
by cyclin B proteolysis (Brito and Rieder, 2006). As shown in 
Fig. 2 A, yeast GAL1-MAD2 cells slipped out of mitosis and 
started reaccumulating in G1 7 h after release from G1 in the 
presence of galactose, with concomitant decrease of securin 
(Pds1) and cyclin B (Clb2) levels, whereas Mad2 levels remained 
constantly high. A similar independent experiment showed that 
GAL1-MAD2 cells carrying the tetracycline operator/repressor 
(tetO/tetR)–GFP system to monitor sister chromatid separation 
(Michaelis et al., 1997) also started separating sister chroma-
tids around the same time (Fig. 2 B). We then analyzed mitotic 
slippage in other conditions that engage the SAC by releas-
ing G1-arrested wild-type cells carrying the aforementioned 
tetO/tetR-GFP system in the presence of the microtubule- 
depolymerizing drugs nocodazole or benomyl. Bipolar spindles 
did not assemble in either condition, although a fraction of 
benomyl-treated cells displayed cytoplasmic microtubules 4 and 
6 h after release (see next paragraph). In spite of the complete 
absence of spindles, both nocodazole- and benomyl-treated 
cells underwent Pds1 and Clb2 degradation, separated sister 
chromatids, and slipped out of mitosis, although cells seemed 
to adapt faster in benomyl than in nocodazole (Fig. 2 C). 
In fact, benomyl-treated cells underwent almost complete Pds1 
and Clb2 degradation, which resulted in cell division and reac-
cumulation of unbudded cells within 10 h after release. At the 
same time, a considerable fraction of nocodazole-treated cells 
was still arrested as large-budded cells with relatively high levels 
of Clb2 (Fig. 2 C).
To assess if adaptation in yeast correlates with silencing 
of SAC signaling, we monitored the levels of Mad1–Bub3 inter-
action, which takes place only in the presence of unattached 
kinetochores (Brady and Hardwick, 2000; Fraschini et al., 
2001b) and therefore is a good readout for SAC signaling. 
G1-arrested cells expressing HA-tagged Bub3 (Bub3-HA3) were 
released in the presence of benomyl or nocodazole, followed by 
monitoring cell cycle progression by FACS analysis and Mad1–
Bub3 interaction by coimmunoprecipitation. Again, 4 and 6 h 
after G1 release, a fraction of benomyl-treated cells (10 and 
50%, respectively) displayed cytoplasmic microtubules (Fig. 2 E), 
which, in some cases, could drive an abnormal chromosome 
segregation (not depicted), but no bipolar spindles were detect-
able. Mad1–Bub3 interaction was stable up to 8 h after the G1 
release in nocodazole-treated cells that were still arrested with 
2C DNA content, whereas it started decreasing in the presence 
of benomyl after 4 h and was undetectable by 8 h, when most 
cells had exited mitosis (Fig. 2 D). The total levels of Mad1, but 
not of Bub3, also decreased in benomyl during the course of the 
prophase and prometaphase, the SAC proteins Bub3, Mad2, 
and Mad3/BubR1 form the mitotic checkpoint complex (MCC), 
which inhibits the activity of Cdc20–APC, thereby preventing 
sister chromatid separation and mitotic exit until all chromosomes 
reach proper bipolar attachment to the mitotic spindle. Other 
SAC proteins, such as Mad1, Bub1, Mps1, and Ipl1/AuroraB, 
amplify the signal and regulate the rate of MCC formation 
(Musacchio and Salmon, 2007). Most SAC proteins accumu-
late at unattached kinetochores during prophase and prometa-
phase and generate from this location the stop anaphase signal 
leading to Cdc20–APC inhibition, possibly by accelerating the 
rate of MCC formation (Musacchio and Salmon, 2007).
Cells do not arrest inde!nitely upon SAC activation, but 
they escape mitosis after a variable amount of time in the pres-
ence of unattached kinetochores. The process by which cells 
leak through the SAC-induced cell cycle arrest when the check-
point is not satis!ed is called adaptation or mitotic slippage 
(Rieder and Maiato, 2004). This process is largely responsible 
for the failure to ef!ciently block tumor progression with chemo-
therapeutic compounds targeting the mitotic spindle, such as 
taxanes and vinca alkaloids. In mammalian cells, mitotic slip-
page depends on progressive degradation of cyclin B, with SAC 
proteins being retained at kinetochores (Brito and Rieder, 2006; 
Gascoigne and Taylor, 2008). In yeast, inhibitory phosphoryla-
tion of cyclin B/Cdks has been proposed to accelerate adapta-
tion to prolonged SAC activation (Minshull et al., 1996).
Here, we report a role for the budding yeast RSC (remodel 
the structure of chromatin) chromatin-remodeling complex in 
timely mitotic exit and adaptation to the SAC as a novel com-
ponent of the FEAR network. The Rsc2-bound form of RSC ap-
pears to in"uence the rate of mitotic slippage by facilitating the 
nucleolar release of Cdc14, which then brings about cyclin B 
proteolysis and mitotic exit. Furthermore, our data suggest that 
Rsc2 regulates the FEAR function of the polo kinase Cdc5 in 
conditions that activate the SAC, but independently of SAC 
components, and provide a link between chromatin structure and 
the regulation of mitotic exit.
Results
MAD2 overexpression as a tool to study 
adaptation to the SAC
To study adaptation to the SAC, we set up conditions that lead 
to SAC hyperactivation without perturbing kinetochore attach-
ment to the mitotic spindle. We cloned MAD2 behind the strong 
galactose-inducible GAL1 promoter (GAL1-MAD2) and inte-
grated this construct in multiple copies in the yeast genome. 
We estimated that the levels of overexpressed Mad2 after 2 h 
in galactose are 20-fold higher than those of endogenous Mad2 
(unpublished data). GAL1-MAD2 cells released from G1 in the 
presence of galactose arrested transiently as large-budded cells 
with undivided nuclei, metaphase spindles, and high levels of 
nuclear Pds1 (Fig. 1 A). This metaphase arrest was caused by 
SAC hyperactivation as it was bypassed by MAD1 and MAD3 
deletions (not depicted), by PDS1 deletion (Fig. S1 C), and by 
expression of the dominant CDC20-107 allele (Fig. S1, A and B), 
which is refractory to SAC inhibition (Hwang et al., 1998).
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Figure 1. MAD2 overexpression induces a transient metaphase arrest. (A) Wild-type (wt; ySP4806) and GAL1-MAD2 (ySP8526) cells were grown in 
YEPR, arrested in G1 with A-factor, and then released in YEPRG medium (t = 0). Samples were collected at the indicated times for FACS analysis of DNA 
contents and kinetics of budding, nuclear division, mitotic spindle formation/elongation, and Pds1 nuclear accumulation. Micrographs show examples of 
nuclear and microtubule staining (t = 150 min after release; bar, 5 µm). (B) Wild-type (W303) and GAL1-MAD2 (ySP6170) cells were grown in YEPR, 
arrested in G1 with A-factor (unbudded cells), and spotted on YEPRG plates (t = 0). At the indicated times, 200 cells for each strain were scored to deter-
mine the frequency of single cells and of microcolonies of two, four, or more than four cells.
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Figure 2. Mitotic slippage upon prolonged treatment with microtubule destabilizers correlates with degradation of APC substrates and dissociation be-
tween Mad1 and Bub3. (A) A-factor–arrested GAL1-MAD2 (ySP8599) cells were released in YEPRG at 30°C (t = 0). A-factor was readded at 3 µg/ml after 
2 h. Samples were collected at the indicated times for Western blot analysis of Pds1-myc18, Clb2, Mad2, and Swi6 (loading control). Cyc, cycling cells. 
(B) G1-arrested GAL1-MAD2 cells carrying the tetO/tetR-GFP markers to score sister chromatid separation (ySP6699; Michaelis et al., 1997) were released 
in YEPRG at t = 0. (C) A-factor–arrested wild-type cells (ySP8534) were released in the presence of nocodazole or benomyl at t = 0. A-factor was readded 
at 3 µg/ml after 2 h, and samples were collected at the indicated times for Western blot analysis (top) of Pds1-myc18, Clb2, and Cdc11 (loading control), 
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cannot undergo Tyr19 inhibitory phosphorylation, or nondegrad-
able Clb2. In contrast, deletion of the cyclin B/Cdk inhibitor Sic1 
(Mendenhall, 1993; Schwob et al., 1994) had no effect.
We then asked whether SAC adaptation depends on cell 
cycle regulators that modulate mitotic exit and proteolysis of 
mitotic cyclins. Indeed, CDC20 repression from the MET3 
promoter markedly prolonged the metaphase arrest of GAL1-
MAD2 cells (Fig. 3 C), suggesting that high levels of Mad2 are 
not suf!cient to maintain Cdc20–APC inhibition for a long time. 
Inactivation of the polo kinase Cdc5 through a MET3-CDC5 
fusion yielded similar results (Fig. 3 C).
Adaptation to the SAC upon MAD2 overexpression might 
also be in"uenced by advancing or delaying activation of the 
experiment but not as dramatically as in the Bub3 immuno-
precipitates. Therefore, adaptation to the SAC in yeast is accompa-
nied by silencing of checkpoint signaling.
Adaptation to the SAC requires cyclin B 
degradation, Cdc20, the polo kinase Cdc5, 
and Cdc14 nucleolar release
As SAC adaptation involves Clb2 proteolysis, we asked whether 
cyclin degradation, Cdk inhibitory phosphorylation, and/or Cdk 
inhibitors were required for mitotic slippage upon MAD2 over-
expression. As shown in Fig. 3 (A and B), microcolony formation 
of GAL1-MAD2 cells on galactose plates was effectively de-
layed by expression of either the Cdk1 variant Cdc28-F19, which 
as well as to monitor kinetics of budding, bipolar spindle formation, and sister chromatid separation (bottom graphs). (D and E). Cells expressing Bub3-
HA3 (ySP8709) were treated as in C. At the indicated times, interaction between Bub3-HA3 and Mad1 was assessed by coimmunoprecipitation using 
anti-HA antibodies followed by Western blotting with anti-Mad1 and anti-HA antibodies. At the same times, DNA contents were measured by FACS analysis 
(D, histograms) and for tubulin staining by immunofluorescence (E). MTs, microtubules. WCE, whole cell extract. Bar, 5 µm.
 
Figure 3. SAC adaptation requires mitotic exit regulators. (A) GAL1-MAD2 (ySP6170), GAL1-MAD2 sic1% (ySP8706), and GAL1-MAD2 CDC28-F19 
(ySP8704) cells were grown in YEPR, arrested in G1 with A-factor (unbudded cells), and spotted on YEPRG plates (t = 0) at 30°C. 200 cells were scored 
at each time point for microcolony formation. (B) Cycling cultures of GAL1-MAD2 (ySP3344) and GAL1-MAD2 GAL1-CLB2%DB (ySP8710) cells grown 
in YEPR were spotted on YEPRG plates (t = 0) at 30°C to follow microcolony formation. A fraction of GAL1-MAD2 GAL1-CLB2%DB cells remained unbud-
ded because Clb2$DB inhibits budding (Surana et al., 1993). (C) GAL1-MAD2 (ySP6170), GAL1-MAD2 MET3-CDC20 (ySP8138), and GAL1-MAD2 
MET3-CDC5 (ySP8226) cells were grown in raffinose-containing medium lacking methionine, arrested in G1 with A-factor (unbudded cells), and spotted 
on YEPRG supplemented with 2 mM methionine (t = 0) to follow microcolony formation. (D) GAL1-MAD2 (ySP6170), GAL1-MAD2 bub2% (ySP7677), and 
GAL1-MAD2 NET1-6Cdk (ySP7958) cells were treated as in A.
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this phenotype carried the transposon insertion 3 to the RSC2 
gene, encoding an accessory subunit of the chromatin-remodeling 
complex RSC (Cairns et al., 1999). Indeed, the Rsc2-containing 
RSC complex seemed a good candidate for adaptation to the 
SAC because it had been previously implicated in chromosome 
segregation, mitotic progression, and regulation of sister chro-
matid separation (Hsu et al., 2003; Baetz et al., 2004; Huang and 
Laurent, 2004). Moreover, RSC2 deletion was shown to have 
synthetic effects with mutations altering kinetochore compo-
nents or cohesin (Baetz et al., 2004).
The latter observations were extended by analyzing the 
effects of RSC2 deletion in a set of mutants in kinetochore 
components (Dam1 and Cep3) or microtubule-binding proteins 
(Stu2 and Cin8; Fig. S2 A). Besides con!rming genetic inter-
actions previously reported by others, RSC2 deletion caused hyper-
sensitivity to benomyl and decreased the maximal permissive 
temperature of the kinetochore mutants dam1-11, cep3-10, and 
stu2-10, as well as that of cin8% cells lacking the BimC family 
kinesin Cin8, which has a major role in spindle assembly (Hoyt 
et al., 1992). Because the aforementioned mutations and beno-
myl treatment engage the SAC, the deleterious effects of RSC2 
deletion in these conditions might be caused by prolonged 
Cdc14 phosphatase that is necessary for mitotic exit. We thus 
forced unscheduled activation of the MEN and subsequent 
Cdc14 nucleolar release by eliminating the MEN inhibitor Bub2 
(Piatti et al., 2006). Conversely, we delayed Cdc14 activation by 
expression of a nonphosphorylatable Net1 variant (Net1-6Cdks) 
that does not allow the transient release of Cdc14 from the 
nucleolus in early anaphase (Azzam et al., 2004). Notably, 
BUB2 deletion accelerated microcolony formation of GAL1-
MAD2 cells on galactose plates, whereas NET1-6Cdk expres-
sion slowed it down (Fig. 3 D), suggesting that Cdc14 release 
from the nucleolus might be important for SAC adaptation.
The chromatin-remodeling RSC complex is 
involved in adaptation to the SAC
Because MAD2 overexpression provides a good experimental 
setup to study the molecular bases of SAC adaptation in the 
absence of spindle/kinetochore defects, we used transposon 
mutagenesis of GAL1-MAD2 cells to identify factors in-
volved in adaptation and/or in !ne tuning of mitotic exit. To 
this end, we screened for clones that were hypersensitive to 
MAD2 overexpression and likely prolonged their cell cycle 
arrest under these conditions. We found that several clones with 
Figure 4. The RSC complex is involved in SAC adaptation. (A) GAL1-MAD2 (ySP6170) and GAL1-MAD2 rsc2% (ySP6850) cells were grown in uninduced 
conditions (YEPR), arrested in G1 with A-factor (unbudded cells), and spotted on YEPD (Glu) and YEPRG (Gal) plates (t = 0) at 30°C. 200 cells were scored 
at each time point for microcolony formation. (B) The same strains as in A were grown in uninduced conditions, arrested in G1 with A-factor at 25°C, and 
released on YEPRG medium (t = 0) at 30°C. Samples were collected at the indicated times for Western blot analysis of Mad2 levels (arrow). Cyc, cycling 
cells. (C) The same strains as in A were treated as in B and plated at different times on YEPD plates to assess cell viability. Percentages represent mean 
values of three independent experiments. (D) GAL1-MAD2 (ySP6170) and GAL1-MAD2 GAL1-UBR1 CUP1-sth1td (ySP7808) cells were grown in YEPR 
supplemented with 0.1 mM CuSO4, arrested in G1 with A-factor (unbudded cells), and spotted on YEPRG plates (t = 0) at 37°C to follow microcolony 
formation. Data are representative of three independent repeats.
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RSC2 deletion could prevent mitotic exit and rereplica-
tion of nocodazole-treated SAC mutants by either restoring 
Cdc20–APC inhibition or impinging on pathways controlling 
mitotic exit, such as the FEAR or MEN pathways for Cdc14 
nucleolar release. In fact, whereas Cdc20–APC is required 
for degradation of securin and a fraction of cyclin B, Cdc14 
triggers Cdh1/APC activation, which completes cyclin B deg-
radation and drives accumulation of the Cdk inhibitor Sic1 
(Visintin et al., 1998). To distinguish between these two pos-
sibilities, we !rst analyzed Pds1 and Clb2 degradation, as well 
as Sic1 accumulation, in wild-type, mad2%, rsc2%, and mad2% 
rsc2% cells that were released from G1 in the presence of 
nocodazole. As shown in Fig. 5 C, Pds1 was degraded in both 
mad2% and mad2% rsc2% cells, whereas a fraction of Clb2 was 
stabilized and Sic1 did not accumulate in mad2% rsc2% cells, 
in contrast to mad2% cells. These results are consistent with 
the role of RSC in the regulation of mitotic exit and, in par-
ticular, of Cdc14 nucleolar release (see next paragraph), rather 
than in Cdc20–APC activation. Like RSC mutations, mutations 
affecting the FEAR pathway, such as esp1-1 (Fraschini et al., 
2001a), spo12% bns1%, slk19% (Fig. S4 B), and NET1-6Cdk 
(not depicted) prevented rereplication of nocodazole-treated 
mad2% cells. In addition, simultaneous deletion of SLK19, 
SPO12, and BNS1 retarded microcolony formation of GAL1-
MAD2 cells on galactose plates (Fig. S4 C). Similarly to FEAR 
mutations, RSC2 deletion only modestly delayed mitotic exit 
both in unperturbed conditions (Fig. 6 A) and during recovery 
from nocodazole arrest (Fig. 6 B), as judged by the kinetics of 
spindle disassembly relative to spindle elongation and nuclear 
division. Conversely, lack of Rsc2 delayed the onset of ana-
phase (i.e., spindle elongation and nuclear division) relative to 
bipolar spindle assembly (Fig. 6, A and B), which is consis-
tent with previous observations (Hsu et al., 2003; Baetz et al., 
2004). Thus, RSCRsc2 might regulate mitotic exit in a way simi-
lar to the FEAR pathway in conditions of SAC hyperactivation 
or in the presence of kinetochore/microtubule defects.
Lack of Rsc2 impairs Cdc14 release 
from the nucleolus at the metaphase-to-
anaphase transition
The persistence of Clb2 and the lack of Sic1 accumulation in 
nocodazole-treated mad2% rsc2% cells, together with the simi-
lar effects caused by RSC and FEAR inactivation in SAC mu-
tants upon microtubule disruption, suggested that RSCRsc2 might 
be involved in the control of Cdc14 release from the nucleolus. 
We therefore analyzed Cdc14 nucleolar release in mad2%, 
rsc2%, and mad2% rsc2% cells released from G1 in the presence 
of nocodazole. Although mad2% cells transiently released 
Cdc14, all other strains retained it in the nucleolus (Fig. 7 A), 
suggesting that RSCRsc2 is required for Cdc14 release in these 
conditions. Strikingly, expression of the Cdc14TAB6-1 dominant 
variant that associates loosely to its inhibitor Net1 (Shou et al., 
2001) restored the ability of nocodazole-treated mad2% rsc2% 
cells to rereplicate DNA (Fig. 7 B), whereas it was not suf!cient 
by itself to promote mitotic exit in these conditions (not de-
picted). These data support the notion that RSCRsc2 inactivation 
interferes with Cdc14 nucleolar release and activation, prompting 
SAC activation. Indeed, RSC2 deletion turned out to be lethal 
for GAL1-MAD2 cells in the presence of galactose (Fig. S2 B and 
Fig. 4 C). We then scored microcolony formation of GAL1-MAD2 
and GAL1-MAD2 rsc2% cells upon plating G1-synchronized 
cells on media containing either glucose (GAL1-MAD2 off) or 
galactose (GAL1-MAD2 on). Deletion of RSC2 slightly delayed 
cell cycle progression on glucose plates compared with other-
wise wild-type cells in the presence of galactose (Fig. 4 A). Strik-
ingly, the presence of galactose caused GAL1-MAD2 rsc2% 
cells to remain arrested in mitosis as large-budded cells for a 
longer time than GAL1-MAD2 cells (Fig. 4 A), in spite of com-
parable levels of Mad2 (Fig. 4 B). This behavior paralleled with 
the dramatic lethal effect of GAL1-MAD2 overexpression in 
rsc2% cells (Fig. 4 C).
Deletion of RSC1, encoding an RSC subunit alternative to 
Rsc2 (Cairns et al., 1999), had no effect on the mitotic escape of 
GAL1-MAD2 cells on galactose plates (Fig. S3 A), suggesting 
that the Rsc2-containing form of RSC (RSCRsc2) is speci!cally 
implicated in this process. The lack of Rsc2 also prolonged the mi-
totic arrest of MPS1-overexpressing cells (Fig. S3 B), which tran-
siently hyperactivate the SAC and eventually adapt (Hardwick 
et al., 1996), and of benomyl-treated cells (Fig. S3 C).
We then asked whether Rsc2 has a role in SAC adaptation 
as part of the RSC complex or independently of it. This was not 
trivial because all core RSC subunits are essential and must be in-
activated by temperature-sensitive mutations, whereas the GAL1 
promoter required to overexpress MAD2 is very inef!cient at high 
temperatures. Indeed, GAL1-MAD2 cells showed only a modest 
cell cycle arrest at 37°C, as almost 50% of the cells had escaped 
from the arrest and formed microcolonies of four or more cells on 
galactose within 4 h after plating (Fig. 4 D). However, RSC inacti-
vation by the temperature-sensitive degron allele of STH1 (sth1td; 
Parnell et al., 2008), which encodes the RSC catalytic subunit, 
delayed adaptation of GAL1-MAD2 cells by Y2 h, suggesting that 
the whole RSC complex is involved in this process.
RSCRsc2 inactivation prevents mitotic exit 
of SAC-deficient mutants in the presence 
of microtubule-depolymerizing drugs
As RSC inactivation might delay escape from mitosis by pro-
longing the SAC-dependent cell cycle arrest, we investigated 
its effects in SAC-de!cient mutants treated with microtubule- 
depolymerizing drugs. To this end, wild-type, mad2%, rsc2%, 
and mad2% rsc2% cells were arrested in G1 by A-factor and 
released in the presence of nocodazole. As expected, mad2% 
cells rereplicated their DNA ef!ciently and accumulated DNA 
contents higher than 2C under these conditions, which instead 
caused the double mad2% rsc2% mutant to arrest in mitosis 
similarly to wild-type and rsc2% cells (Fig. 5 A). Deletion of 
RSC2 prevented mitotic exit also of nocodazole-treated mad1%, 
mad3%, bub1%, bub3%, cdc55%, and CDC20-107 cells (un-
published data). Moreover, rereplication of mad2% cells upon 
microtubule disruption was inhibited also by Sth1 inactivation 
through the sth1td allele (Fig. 5 B), whereas it was not affected 
by RSC1 deletion (Fig. S4 A). Altogether, these data suggest 
that RSCRsc2 is required for the unscheduled mitotic exit of SAC 
mutants in the presence of spindle defects.
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bns1% cells arrested in telophase and showed no sign of total 
Cdc14 release. Moreover, Cdc14 partial release was abolished 
in GAL1-BFA1 spo12% bns1% cells and severely compromised 
in GAL1-BFA1 rsc2% cells (Fig. 7 C). Thus, Rsc2 and presum-
ably the whole RSCRsc2 complex contribute to the early ana-
phase release of Cdc14 from the nucleolus.
Deletion of RSC2 has synthetic effects 
with mutations affecting the MEN
We analyzed the relationships between RSC and the FEAR or the 
MEN cascades by combining RSC2 deletion with FEAR or MEN 
mutations. Deletion of RSC2 caused little or no synthetic growth 
defects when combined with the FEAR mutations slk19%, spo12% 
bns1%, and esp1-1 (unpublished data), suggesting that RSCRsc2 
works together with or in parallel to the FEAR pathway.
Inactivation of the FEAR pathway is known to be lethal for 
cells lacking the nonessential MEN activator Lte1 (Stegmeier 
et al., 2002). Similarly, RSC2 deletion was found to be lethal 
with LTE1 deletion (Ye et al., 2005). In fact, rsc2% lte1% cells 
us to directly compare the kinetics of Cdc14 release from the 
nucleolus in rsc2% cells versus wild type and the FEAR mutant 
spo12% bns1%. To monitor only the partial Cdc14 release at the 
anaphase onset, we prevented MEN activation by overexpressing 
BFA1 from the GAL1 promoter (Li, 1999). Wild-type, GAL1-BFA1, 
GAL1-BFA1 rsc2%, and GAL1-BFA1 spo12% bns1% cells were 
synchronized in G1 and released in galactose-containing me-
dium. We then followed partial and total Cdc14 release from 
the nucleolus during the cell cycle. As expected, wild-type cells 
started releasing Cdc14 after metaphase spindles had been 
assembled and concomitant to spindle elongation (Fig. 7 C). 
Nuclear division immediately followed, and Cdc14 was com-
pletely released into the nucleoplasm and cytosol before cyto-
kinesis. Consistent with MEN inhibition, GAL1-BFA1 cells 
arrested in telophase as large-budded cells with 2C DNA con-
tents, divided nuclei, and elongated spindles. As expected, 
Cdc14 total release was abolished in these cells, and only the 
partial release in anaphase could be observed (Fig. 7 C). Like 
GAL1-BFA1 cells, GAL1-BFA1 rsc2% and GAL1-BFA1 spo12% 
Figure 5. Lack of the RSC complex prevents mitotic exit of nocodazole-treated SAC-defective cells. (A) Cultures of wild-type (wt), mad2%, rsc2%, and 
mad2% rsc2% cells (ySP4806, ySP1084, ySP6997, and ySP7543) were grown in YEPD, arrested in G1 by A-factor, and then released into medium con-
taining nocodazole (t = 0). At the indicated times, cell samples were withdrawn for FACS analysis of DNA contents. (B) Cultures of mad2% (ySP1070) and 
GAL1-UBR1 CUP1-sth1td mad2::TRP1 (ySP7869) cells were grown in YEPR containing 0.1 mM CuSO4 and arrested in G1 with A-factor at 27°C. 1 h after 
2% galactose addition, cells were released in nocodazole-containing YEPRG at 37°C (t = 0), followed by FACS analysis of DNA contents at the indicated 
times. (C) The same strains and procedure as in A were used, but 10 µg/ml A-factor was readded to all cultures at t = 100 min after release (>90% of 
budded cells). At the indicated times, cells were collected for FACS analysis of DNA contents (not depicted) and for Western analysis of Pds1, Clb2, Sic1, 
and Swi6 (loading control). Cyc, cycling cells.
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cells contained Cdc5-Flag3, which was instead absent in the 
immunoprecipitates from the untagged Rsc2 strain (Fig. 9 A). 
Rsc2 could also bind the polo-box domain (PBD) of Cdc5, 
which normally binds substrates previously primed by phos-
phorylation by another kinase (Elia et al., 2003a). Indeed, Rsc2-
HA3 bound to a recombinant GST-PBD fusion protein (Miller 
et al., 2009) but not to GST alone (Fig. 9 B). Surprisingly, this 
binding was not disrupted by mutating the critical W517V518L530 
residues (Elia et al., 2003b) into FAA, suggesting that it might 
be independent of preliminary phosphorylation.
Because Rsc2 binds to Cdc5 and is required for timely re-
lease of Cdc14 from the nucleolus, we evaluated whether RSC2 
deletion affected Net1 phosphorylation, which depends on 
Cdc5 and is required to release Net1-Cdc14 association (Shou 
et al., 2002; Yoshida and Toh-e, 2002). As shown in Fig. 9 D, 
a slow-migrating band corresponding to phosphorylated Net1 
(Visintin et al., 2003; Queralt et al., 2006) appeared during ana-
phase in wild-type cells (80–90 min after release from G1 arrest; 
Fig. 9 C), whereas it was barely detectable in the absence of Rsc2, 
suggesting that the FEAR function of Cdc5 might require the 
RSCRsc2 complex.
RSC was previously involved in sister chromatid cohe-
sion (Baetz et al., 2004; Huang and Laurent, 2004), and Cdc5 
facilitates cohesin cleavage and sister chromatid separation 
besides promoting Cdc14 activation (Alexandru et al., 2001). 
We then asked whether Cdc5 distribution along chromosomes 
was altered in the absence of Rsc2 by studying Cdc5-Flag3 chro-
mosomal distribution by ChIP (chromatin immunoprecipitation)- 
on-chip on the whole genome of yeast cells arrested in mitosis. 
were, in most cases, inviable or extremely sick also in our ge-
netic background (Fig. 8 A), and this lethality could be rescued 
by BUB2 deletion (not depicted), suggesting that it was caused 
by constitutive trapping of Cdc14 in the nucleolus. RSC2 dele-
tion also caused sickness and lethality when combined with the 
temperature-sensitive alleles cdc5-2, affecting polo kinase, and 
cdc14-3, respectively (Fig. 8 A). In addition, it decreased the 
maximal permissive temperature of the tem1-3, cdc15-2, dbf2-2, 
and cdc14-1 MEN mutants (Fig. 8 B), supporting the notion that 
RSCRsc2 regulates Cdc14 release from the nucleolus. Accord-
ingly, RSC2 overexpression suppressed cdc15-2 lethality at 
32°C (Fig. 8 C). Thus, RSCRsc2 controls Cdc14 release from the 
nucleolus at the metaphase/anaphase transition independently 
of MEN and in concert with the FEAR pathway.
Rsc2 interacts with the polo kinase  
Cdc5 and contributes to timely  
Net1 phosphorylation
FEAR components have been recently found to interact with 
the polo kinase Cdc5 (Rahal and Amon, 2008), which has a key 
role in Cdc14 nucleolar release acting in both the FEAR and 
the MEN pathways (Stegmeier and Amon, 2004). The Xenopus 
laevis homologue of Rsc2, polybromo-1/BAF180, was found to 
interact with polo kinase (Yoo et al., 2004), and Rsc2 itself was 
predicted to be a likely binding partner of Cdc5 (Snead et al., 
2007). To investigate whether Rsc2 interacts with Cdc5, we ex-
pressed Flag-tagged Cdc5 (Cdc5-Flag3) in cells expressing either 
untagged Rsc2 or HA-tagged Rsc2 (Rsc2-HA3). Rsc2-HA3 
immunoprecipitates from both cycling and nocodazole-arrested 
Figure 6. Cell cycle progression of rsc2% cells and their recovery from SAC activation. (A) Cultures of wild-type (wt; ySP4806) and rsc2% (ySP6997) cells 
were grown in YEPD, arrested in G1 by A-factor, and then released in fresh medium (t = 0). At the indicated times, samples were analyzed as in Fig. 1 A. 
(B) The same strains as in A were grown in YEPD, arrested in mitosis by 5 µg/ml nocodazole treatment, and then released (t = 0) in 10 µg/ml YEPD con-
taining A-factor, followed by the same analyses as in Fig. 1 A.
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level, drives cells out of mitosis (Brito and Rieder, 2006; 
Gascoigne and Taylor, 2008). We show here that, similar to ver-
tebrate cells, mitotic slippage in budding yeast, either in the pres-
ence of microtubule inhibitors or upon SAC hyperactivation in 
the absence of spindle damage, is accompanied by securin and 
cyclin B degradation and is delayed by expression of nondegrad-
able cyclin B. As in mammalian cells (Brito and Rieder, 2006; 
Gascoigne and Taylor, 2008), the timing of mitotic slippage is 
highly variable depending on the conditions, ranging from Y4 
to 5 h in benomyl, 5 to 6 h upon MAD2 overexpression, and 8 to 
10 h in nocodazole. We also !nd that, as recently shown in mam-
malian cells (Lee et al., 2010), Cdc20 and other canonical regu-
lators of cyclin B proteolysis and mitotic exit, such as the polo 
kinase Cdc5, are involved in SAC adaptation. In addition, the 
unphosphorylatable Cdc28-F19 variant delays mitotic slippage 
upon Mad2 overexpression consistently with the older proposal 
that inhibitory phosphorylation of cyclin B/Cdks accelerates 
adaptation to prolonged SAC activation (Minshull et al., 1996). 
Cdc5 localized at centromeres and discrete sites along chromo-
some arms corresponding to cohesin-binding sites (see the left 
arm of chromosome VI as an example; Fig. 10, A and B), and it 
could be found also at recombinant DNA (rDNA; not depicted). 
RSC2 deletion did not affect Cdc5 chromosomal distribution at 
any locus (Fig. 10 A and not depicted), suggesting that Rsc2 
might regulate Cdc5 at levels other than its recruitment to spe-
ci!c chromosomal regions.
Discussion
Adaptation to the SAC depends on 
regulators of mitotic exit
Eukaryotic cells ultimately adapt to persistent SAC signaling 
and exit from mitosis, eventually leading to unbalanced chro-
mosome segregation or cell death (Rieder and Maiato, 2004). 
Mitotic exit under these conditions is linked to a progressive 
decline in cyclin B/Cdk activity that, after reaching a threshold 
Figure 7. Rsc2 controls the early release of Cdc14 from nucleolus. (A) A-factor–arrested wild-type (wt; W303), mad2% (ySP1070), rsc2% (ySP6858), 
and mad2% rsc2% (ySP7088) cells were released in medium containing nocodazole (t = 0). At the indicated times, cells were collected for FACS 
analysis of DNA contents (not depicted) and for detecting Cdc14 release by immunofluorescence. (B) Cultures of mad2% rsc2% (ySP7088) and mad2% 
rsc2% CDC14TAB6-1 (ySP7645) were treated as in A. At the indicated times after release (t = 0), cells were collected for FACS analysis of DNA contents. 
(C) Cultures of wild-type, GAL1-BFA1, GAL1-BFA1 rsc2%, and GAL1-BFA1 spo12% bns1% (W303, ySP1283, ySP7764, and ySP7803) cells were grown in 
YEPR, arrested in G1, and then released in YEPRG (t = 0). Samples were collected at the indicated times for FACS analysis of DNA contents and to follow 
the kinetics of budding, nuclear division, mitotic spindle formation/elongation, and Cdc14 partial/total release.
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relies on the inability of the SAC to inhibit all Cdc20–APC com-
plexes inside the cell (Brito and Rieder, 2006). Presumably, a 
fraction of Cdc20–APC remains active upon SAC activation and 
promotes cyclin B destruction until cyclin B/Cdk activity drops 
below a threshold level suf!cient to drive cells out of mitosis.
Cells expressing Cdc28-F19 were previously shown to be de-
fective in Cdc20–APC activation (Rudner et al., 2000), thereby 
explaining their ability to retard adaptation to the SAC. All these 
data indicate that mitotic slippage requires conventional regula-
tors of mitotic exit and are consistent with the proposal that it 
Figure 8. Functional interactions between RSC2 and MEN genes. (A) Ratio of found/expected segregants observed over expected numbers of viable 
spores with the indicated genotypes after dissection of meiotic tetrads generated from diploid strains heterozygous for the rsc2% (ySP6859) and lte1% 
(ySP3418) alleles, the cdc5-2 (ySP324) and rsc2% (ySP6859) alleles, or the rsc2% (ySP6859) and cdc14-3 (ySP284) alleles. *, very sick viable spores. 
(B) Serial dilutions of strains with the indicated genotypes were spotted on YEPD plates and incubated at the indicated temperatures. (C) Serial dilutions of 
strains with the indicated genotypes were spotted on YEPD (Glu, GAL1 promoter off) and YEPRG (Gal, GAL1 promoter on) plates and incubated for 2 d 
at 30°C and 32°C. wt, wild type.
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Figure 9. Rsc2 interacts physically with Cdc5 and is required for timely Net1 and Cdc14 phosphorylation. (A) Wild type (wt; W303), CDC5-FLAG3 
(ySP7797), and RSC2-HA3 CDC5-FLAG3 (ySP7814) were grown exponentially or arrested in nocodazole for 3 h. Protein extracts were analyzed by 
Western blotting with anti-HA (Rsc2) or anti-Flag (Cdc5) antibodies either directly (total) or after Rsc2 immunoprecipitation with anti-HA antibodies (IPs). 
(B) A protein extract prepared from nocodazole-arrested cells expressing Rsc2-3HA (ySP7092) was incubated with glutathione-Sepharose beads carrying 
GST, GST-PBD, or mutated GST-PBD-FAA. Input and pull-down samples were analyzed by Western blotting with anti-HA or anti-GST antibodies. The bar 
with an asterisk denotes truncated forms of GST-PBD. (C and D) A-factor–arrested wild-type (ySP8573) and rsc2% (ySP8596) cells expressing Net1-myc3 
were released in fresh medium at 25°C (t = 0). At the indicated times, cell samples were collected for FACS analysis of DNA contents (C, histograms), to 
measure the kinetics of budding, spindle formation/elongation, and nuclear division (C, graphs), and for Western blot analysis (D) of Net1-myc3, Clb2, 
and Pgk1 (loading control).
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SAC signaling is a cause or a consequence of adaptation re-
mains to be established.
A role for the RSC complex in the early 
anaphase release of Cdc14 from the 
nucleolus and in mitotic exit regulation
We provide experimental evidence of a novel role for the 
chromatin-remodeling complex RSC in regulation of Cdc14 
nucleolar release and mitotic exit. Remarkably, histone post-
translational modi!cations have been recently implicated in the 
regulation of Cdc14 release from nucleolar chromatin in early 
anaphase (Hwang and Madhani, 2009), suggesting that multiple 
chromatin modi!ers cooperate in this process.
The RSC complex regulates transcription mainly at PolII 
and PolIII promoters (Parnell et al., 2008) and has been implicated 
in several cell cycle processes, such as kinetochore function (Hsu 
et al., 2003) and sister chromatid cohesion (Baetz et al., 2004; 
Upon prolonged treatment with nocodazole, adaptation in 
vertebrate cells takes place with SAC proteins still at kineto-
chores, leading to the proposal that it occurs through SAC 
signaling override (Brito and Rieder, 2006). We show that adap-
tation to the SAC in budding yeast coincides with Mad1 dis-
sociation from Bub3, suggesting that the SAC is silenced. 
Microtubule-binding proteins, such as dynein and spindly, are 
involved in vertebrate SAC silencing through poleward trans-
port of SAC proteins along microtubules (Howell et al., 2001; 
Wojcik et al., 2001; Gassmann et al., 2010). Therefore, it is 
likely that spindle disruption by nocodazole impairs this mecha-
nism, thus accounting for the persistence of SAC proteins at 
unattached kinetochores during adaptation. In addition, Cdk 
activity is required to sustain the SAC (Li and Cai, 1997; 
Kitazono et al., 2003; Yamaguchi et al., 2003), and it drops dur-
ing adaptation, suggesting that SAC signaling is likely to de-
cline during mitotic slippage. In any case, whether silencing of 
Figure 10. RSC2 deletion does not affect Cdc5 chromosomal distribution. Wild-type (wt; ySP7797) and rsc2$ cells (ySP8200) expressing FLAG-tagged 
Cdc5 (A) and wild-type cells expressing PK-tagged Scc1 (B) were arrested in mitosis with benomyl and treated for ChIP-on-chip analysis. Enrichment of DNA 
fragments in the immunoprecipitate relative to a whole-genome DNA sample is shown along the first 160 kb (left arm and centromere) of chromosome VI. 
The y-axis scale is log2. Orange signals represent significant binding as previously described (Katou et al., 2003). The used statistical algorithm is identical 
to that for the GeneChip Operating Software (Affymetrix). The greenish signal indicates the centromere. Blue bars above and below the midline represent 
ORFs transcribed from left to right and opposite, respectively. A region around 140 kb masked by a gray box corresponds to Ty retrotransposon, which 
exists in multiple copies in the genome and was omitted from the analysis.
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Cdc14 nucleolar release by RSC might be exerted at levels differ-
ent from the rDNA. Several other possibilities can be envisioned: 
for example, RSC could have roles independent from its binding 
to chromatin, or it could locally regulate Cdc5 kinase activity 
and/or access to its substrates. Alternatively, because Cdc14 and 
Net1 bind to different sequences within the rDNA (Huang and 
Moazed, 2003; Stegmeier et al., 2004), and their binding is regu-
lated by Cdc5 (Shou et al., 2002), changes in chromatin structure 
might affect interactions within the RENT complex and/or make 
it more susceptible to Cdc5-dependent regulation. Interestingly, 
sister chromatid cohesion at the transcriptionally silent mating 
type loci requires both Sir2, which is also part of the RENT com-
plex (Shou et al., 1999), and RSCRsc2 (Chang et al., 2005), sug-
gesting that functional interactions between RSC and Sir2 may 
take place at other chromosomal locations.
Knowing the exact function of Cdc5 in the FEAR network 
and Cdc14 nucleolar release will certainly help addressing the 
role of RSCRsc2 in Cdc5 regulation. The FEAR function of Cdc5 
has been recently attributed primarily to Cdc5’s ability to stimu-
late degradation of Swe1, the Wee1-like Cdk inhibitory kinase 
(Liang et al., 2009). However, SWE1 deletion could not bypass 
the mitotic arrest of nocodazole-treated mad2% rsc2% cells (un-
published data), whereas the CDC14TAB6-1 allele could do so, 
indicating that Cdc5 targets other substrates besides Swe1 to 
carry out its FEAR function. Interestingly, Cdc5 was recently 
shown to interact with Cdc14 (Snead et al., 2007; Rahal and 
Amon, 2008), suggesting that it might directly regulate its bind-
ing to Net1 and/or its phosphatase activity.
Budding yeast as a tool for the discovery 
of fine-tuning regulators of mitotic exit and 
candidate targets in cancer therapy
Recent data showed that cancer cells undergo two alternative 
and competing pathways after prolonged treatment to micro-
tubule toxins: either they die by apoptosis or slip out of mitosis 
(Gascoigne and Taylor, 2008). Both the apoptotic and slippage 
pathways have thresholds, and the fate of the cell is dictated 
by which threshold is breached !rst. Importantly, inhibiting the 
cell death pathway by caspase inactivation commits cells to slip 
out of mitosis, whereas interfering with cyclin B degradation 
and mitotic exit channels cells into the apoptotic pathway. Thus, 
discovering the factors that in"uence the rate of adaptation to 
microtubule toxins in different organisms is clearly a crucial 
issue in cancer research. For example, the ef!cacy of antimitotic 
drugs could be markedly increased by inhibiting factors involved 
in mitotic slippage, thus favoring cell death.
Our data indicate that the molecular bases for adaptation 
to chronic SAC activation are likely conserved in all eukaryotic 
cells, making budding yeast a good model system to identify 
factors in"uencing the rate of mitotic slippage. Indeed, MAD2-
overexpressing cells have proven to be a valuable tool to !nd 
novel factors involved in !ne-tuning regulation of mitotic exit 
and SAC adaptation, which are potential targets for cancer 
treatment. Strikingly, mitotic exit has recently been proposed 
to be a better cancer therapeutic target than spindle assembly 
because Cdc20 inhibition ef!ciently kills cancer cells, prevent-
ing mitotic slippage and providing more time for apoptosis 
Huang and Laurent, 2004). However, transcriptional regulation of 
several classes of mitotic genes seems unaffected by RSC inacti-
vation (Cao et al., 1997), suggesting that this complex might 
have additional and perhaps more direct functions in cell cycle 
progression. Other chromatin regulators have been involved in cell 
cycle processes unrelated to their transcriptional function. For 
example, chromatin-remodeling proteins were also found at 
human centrosomes, where they regulate the recruitment of 
centrosomal proteins, microtubule organization, and cytokinesis 
(Sillibourne et al., 2007).
Budding yeast RSC associates with two alternative and 
closely related subunits, Rsc1 and Rsc2 (Cairns et al., 1999), 
which were previously found to be differentially involved in 
mitotic processes, such as sister chromatid cohesion and 2-µm 
plasmid partitioning (Wong et al., 2002; Baetz et al., 2004). 
However, Rsc1 and Rsc2 bind to the same chromosomal regions 
(Ng et al., 2002), raising the possibility that differences in their 
abundance might account for their unique properties. Our data 
indicate that RSCRsc2, and not RSCRsc1, is speci!cally implicated 
in Cdc14 activation and adaptation to the SAC. The involvement 
of RSCRsc2 in the control of mitotic exit is particularly apparent 
in conditions that activate the SAC, such as upon microtubule 
disruption or MAD2 overexpression. Indeed, RSC impairment 
through RSC2 deletion delays mitotic exit under these condi-
tions but not during the unperturbed cell cycle. In this respect, 
RSC mutants behave similarly to FEAR mutants, which show 
a marked mitotic exit defect only when the MEN is partially 
inactive (Stegmeier et al., 2002). This raises the interesting pos-
sibility that RSC is itself part of the FEAR or acts in a parallel 
pathway. Indeed, RSC2 deletion, like FEAR mutations (Stegmeier 
et al., 2002; Queralt and Uhlmann, 2008), impairs Net1 phos-
phorylation and prevents the partial nucleolar release of Cdc14 
in early anaphase. Furthermore, it is lethal for lte1% cells and 
causes synthetic lethality/sickness to several MEN mutants. 
How RSCRsc2 might regulate Cdc14 release from the nucleolus 
remains an open question, but our !nding that Rsc2, like other 
FEAR components (Rahal and Amon, 2008), interacts physi-
cally with Cdc5 provides a possible mechanistic explanation. 
The Rsc2–Cdc5 interaction does not seem to require the critical 
residues in the PBD that are involved in phosphoepitope recog-
nition (Song et al., 2000; Elia et al., 2003b), suggesting that it 
might be independent of prior Rsc2 phosphorylation and follow 
unconventional rules. Interestingly, the homologue of Rsc2 in 
higher eukaryotes, Baf180, interacts with the polo-like kinase 
in X. laevis (Yoo et al., 2004).
How could RSC regulate the FEAR function of Cdc5? 
Because RSC was found at numerous PolII and PolIII promot-
ers (Ng et al., 2002) as well as at centromeres (Hsu et al., 2003), 
we wondered whether RSC might regulate Cdc5 recruitment to 
speci!c chromosomal regions. However, our ChIP-on-chip data 
rule out this possibility. We found that Cdc5 binds to the rDNA, 
where it might interact with the RENT complex and promote 
Cdc14 release, but this chromosomal location is also unaffected 
by RSC2 deletion (unpublished data). In addition, deletion of the 
whole rDNA region from chromosome XII did not rescue the 
ability of mad2% rsc2% cells to rereplicate DNA in the presence 
of nocodazole (unpublished data), suggesting that the control of 
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Cdc11 (Santa Cruz Biotechnology, Inc.), Pgk1 (Invitrogen), Sic1, and 
Swi6. Secondary antibodies were obtained from GE Healthcare, and 
proteins were detected by an enhanced chemiluminescence system (ECL; 
GE Healthcare) according to the manufacturer.
Other techniques
Flow cytometric DNA quantitation and in situ immunofluorescence were 
performed according to Fraschini et al. (1999). Nuclear division was 
scored with a fluorescence microscope (Eclipse E600; Nikon) on cells 
stained with propidium iodide. To detect spindle formation and elongation, 
B-tubulin immunostaining was performed with the YOL34 mAB (AbD Sero-
tec) followed by indirect immunofluorescence using rhodamine-conjugated 
anti–rat antibody (Thermo Fisher Scientific). Cdc14 immunostaining was 
performed with sc-12045 polyclonal antibodies (Santa Cruz Biotechnol-
ogy, Inc.) followed by indirect immunofluorescence using CY3-conjugated 
anti–goat antibody (GE Healthcare). Immunostaining of Pds1-myc18 was 
performed by incubation with the 9E10 mAb followed by indirect immuno-
fluorescence using CY3-conjugated anti–mouse antibody (GE Healthcare). 
ChIP-on-chip analysis was performed as previously described (Sutani et al., 
2009). Digital images were acquired at room temperature on a fluorescence 
microscope equipped with a charge-coupled device camera (DC350F; Leica) 
with an oil 100× 1.3 NA Plan Fluor objective (Nikon) using FW4000 soft-
ware (Leica).
Online supplemental material
Fig. S1 shows that the mitotic arrest induced by MAD2 overexpression 
depends on SAC proteins and securin. Fig. S2 shows genetic interactions 
obtained combining RSC2 deletion with mutations in kinetochore compo-
nents or microtubule-binding proteins. Fig. S3 shows the effects of RSC2 
deletion on adaptation to the SAC upon MAD2 or MPS1 overexpres-
sion, as well as upon microtubule depolymerization by benomyl. Fig. S4 
shows that FEAR components, but not Rsc1, are required for mitotic exit 
of mad2% cells treated with nocodazole, as well as for adaptation upon 
MAD2 overexpression. Table S1 contains the list of yeast strains used in 
this study. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201007025/DC1.
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Materials and methods
Strains, media, and reagents
All yeast strains (Table S1) were derivatives of or were backcrossed at least 
three times to W303 (ade2-1, trp1-1, leu2-3,112, his3-11,15, ura3, and 
ssd1). Cells were grown in synthetic complete–selective medium (6.7 g/liter 
yeast nitrogen base supplemented with the appropriate nutrients and sugar) 
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yeast extract, 2% bactopeptone, and 50 mg/liter adenine) supplemented 
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BAR1 and 0.2 µg/ml for bar1 strains. Nocodazole was used at 15 µg/ml 
for prolonged mitotic arrests and 5 µg/ml for nocodazole washout experi-
ments. Benomyl was used at 12.5 µg/ml to test the sensitivity of strains or at 
80 µg/ml for adaptation experiments. For galactose induction of A-factor– 
synchronized cells, galactose was added 0.5 h before release.
Plasmid constructions and genetic manipulations
To clone MAD2 under control of the GAL1-10 promoter (plasmid pSP493), 
a BamHI PCR product containing the MAD2 coding region and 200 bp 
of downstream sequence was cloned into the BamHI site of a GAL1-10– 
bearing YIplac211 vector; pSP493 integration was directed to the URA3 
locus by StuI digestion. To clone RSC2 behind the GAL1-10 promoter (plas-
mid pSP679), a PstI PCR product containing the RSC2 coding region and 
200 bp of downstream sequence was cloned in the PstI site of a GAL1-10–
bearing YIplac128 vector. pSP679 integration was directed to the LEU2 
locus by AflII digestion. Copy number of the integrated plasmids was veri-
fied by Southern analysis. RSC2, LTE1, and RSC1 chromosomal deletion 
were generated by one-step gene replacement (Wach et al., 1994). RSC2 
was tagged immediately before the stop codon by one-step gene tagging 
(Knop et al., 1999). CDC5-3Flag was a gift from E. Schwob (Institute of 
Molecular Genetics, Montpellier, France).
Screen for mutants hypersensitive to MAD2 overexpression
MATa and MATB GAL1-MAD2 strains (ySP6170 and ySP6273) were trans-
formed with an mTn-lacZ/LEU2–mutagenized yeast library (Kumar et al., 
2002). 3.2 × 104 Leu+ transformants were then replica plated on synthetic 
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lism, we streaked out the selected clones on 5-fluoro-orotic acid plates to 
select for their derivatives that had lost the GAL1-MAD2 construct marked 
URA3. The transposons were recovered and sequenced as previously de-
scribed (Kumar et al., 2002) to identify their chromosomal insertion sites.
Immunoprecipitations, pull-downs, and Western blot analysis
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Triton X-100, and 1 mM DTT supplemented with a cocktail of protease 
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were performed as previously described (Brady and Hardwick, 2000; 
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Saccharomyces  cerevisiae  cells  with  a single  double-strand  break  (DSB)  activate  the  ATR/Mec1-dependent
checkpoint  response  as  a  consequence  of  extensive  ssDNA  accumulation.  The  recombination  factor
Tid1/Rdh54,  a member  of the  Swi2-like  family  proteins,  has  an  ATPase  activity  and  may  contribute  to  the
remodelling  of nucleosomes  on DNA.  Tid1  dislocates  Rad51  recombinase  from  dsDNA,  can  unwind  and
supercoil  DNA  filaments,  and  has  been  implicated  in  checkpoint  adaptation  from  a G2/M  arrest  induced
by an unrepaired  DSB.
Here  we show  that  both  ATR/Mec1  and  Chk2/Rad53  kinases  are  implicated  in the  phosphorylation
of Tid1  in the presence  of  DNA  damage,  indicating  that the protein  is  regulated  during  the  DNA  damage
response.  We show  that  Tid1  ATPase  activity  is  dispensable  for  its  phosphorylation  and for  its recruitment
near  a DSB,  but  it  is required  to  switch  off Rad53  activation  and  for  checkpoint  adaptation.  Mec1  and
Rad53  kinases,  together  with  Rad51  recombinase,  are  also implicated  in  the  hyper-phosphorylation  of
the ATPase  defective  Tid1-K318R  variant  and  in  the  efficient  binding  of the  protein  to  the DSB  site.
In  summary,  Tid1  is  a novel  target  of  the DNA damage  checkpoint  pathway  that  is  also  involved  in
checkpoint  adaptation.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
In Saccharomyces cerevisiae cells, formation of one irreparable
DSB elicits a robust activation of Rad53 kinase, a central player
of the DNA damage checkpoint pathway, and a transient cell
cycle block in metaphase (reviewed in [1]). Rad53 is activated
through phosphorylation by the upstream kinase Mec1, which is
recruited to 5′–3′ resected DSB ends [1]. Rad53 phosphorylation
can be analyzed by Western blotting, and the phosphorylation
is commonly used as a biochemical marker to test activation
of the Mec1-induced DNA damage checkpoint pathway. It has
been observed that the checkpoint signalling is switched off
12–15 h after the formation of one irreparable DSB. Concomitantly,
Rad53 becomes dephosphorylated and the cell cycle can restart in
the presence of a damaged chromosome [2]. This phenomenon is
Abbreviations: DSB, double strand break; MMS,  methyl methanesulfonate; HU,
hydroxyurea.
∗ Corresponding author. Tel.: +39 02 50315036; fax: +39 0250315044.
E-mail address: achille.pellicioli@unimi.it (A. Pellicioli).
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called checkpoint adaptation and it has also been observed in other
eukaryotic organisms in response to various types of DNA damage
and replication stress [3].  Interestingly, checkpoint adaptation has
been suggested to promote uncontrolled proliferation of cancer
cells, and may  play a role in the development of therapy-resistance
tumours. Therefore, a better understanding of the mechanisms
and factors involved in checkpoint adaptation is a relevant goal in
cancer biology, and it may  be useful to develop novel therapeutic
strategies. Notably, PLK1-like kinases promote checkpoint adap-
tation in multicellular eukaryotes [3],  and specific PLK1 inhibitors
are in clinical trials for cancer therapy [4].
Budding yeast has proven to be an ideal system for the study
of activation and inactivation of the DNA damage checkpoint and,
in particular, for analysis of checkpoint adaptation in the presence
of a single irreparable DSB lesion. A single DSB can be induced
at a specific locus through the conditional overexpression of HO
endonuclease. By using this genetic system, several proteins have
been implicated in checkpoint adaptation in yeast [1].  Among
these factors is Tid1 (also called Rdh54), a member of the Swi2-
like family, which includes proteins having dsDNA-dependent
ATPase activity that are able to translocate along a DNA molecule,
thus contributing to nucleosome remodelling around the DSB
1568-7864/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.dnarep.2013.02.004
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site. Moreover, these factors can supercoil and unwind DNA and
promote D-loop formation and branch migration in homologous
recombination processes [5].  A number of in vitro and in vivo data
indicate that Tid1 dissociates Rad51 recombinase from dsDNA,
thus preventing the accumulation of toxic Rad51-DNA interme-
diates and also ensuring that a sufficient amount of Rad51 will be
available for DSB repair and recombination [6].
Tid1 shares some molecular functions and mechanisms with
the Swi2-like homologs Rad54 and Usl1. However, they likely
have distinct functions, as indicated by the distinct phenotypes of
the corresponding mutants [6].  Tid1 plays major role in meiotic
recombination, while it is involved in minor pathway in mitotic
recombination, specifically in a diploid [7,8]. Interestingly, Tid1 has
been involved in checkpoint adaptation from a G2/M arrest induced
by an irreparable DSB [2].  To further address the functional role of
Tid1 in cells responding to DSB and in checkpoint adaptation, we
tested whether Tid1 protein is post-translationally regulated in the
presence of an irreparable DSB. We  found that Tid1 is phosphory-
lated by the Mec1 and Rad53 kinases, similar to other factors such
as Srs2, Rad51, Sae2, and Cdc5 involved in turning off Rad53 during
checkpoint adaptation [9–12]. Therefore, Tid1 belongs to a hetero-
geneous family of factors which are targets of the DNA damage
checkpoint pathway, and are involved in silencing the checkpoint
response in the presence of one irreparable DSB.
2. Materials and methods
2.1. Yeast strains
All strains are derivatives of JKM background (MAT  ˛ or MATa,
hml!::ADE1,  hmr!::ADE1 ade1-100, trp1!::hisG, leu2-3,  leu2-112,
lys5, ura3-52, ade3::GAL::HO), generously provided by J. Haber
(Brandeis University, Waltham, Boston). Y454 was  obtained by
integration of the 3XHA tag at the C-end of the TID1 locus
by the one-step PCR system [13]. Standard genetic procedures
for transformation and tetrad analysis were followed to con-
struct the various strains. Y841 was obtained by integrating
of NvuI-digested pHK255 plasmid into the TID1-3XHA locus in
Y454 strain. After pop-out by treatment with 5-FOA, the integra-
tion of the tid1-K318R mutation was confirmed by sequencing
analysis. In previous papers [14,15],  the K318R mutation was
indicated as K352R due to the annotation of an upstream ATG
start site. We  verified by DNA sequencing the ATG start codon
in the genetic background used here (data not shown). Y522
(MATa, mec1!,  TID1-3XHA) was obtained by crossing Y454 with
Y138 (MAT˛, mec1!); Y876 (MATa, mec1!,  tid1-K318R-3XHA)
was obtained by crossing Y841 with Y138 (MAT˛, mec1!); Y962
(MAT˛, rad53-K227A, TID1-3XHA) was obtained by crossing Y454
with Y677 (MAT  ˛ rad53-K227A); Y966 (MATa rad53-K227A tid1-
K318R-3XHA) was obtained by crossing Y841 with Y677 (MAT˛
rad53-K227A); Y741 (MATa, rad51!,  TID1-3XHA) was  obtained
by crossing Y623 (MAT˛, TID1-3XHA) with Y608 (MATa, rad51!);
Y873 (MATa, rad51!, tid1-K318R-3XHA) was obtained by crossing
Y841 with Y736 (MAT˛, rad51!);  Y1768 (MAT˛, dun1!,  TID1-
3XHA) was obtained by crossing Y623 with Y1741 (MATa, dun1!);
Y1769 (MAT˛, dun1!, tid1-K318R-3XHA)  was obtained by crossing
Y869 (MAT  ˛ tid1-K318R-3XHA) with Y1741; Y967 (MATa rad53-
K227A rdh54-K318R-3XHA) was obtained by crossing Y 869 with
Y677; Y1771 (MAT  ˛ chk1! rad53-K227A rdh54-K318R-3XHA) was
obtained by crossing Y967 with Y1061 (MAT  ˛ chk1!). Y811 was
obtained by integration of the 3XHA tag at the C-end of the
TID1 locus by the one-step PCR system in YMV80 background
[16]. All the strains used in this work are haploid; moreover, all
the mec1! strains also have the sml1! mutation, to keep cells
viable.
2.2. Western blot analysis
The TCA protein extraction and the Western blot procedures
have been previously described [17]. Rad53 and Tid1-3XHA pro-
teins were analysed using Mab.EL7 [17], and 12CA5 monoclonal
antibodies, respectively.
2.3. Immunoprecipitation analysis
Tid1-3XHA protein was  immunoprecipitated with the 12CA5
monoclonal antibody using a standard procedure. 2 ×109 cells
were resuspended in 400 !l of lysis buffer (50 mM Tris–HCl, 50 mM
NaCl, 60 mM "-glycerolphosphate, 1 mM DTT, 1 mM Sodium Ortho-
vanadate, 1% NP40, supplemented with protease inhibitor cocktail
(Roche)), and disrupted with glass beads by Fast Prep (MPBio).
Crude extracts were incubated for 2 h at 4 ◦C in the presence
of magnetic beads (Dynal), which were pre-incubated with the
12CA5 antibody. The beads were then washed with lysis buffer and
resuspended with 30 !l of Laemmli sample buffer. The immuno-
precipitates were analysed by Western blot using 12CA5 (anti-HA)
and anti-phospho-S/T-Q motifs antibody (Cell Signalling).
2.4. Cell synchrony and flow cytometry
Cells were pre-synchronized in G1 with #-factor (2 !g/ml) and
then released in fresh medium. Cells were arrested in G1  and G2/M
with #-factor (10 !g/ml) or nocodazole (15 !g/ml), respectively.
DNA content was analyzed by FACSCalibur (Bekton-Dickinson) and
Cell-Quest software (Bekton-Dickinson).
2.5. In vitro dephosphorylation assay
Crude extracts were prepared as described [18], and resus-
pended in $ phosphatase buffer with or without 4000 U of $
phosphatase (Biolabs). Samples were incubated 30 min  at 30 ◦C and
resuspended in Laemmli sample buffer.
2.6. Chromatin immunoprecipitation analysis (ChIP)
ChIP analysis was  performed as described previously [19]. Mul-
tiplex PCRs were carried out by using primer pairs complementary
to DNA sequences located 1 kb from the HO-cut site at MAT  (DSB)
and to DNA sequences located 66 kb from MAT  (CON). Gel quanti-
tation was  determined using the Quantity One program (Biorad).
The relative fold enrichments of DSB-bound protein were calcu-
lated as follow: [DSB IP/CON IP]/[DSB input/CON input], where IP
and Input represent the amount of PCR product in the immuno-
precipitates and in input samples before immunoprecipitation,
respectively.
3. Results
3.1. Tid1 is phosphorylated in response to DSB formation
In S. cerevisiae, it has been shown that Srs2, Rad51, Sae2 and Cdc5
factors are involved in DNA damage checkpoint inactivation and
adaptation, and that they are regulated through Mec1-dependent
phosphorylation in the presence of DSB lesions [9–12]. We tested
whether Tid1, a DNA translocase required for checkpoint adapta-
tion, was  specifically modified in response to a single irreparable
DSB. To visualize Tid1 on Western blots of crude yeast protein
extracts, we initially inserted a 3XHA tag sequence at the C-terminal
of the TID1 gene. The sensitivity of haploid cells carrying the
TID1::3XHA allele to various DNA damaging agents (the alkylating
agent methyl methanesulfonate (MMS), UV irradiation, bleocin,
camptothecin) was  similar to that of the wild type strain (data
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not shown), indicating that the presence of the 3XHA tag at the
C terminal of Tid1 does not affect the functionality of the protein.
We then tested the stability of Tid1 and the electrophoretic
mobility of the protein throughout the cell cycle. Protein sam-
ples were prepared from yeast cells, blocked in G1 phase by
!-factor treatment and released into fresh medium with or with-
out the ribonucleotide reductase inhibitor hydroxyurea (HU, 0.2 M)
or the DNA alkylating agent MMS,  0.02% (Fig. 1). As expected, the
HU-treated cells remained blocked into S-phase because of the
deprivation of dNTPs pools, and the MMS-treated cells delayed DNA
replication because of the activation of the DNA damage check-
point, while untreated cells progressed synchronously through S
phase and the mitotic transitions, as shown by the FACS pro-
files (Fig. 1 A, C and E). In parallel, cells were grown for 6 h in
medium containing galactose to overproduce the HO endonucle-
ase and induce the formation of a single irreparable DSB at the
MAT  locus and, as a consequence, cells activated the DNA damage
checkpoint and blocked in G2/M cell cycle phase [2].  Protein sam-
ples were prepared at the indicated time points and analysed by
Western blotting using anti-HA antibodies (Abs) to visualize Tid1
and anti-Rad53 Abs to test activation of DNA damage checkpoint
signalling. We  found that Tid1 is a stable protein throughout the cell
cycle, showing a modest increase in its level in early S-phase, likely
linked to increased gene expression during this cell cycle phase.
In the experimental conditions used here, we did not observe any
Tid1 electrophoretic mobility shift either in untreated or in HU- and
MMS-treated cells (Fig. 1B, D, F). Surprisingly, we  found that Tid1
migrated as a doublet band in protein samples prepared from cells
in which one irreparable DSB was induced by HO overexpression
([DSB] lane in Fig. 1B and D). The altered electrophoretic mobil-
ity of the upper band was reverted by in vitro treatment of the
protein sample with phosphatase, indicating that Tid1 was mod-
ified by phosphorylation (Fig. 1G). Interestingly, we also found that
Rad53 phosphorylation, which is used as a biochemical marker for
Mec1-dependent checkpoint activation, did not always correlate
with Tid1 phosphorylation; in fact, Rad53 is phosphorylated in HU-
and MMS-treated cells, while Tid1 is not modified in such condi-
tions (Fig. 1D and F). Tid1 has been identified in a proteome wide
screening for proteins phosphorylated in the presence of MMS  [20];
however, we can not see this modification by Western blotting
(Fig. 1F); therefore, we believe that the Tid1 phosphorylation we
observed in the presence of one irreparable DSB should be differ-
ent in respect to the one identified by mass spectrometry in the
presence of MMS,  suggesting the idea that Tid1 would be regulated
through distinct mechanisms in the presence of different types of
DNA damage.
Moreover, we found that the Tid1 protein, immunoprecipi-
tated from cells with one irreparable DSB, was recognized by
anti-phosphorylated S/T-Q motifs specific antibodies (Fig. 1F). It is
known that ATM/Tel1 and ATR/Mec1 kinases preferentially phos-
phorylate S/T-Q motifs in response to DNA damage [21], suggesting
that they could be likely involved in Tid1 phosphorylation following
a single irreparable DSB formation. Interestingly, in the presence of
MMS it was reported that Tid1 is phosphorylated at the S51 residue
[20], which is not a SQ motif, supporting the idea that MMS-induced
and DSB-induced Tid1 phosphorylation could be different.
3.2. Analysis of the HO-induced Tid1 phosphorylation
It is known that one irreparable DSB is processed and activates a
full Mec1-dependent checkpoint pathway in G2-blocked cells, but
not in G1-blocked cells [22,23], thus we tested Tid1 and Rad53
phosphorylation in cells treated with !-factor or nocodazole to
block the cell cycle in G1 or G2 phases, respectively. We  found
that Tid1 is not phosphorylated after one irreparable DSB induced
in G1-blocked cells, while its phosphorylation is accumulated in
G2-blocked cells, following the formation of one irreparable DSB
and the activation of Rad53 (Fig. 2A). We  then analysed Tid1 phos-
phorylation in a specific genetic background (YMV80), where the
conditional overproduction of HO nuclease induces the formation
of one DSB that can be repaired through a single strand annealing
process (SSA). As previously reported [16], in these cells the accu-
mulation of long ssDNA tails at the resected DSB elicits a robust
Rad53 phosphorylation, which is reverted after the DSB has been
completely repaired (Fig. 2B). Similarly to Rad53, we  found that
Tid1 is phosphorylated during the prolong SSA process (Fig. 2B),
and its phosphorylation disappears during the checkpoint recov-
ery, accordingly with the idea that Tid1 protein is a target of the
DSB-induced checkpoint signalling.
3.3. Phosphorylation of the ATPase-inactive Tid1 protein variant
The ATPase activity of Tid1 is essential for its function during
recombination and checkpoint adaptation [15,24]. We  thus tested
whether Tid1 ATPase activity was required for the DSB-induced
phosphorylation of the protein. To this purpose, the site specific
K318R mutation, which is known to abrogate the ATPase activ-
ity of the catalytic domain of Tid1 [15], was introduced into the
TID1::3XHA locus. As expected [24,25], tid1-K318R cells were sen-
sitive to MMS  and did not adapt to a single irreparable DSB (data
not shown).
HO endonuclease was overproduced in wild type and tid1-
K318R cells to induce the formation of one irreparable DSB, and
the phosphorylation state of both Tid1 and Rad53 proteins was
analysed by Western blotting at several time points after the
DSB formation (Fig. 3A). We  found that in wild type cells, the
HO-induced Tid1 phosphorylation parallels the Mec1-dependent
activation of Rad53 and disappears at late time points during check-
point adaptation. Similar to what was observed in wild type cells,
the Tid1-K318R protein variant started to be phosphorylated 3 h
after HO induction. However, at longer time points, essentially all
the protein was modified and it remained phosphorylated until
the end of the experiment, mirroring the extend of Rad53 activa-
tion, which was not dephosphorylated in the adaptation-defective
tid1-K318R cells. Moreover, the electrophoretic mobility shift of the
phosphorylated Tid1-K318R variant at 6–9 h after the HO induction
appeared slightly higher than that observed for the wild type pro-
tein, while both proteins had the same electrophoretic mobility in
undamaged conditions.
The results described above prompted us to test whether Mec1,
the main protein kinase responding to DSB lesion in budding yeast,
is required for Tid1 phosphorylation. We  deleted the MEC1 gene
both in TID1::3XHA and tid1-K318R::3XHA strains, also carrying
deletion of SML1 gene to keep the cells viable. The HO gene was
overexpressed in these strains to induce the formation of one
irreparable DSB and samples were taken at various time points
to analyse the phosphorylation state of both Tid1 and Rad53. As
shown in Fig. 3B and C, the HO-induced modification of the wild
type Tid1 and the Tid1-K318R variant are completely abrogated in
mec1! cells, supporting the notion that Tid1 is regulated through
Mec1-dependent phosphorylation in the presence of DSB lesions.
We  then analysed Tid1 phosphorylation in G2-blocked cells
treated with 4-Nitroquinoline-1-oxide (4NQO, an oxidizing agent
that also acts as UV mimetic) and zeocin (a DSB inducing agent).
Wild type and mec1! cells were treated with nocodazole to block
cell cycle in G2 phase, then 4 "g/ml 4NQO or 10 "g/ml zeocin
were added to the cultures, as indicated in Fig. 3D.  We  found
that both Tid1 and Tid1-K318R variant were phosphorylated in
a Mec1-dependet manner in the presence of 4NQO and zeocin in
G2-blocked cells, suggesting that Tid1 is phosphorylated in the
presence of multiple DNA lesions induced by zeocin and 4NQO
treatments. Moreover, as 4NQO not only causes DNA adducts
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Fig. 1. Analysis of Tid1 protein with or without DNA damage throughout the cell cycle. (A–F) An exponentially growing culture of the strain Y454 (wild type, TID1-3XHA)
was  grown in YEP + raffinose and pre-synchronized in G1 by !-factor (!F) treatment and released from the G1 block in fresh medium with/without 0.2 M HU or 0.02% MMS.
(A,  C, E) Samples were taken at the indicated time points to test FACS profiles. (B, D, F) Protein extracts were prepared and analysed by Western blot using 12CA5 (anti-HA)
and  Ma.EL7 (anti-Rad53) antibodies. Moreover, one part of the original culture was also split and treated with 2% galactose for 6 h to induce the overexpression of HO and
the  formation of one irreparable DSB; as a consequence, cells remained blocked in G2/M cell cycle phase (data not shown). Protein extract, labelled [DSB], was analysed in
the  same gels (B and D). (G) Protein extracts obtained after DSB formation (similarly to the lane [DSB] in B and D) were treated with " phosphatase before gel electrophoresis
and  tested with 12CA5 (anti-HA) antibody. (H) Exponentially growing culture of the strain Y454 (wild type, TID1-3XHA) was grown in YEP + raffinose and synchronized at
G2/M  transition by nocodazole. Half of the culture was  treated with galactose for 6 h to ensure DSB formation. Tid1-3XHA was  isolated by immunoprecipitation with anti
HA  antibody and phosphorylation on SQ/TQ motifs tested by Western blot with anti pSQ/pTQ antibody (Cell Signalling).
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Fig. 2. Kinetic analysis of Tid1 phosphorylation in the presence of one HO-induced
DSB throughout the cell cycle. (A) An exponentially growing culture of the JKM-
background strain Y454 (wild type, TID1-3XHA) was  grown in YEP + raffinose. Half
of  the culture was treated with !-factor (!F) to block cell cycle in G1 phase; the
other part was  treated with nocodazole (N) to block the cell cycle in G2 phase. 2%
galactose was added (time zero) to induce the formation of one irreparable DSB
and samples were taken at the indicated time points. (B) An exponentially growing
culture of the YMV80-background strain Y811 (wild type, TID1-3XHA) was  grown
in  YEP + raffinose. 2% galactose was added (time zero) to induce the formation of
one repairable DSB and samples were taken at the indicated time points. Protein
extracts were prepared and analysed by Western blot using 12CA5 (anti-HA) and
Ma.EL7 (anti-Rad53) antibodies.
similarly to UV, but can also induce the formation of DSB lesions,
it is possible that the Tid1 phosphorylation we observed in 4NQO-
treated cells may  be due to DSBs as well. Accordingly with previous
results with the HO-induced DSB in Fig. 2A, we also found that the
mobility shift of the Tid1-K318R variant in the presence of 4NQO
and zeocin is higher than that seen in the wild type protein.
In summary, the Tid1 ATPase activity, although essential for
its functional role in recombination and checkpoint adaptation, is
not required to promote its DSB-induced phosphorylation. More-
over, in agreement with previous evidence showing that the ATPase
activity of Tid1 is essential to restart cell cycle progression in the
presence of one irreparable DSB [24], we found that this activ-
ity is required to mediate Rad53 inactivation during checkpoint
adaptation.
3.4. Genetic requirement for the Tid1 phosphorylation
We further tested whether Rad53, which is one of the main
protein kinases activated by Mec1, and Dun1, that is a protein
kinase activated by Rad53 itself [1],  were required for Tid1
phosphorylation. We  deleted the DUN1 gene and generated the
kinase inactive rad53-K227A allele both in TID1::3HA and tid1-
K318R::3HA strains. The HO gene was  overexpressed in these
strains to induce the formation of one irreparable DSB and samples
were taken at various time points to analyse the phosphorylation
state of both Tid1 and Rad53. As shown in Fig. 4A, the HO-induced
modification of wild type Tid1 and the Tid1-K318R variant are not
affected in dun1! cells. Interestingly, the rad53-K227A mutation
does not affect the HO-induced phosphorylation of the wild type
Tid1 protein (Fig. 4B). However, the hyper-phosphorylation state
of the Tid1-K318R variant is not seen in the rad53-K227A mutant,
and the phosphorylation state of the Tid1-K318R protein variant
was similar to that observed for the wild type protein. These
results, together with previous findings in Fig. 1, suggest that both
Mec1 and Rad53 kinases are involved in the HO-induced Tid1
phosphorylation, but the Rad53 contribution becomes evident only
when the ATPase-inactive Tid1-K318R variant is analyzed, raising
specific questions on the functional regulation of Tid1, as it will be
discussed below. We  also tested whether Chk1, which is another
kinase activated by Mec1 [1],  was  responsible for the residual Tid1
phosphorylation observed in the double mutant rad53-K227A
tid1-K318R cells. To this aim, we  generated the deletion of CHK1
gene in the rad53-K227A cells, carrying the tid1-K318R::3HA allele,
and induced one irreparable DSB as in previous experiments. We
found that the residual phosphorylation of the Tid1-K318R variant
is still present in the triple mutant tid1-K318R rad53-K227A chk1!
(Fig. 4C), further supporting the idea that it could be mediated by
Mec1.
It is known that Tid1 is recruited to a DSB through its inter-
action with Rad51 [14]. We  thus tested whether Rad51 had any
contribution to the HO-induced Rdh54 phosphorylation. Again
we overexpressed the HO gene to induce the formation of one
irreparable DSB in wild type and rad51!  cells, carrying the
TID1::3HA or tid1-K318R::3HA alleles. As shown in Fig. 4D, the
DSB-induced phosphorylation of wild type Tid1 is not completely
compromised in the absence of Rad51, although it appeared to
be delayed. Interestingly, we found that hyper-phosphorylation of
the Tid1-K318R variant is impaired in rad51! cells, with a resid-
ual phosphorylation migrating as the wild type protein (Fig. 4D).
This result recapitulates what we found when Rad53 activity was
impaired by the rad53-K227A mutation, suggesting that Rad53 and
Rad51 may  contribute to a common mechanism required for Tid1
hyper-phosphorylation. Moreover, we noticed that Rad53 phos-
phorylation is persistent in the double mutant tid1-K318R rad51!,
accordingly with the notion that the deletion of RAD51 gene
does not rescue the checkpoint adaptation defect of tid1 mutant
cells [24,26].
3.5. Mec1-checkpoint mediates recruitment of Tid1 near to a DSB
We have shown that the Mec1-dependent checkpoint medi-
ates Tid1 phosphorylation in the presence of one DSB. However,
activation of the Mec1 and Rad53 kinases is not enough per se
to induce such Tid1 phosphorylation since this protein is not
modified in response to DNA replication stress induced by HU  and
MMS  treatments (Fig. 1). Moreover, Tid1 hyper-phosphorylation
requires the Rad51 recombinase (Fig. 4C), which also mediates
Tid1 recruitment to the DSB lesion [14]. One possibility is that Tid1
is phosphorylated at the DSB site, and this modification may  some-
how reinforce the binding of the protein to DNA. We  thus tested by
chromatin immunoprecipitation (ChIP) whether the Mec1 kinase
was also implicated in Tid1 loading near a single irreparable DSB.
To this end, we recovered Tid1 protein from sheared chromatin
prepared from formaldehyde crosslinked cells, at different time
points after DSB formation (Fig. 5). Quantitative multiplex PCR
was then used to monitor the co-immunoprecipitation of DNA
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Fig. 3. Mec1-dependent phosphorylation of the wild type Tid1 and the ATPase-defective Tid1-K318R variant. (A) Exponentially growing cultures of the JKM-background
strains Y454 (wild type, TID1-3XHA) and Y841 (tid1-K318R-3XHA) were grown in YEP + raffinose. 2% galactose was added (time zero) to induce the formation of one irreparable
DSB  and samples were taken at the indicated time points. (B) Exponentially growing cultures of the JKM-background strains Y454 (wild type, TID1-3XHA), Y841 (tid1-K318R-
3XHA), Y522 (mec1!, TID1-3XHA) and Y876 (mec1!, tid1-K318R-3XHA), were grown in YEP + raffinose. 2% galactose was  added (time zero) to induce the formation of one
irreparable DSB and samples were taken at the indicated time points. (C) Exponentially growing cultures of the same strains described in (B), were grown in YPD and treated
with  nocodazole (N) to block cell cycle in G2 phase. Each culture was split in 3 parts and treated for 30 min  with/without 4 !g/ml 4-Nitroquinoline-1-oxide (4NQO) or
10  !g/ml zeocin. Samples were taken at the indicated time points to determine FACS profiles. Protein extracts were prepared and analysed by Western blot using 12CA5
(anti-HA) and Ma.EL7 (anti-Rad53) antibodies.
fragments located either 1 Kb (DSB) or 66 Kb (CON) from the
HO-cut site. PCR analysis of the CON site was used as a control
of the background signal, as previously described [19]. Firstly, we
found that the Tid1-K318R is recruited to the DSB site (Fig. 5),
indicating that the ATPase activity is dispensable for recruitment
of the protein. Interestingly, we noticed that the loading of the
Tid1-K318R variant was significantly higher than that of the wild
type protein, especially at late time points after the induction of the
DSB, and this slight accumulation may  be due to an impairment
of the catalytic defective protein variant to move along DNA
molecules, as showed by previous in vitro assays [27].
Next we  tested the binding to one DSB of both Tid1 and
Tid1-K318R to a DSB in mec1! cells. As shown in Fig. 5, we  found
that loading of Tid1 near the DSB is significantly reduced in mec1!
cells. This defect is particularly evident for the Tid1-K318R variant,
whose binding is normally higher compared to the wild type
protein. Therefore, the Mec1-dependent checkpoint contributes,
together with Rad51, to mediate the Tid1 recruitment. Among
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Fig. 4. Rad53 and Rad51 mediate Tid1 phosphorylation in the presence of one HO-induced persistent DSB. (A–D) Exponentially growing cultures of the JKM-background
strains  Y1768 (dun1!, TID1-3XHA), Y1769 (dun1!, tid1-K318R-3XHA), Y962 (rad53-K227A, TID1-3XHA), Y966 (rad53-K227A tid-K318R-3XHA), Y841 (tid1-K318R-3XHA),
Y1771 (rad53-K227A, chk1! tid1-K318R-3XHA), Y741 (rad51!, TID1-3XHA), Y873 (rad51!, tid1-K318R-3XHA), were grown in YEP + raffinose. 2% galactose was added (time
zero)  and samples were taken at the indicated time points. Protein extracts were prepared and analysed by Western blot using 12CA5 (anti-HA) and Ma.EL7 (anti-Rad53)
antibodies.
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Fig. 5. Recruitment of Tid1 protein to a HO-induced persistent DSB. YEP + raffinose nocodazole-arrested cell cultures of the JKM-background strains Y454 (wild-type, TID1-
3XHA),  Y841 (tid1-K318R-3XHA), Y522 (mec1!, TID1-3XHA), Y876 (mec1!, tid1-K318R-3XHA), were transferred to nocodazole-containing YEP + raffinose + galactose (time
zero),  to induce the formation of one irreparable DSB. Cells were collected at the indicated time points and then subjected to chromatin immunoprecipitation analysis. The
graph  represents the results from four independent experiments.
various possibilities, we favour the idea that Tid1 protein is
recruited to the DSB through its interaction with Rad51, as was
previously showed by others [14]. Then the Tid1 function at
the DSB site may  be regulated through Mec1 and Rad53 phos-
phorylation events, which may  affect its ATPase and translocase
activities. Identification and characterization of the specific Tid1
phosphorylated sites will shed light on this mechanism.
4. Discussion
The Tid1 protein of S. cerevisiae cells has been implicated in sev-
eral molecular pathways including DNA recombination, DSB repair
and checkpoint adaptation. It has been reported that Tid1 is an in
vitro target of the meiotic checkpoint kinase Mek1 [28], and that
it is phosphorylated in the presence of DNA alkylating agent MMS
[20]; however, regulation of Tid1 protein has been poorly stud-
ied. Here we show that Tid1 is phosphorylated in the presence
of one DSB and, based on the different electrophoretic mobility
shifts (see Fig. 1), this phosphorylation appears to be different
from that observed in MMS-treated cells [20]. In our experimen-
tal conditions, the DSB ends are extensively resected and a long
ssDNA filament is generated. As a consequence, Mec1 and Rad53
kinases are activated and the DNA damage checkpoint signalling
contributes to block cell cycle progression in metaphase. Suppor-
ting this model, we did not observe Tid1 phosphorylation after one
DSB induced in G1-blocked cells (Fig. 2A), in which DSB ends are
not efficiently processed and Mec1-signalling is not fully active
[22,23]. Moreover, Tid1 phosphorylation decreases both during
checkpoint recovery and adaptation, in response to one repairable
and irreparable DSB (Figs. 2B and 3A). Indeed, our genetic and bio-
chemical evidences support the idea that the DSB-induced Tid1
phosphorylation is mediated by the Mec1 and Rad53 kinases.
Accordingly to the protein sequence, Tid1 has several potential
Mec1 and Rad53 phosphorylation motifs, suggesting that Tid1 pro-
tein can be directly phosphorylated by both Mec1 and Rad53. In
agreement with this possibility, we found that in response to one
irreparable DSB, immunoprecipitated Tid1 protein is recognized by
specific antibodies directed against phosphorylated S/T-Q motifs
(Fig. 1F), which are often phosphorylated by ATM/Tel1, ATR/Mec1
and Rad53 [20,21,29].  We  do not know yet which Tid1 sites are
phosphorylated, although we are trying to address this issue by
mass spectrometry analysis of the sites phosphorylated in vivo in
response to DSBs.
It is known that ATPase activity is essential for the functional
role of Tid1 in DSB repair, recombination and checkpoint adap-
tation [14,15,24].  However, here we have shown that the ATPase
activity of Tid1 protein is dispensable for its initial recruitment near
an irreparable DSB and that the same is true for Mec1-dependent
Tid1 phosphorylation. We  also observed that the ATPase defective
Tid1-K318R variant is heavily hyper-phosphorylated, and this mod-
ification is abrogated in rad53 and rad51 mutants. It is tempting to
speculate that the Tid1-K318R variant, after being loaded near the
lesion through the interaction with Rad51, remains in a “frozen”
and Rad53-mediated hyper-phosphorylated state. In this condi-
tion the catalytic-defective Tid1-K318R variant cannot translocate
along the DNA filament [27], and we observed a slightly higher
accumulation at the DSB site (Fig. 5). However, our results cannot
exclude the possibility that the wild type Tid1 protein may become
phosphorylated by Rad53-mediated reactions. In fact, because of
its ATPase activity, Tid1 would likely translocate along the DNA  in
a highly dynamic way, perhaps undergoing a faster kinetic load-
ing and dislodging from the DNA, making Rad53-dependent Tid1
phosphorylation very transient and, therefore, very difficult to be
detected by Western blotting.
Our results raise the possibility that phosphorylation of Tid1
protein is relevant to mediate its efficient loading near the DSB
site, and the identification and mutation of the specific Tid1 phos-
phorylated sites will shed light on this mechanism. Alternatively,
or in addition, as the phosphorylation and binding to DSB of Tid1
protein are not completely abrogated in rad51! cells (Fig. 4 and
[14]), we could also hypothesize a two-step Tid1 phosphorylation
mechanism. Firstly Mec1 phosphorylates Tid1 at the DSB  site and
then after Tid1 has been engaged in a Rad51-dependent interme-
diate on the DNA, it is phosphorylated by Rad53. It is possible that
Mec1- and/or Rad53-dependent phosphorylation mediates a func-
tional interaction between Tid1 and Rad51, which, in turn, may
mediate efficient binding of Tid1 near the DSB. Interestingly, in
meiotic yeast cells, a Mek1-dependent phosphorylation of Rad54
(a Tid1 homologue), affects its interaction with Rad51 and mei-
otic recombination outputs [28], suggesting that a fine regulation
of Rad51 protein complexes is a fundamental step to modulate
DNA recombination and DSB repair. In addition, rad51!  cells, as
well as tid1! and tid1! rad51! mutants, do not adapt to a single
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irreparable DSB [24], suggesting that the functional interac-
tion between Tid1 and Rad51 is important to recruit Tid1 onto
irreparable DSB, allowing the checkpoint adaptation process.
Indeed, we found that the hyper-phosphorylation of Tid1-K318R
variant is abrogated in rad51!  cells, despite the fact that Rad53
phosphorylation is persistent (Fig. 4D), according to previous evi-
dences [24,26],  showing checkpoint adaptation defect in the tid1!
rad51! double mutant cells. The functional role of Tid1 in check-
point adaptation is mediated by its ATPase/translocase activity and
may  be linked to its capacity to remodel nucleosomes and dislocate
Rad51 and/or other factors from dsDNA [5].  Indeed, it is known that
specific nucleosome modifications mark several kilobases around
a DSB and, surprisingly, a chromosome-wide spreading of Rad51
molecules was described starting from a persistent DSB [30].
In conclusion, we have shown that Tid1 is a stable protein
throughout the cell cycle, and is phosphorylated in the presence
of one irreparable DSB through Mec1 and Rad53 kinases. The accu-
mulation of the phosphorylated state correlates with the binding of
the protein to the DSB site, which is mediated by Mec1 and Rad53
kinases and Rad51 recombinase [14]. The ATPase activity of Tid1
is dispensable for the recruitment to the DSB and the phosphory-
lation of the protein, but it is necessary for the functional roles of
Tid1 at the DSB site. Further biochemical and genetic analyses will
be required to fully clarify the functional regulation of Mec1- and/or
Rad53-dependent phosphorylation of Tid1, and to understand its
role in checkpoint adaptation.
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Supplementary Figure 1: Schematic representation of the GST-PBD-6XHis resin preparation. The fusion 
polypeptide was expressed in the E. coli strain BL21 CodonPlus, after induction with IPTG 0,5 mM, at 37°C for 
2 hours. Cells were broken with lysozyme and sonication treatments, then the obtained cell crude extract was 
passed trough a Ni-NTA resin in a column (1). Then the polypeptides bound to the resin were eluted by 
imidazole treatment (2), and incubated with a glutathione-sepharose resin (3). The resin was checked by western 
blot with anti-GST antibody and Coomassie staining. In the lane 4 of the gel, a resin obtained only after 
glutathione-sepharose incubation was loaded in order to compare it with the two steps purification method. 
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Supplementary Figure 2: Schematic representation of the screening procedure. The GST-PBD-6XHis resin 
was incubated for 2 hours at 4°C with yeast cell crude extract obtained by DNA damaged cells. After that the 
resin is boiled in Laemmly Buffer and run on a SDS-PAGE. Gel slices containing the putative interacting 
proteins were cut (red squares) and treated with trypsin in order to obtain the proteins peptides required for the 
mass spectrometry analysis. 
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Supplementary Figure 6: Interactions network of the factors identified after 6 hours induction of one 
irreparable DSB by the HO endonuclease (see text for details). 
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Supplementary Figure 4: Interactions network of the factors identified after 12 hours induction of one 
irreparable DSB by the HO endonuclease (see text for details). 
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Supplementary Figure 5: Interactions network of the factors identified after a 3 hours treatment with the 
alkylating agent MMS (see text for details). 
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Supplementary Figure 6: Protein levels of various Sae2 variants. Cells of the strains: sae2Δ, SAE2-3HA, 
sae2-S134A-S179A-S267A-3HA (sae2-3Ala), sae2-S134A-3HA, sae2-S179A-3HA, sae2-S267A-3HA, were 
treated with Nocodazole (N) to induce a cell cycle arrest in G2, or with galactose (G) to induce the formation of 
one irreparable DSB. The samples indicated with L (log) represent the protein extract obtained for exponentially 
growing cells. Crude protein extracts were done and analysed by monoclonal antibodies 12CA5 (αHA). The 
asterisk indicates an unspecific background detected by the 12CA5 Mab. 
	  
	  
	  
	  
Supplementary Figure 7: The Sae2-3Ala protein variant still interacts by pulldown with the Cdc5-PBD. 
Crude extracts of the indicated strains were prepared from exponentially growing cells, and then incubated with 
the GST or GST-PBD-6XHis resins for 2 hours at 4°C. The Input and the eluate were analysed by Western Blot 
using monoclonal antibodies 12CA5 (αHA), and αGST. The arrows indicate the proteins of interest while the 
asterisks indicate an unspecific background detected by the 12CA5 Mab. 
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Supplementary Figure 8: Western blot analysis of the Pulldown effectuated with the Sae2 truncated 
forms. (A) Schematic representation of all the sae2 truncated form used in the pulldown experiments. (B) The 
protein extracts obtained from exponentially growing cells of the strains sae2ΔC170, sae2ΔC225, sae2ΔC255 
and SAE2-3HA were incubated with GST and GST-Cdc5PBD resins for 2 hours at 4°C, then the eluates were 
analysed by SDS-PAGE and western blot using antibodies 12CA5 for the sae2ΔC255 or SAE2-3HA while for 
the sae2ΔC170 and sae2ΔC225 α-FLAG antibodies were used. (C) In order to produce the sae2 N-terminal 
truncated forms, cells of the strains sae2ΔN100, sae2ΔN180 and sae2ΔN250, in which the expression of the 
protein is induced under GAL1 promoter,  and SAE2-3HA were grown in YP+Raffinose overnight, then cells 
were incubated with galactose for 2 hours and protein extracts were prepared. After that the extracts were 
incubated with GST or GST-Cdc5PBD resins and the obtained eluates were analysed by SDS-PAGE and 
western blot with α-HA (12CA5). 
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Supplementary Figure 9: sae2Δ  cells survive to a DSB through a Rad51-dependent pathway. YMV80 and 
isogenic sae2Δ, sae2Δrad51Δ and rad51Δ strains were grown overnight in YP+Raffinose. The cells culture 
concentrations were set to 1x107 cells/ml, and the cells were spotted by a serial dilution on YP+Raffinose and 
YP+Galactose plates and incubated at 28 °C for 2 days. 
	   	  
 Wild Type 
sae2Δ 
sae2Δ rad51Δ 
rad51Δ 
Raffinose Galactose 
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Supplementary Figure 10: Cells viability of various sae2 mutants in the presence of one DSB or 
camptothecin. YMV80 and isogenic strains sae2Δ, sae2-S134A, sae2-S179A, sae2-S267A, sae2-S134A-S267A 
and sae2-3Ala were grown overnight in medium containing raffinose. The cells culture concentrations were set 
to 1x107 cells/ml, and the cells were spotted by a serial dilution on YP+Raffinose and YP+Galactose plates (A), 
or in plates containing the indicated concentration of camptothecin (CPT) (B). The plates were incubated at 28°C 
for 2 days. 
	  
	   	  
 Wild Type 
sae2-S134A 
sae2Δ 
sae2-S134A-S267A 
sae2-3Ala  
sae2-S179A 
sae2-S267A 
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 Wild Type 
sae2-S134A 
sae2Δ 
sae2-S134A-267A 
sae2-3Ala  
sae2-S179A 
sae2-S267A 
DMSO 1% CPT 1,5 µg/ml CPT 3 µg/ml CPT 4,5 µg/ml 
A 
B 
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Supplementary Figure 11: Deletion of RAD9 suppresses the sae2Δ  and sae2-3Ala sensitivity to one DSB. 
YMV80 and isogenic sae2Δ, sae2Δrad9Δ and rad9Δ strains were grown overnight in YP+Raffinose. The cells 
culture concentrations were set to 1x107 cells/ml, and the cells were spotted by a serial dilution on YP+Raffinose 
and YP+Galactose plates and incubated at 28 °C for 2 days. 
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sae2Δ rad9Δ 
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Supplementary Figure 12: Deletion of RAD9 accelerates DSB repair through SSA in sae2Δ  and wild type 
cells. (A) Map of the YMV80 chromosome 3 region containing the HO-cut sites flanked by the LEU2 
homologous sequence spaced 25 kb. The genomic DNA digested with Kpn I and analysed by Southern blotting 
with a specific LEU2 probe shows 2 fragments before the HO cut (parental U2 and parental leu2). After DSB 
induction, the parental U2 band disappears and a faster migrating band appears at the bottom of the gel (HO cut 
band). Later the repair of the lesion by SSA or BIR leads to the appearance of the product band. (B) YP-
Raffinose exponentially growing YMV80 and isogenic sae2Δ, rad9Δ and sae2Δrad9Δ strains were blocked in 
G2 with nocodazole (time 0), then galactose was added to induce to HO cut and, at the indicated time point, cell 
samples were collected and genomic DNA prepared. Then the genomic DNA samples were subjected to 
Southern blotting analysis as described in (A). 
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Supplementary Figure 13: RAD51-dependent pathway is not involved in the sae2Δrad9Δ  cells viability in 
the presence of one DSB. YMV80 and isogenic sae2Δ, sae2Δrad9Δ, sae2Δrad9Δrad51Δ, sae2Δrad51Δ and 
rad51Δ strains were grown overnight in YP+Raffinose. The cells culture concentrations were set to 1x107 
cells/ml, and the cells were spotted by a serial dilution on YP+Raffinose and YP+Galactose plates and incubated 
at 28 °C for 2 days. 
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sae2Δ rad9Δ 
sae2Δ 
sae2Δ rad51Δ 
rad51Δ 
  135 
	  
Supplementary Figure 14: Inactivation of Rad53 kinase activity or deletion of DDC1 does not suppress the 
sae2Δ  sensitivity to one DSB. YMV80 and isogenic ddc1Δ, ddc1Δ sae2Δ, rad53-K227A, rad53-K227A sae2Δ, 
sae2Δ and sae2Δ rad9Δ strains were grown overnight in YP+Raffinose. The cells culture concentrations were set 
to 1x107 cells/ml, and the cells were spotted by a serial dilution on YP+Raffinose and YP+Galactose plates and 
incubated at 28 °C for 2 days. 
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Supplementary Figure 15: Deletion of RAD9 suppresses mre11 nuclease defective mutants sensitivity to 
one DSB. YMV80 and isogenic rad9Δ, mre11-D16A, mre11-D56A, mre11-D16A rad9Δ, mre11-D56A rad9Δ 
strains were grown overnight in YP+Raffinose. The cells culture concentrations were set to 1x107 cells/ml, and 
the cells were spotted by a serial dilution on YP+Raffinose and YP+Galactose plates and incubated at 28 °C for 
2 days. 
	  
	  
Supplementary Figure 16: EXO1-dependent pathway is not involved in the sae2Δrad9Δ  cells viability in 
the presence of one DSB. YMV80 and isogenic sae2Δ, sae2Δ rad9Δ, sae2Δ rad9Δ exo1Δ strains were grown 
overnight in YP+Raffinose. The cells culture concentrations were set to 1x107 cells/ml, and the cells were 
spotted by a serial dilution on YP+Raffinose and YP+Galactose plates and incubated at 28 °C for 2 days. 
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Supplementary Figure 17: SGS1-dependent pathway is involved in the sae2Δrad9Δ  cells viability in the 
presence of one DSB. YMV80 and isogenic sae2Δ, sgs1Δ, sgs1Δ rad9Δ, sae2Δ rad9Δ sgs1Δ strains were grown 
overnight in YP+Raffinose. The cells culture concentrations were set to 1x107 cells/ml, and the cells were 
spotted by a serial dilution on YP+Raffinose and YP+Galactose plates and incubated at 28 °C for 2 days. 
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